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Summary
Introducing genetic modifications into model organisms is of fundamental impor-
tance for unraveling the molecular mechanisms underlying physiological and patho-
logical processes. Over the last decades a wide range of technologies for manip-
ulating the mouse genome have been developed and as a result of their success
the laboratory mouse is one of the most widely used animal models in biomedical
research today.
One approach is pronuclear microinjection of linear recombinant DNA fragments
into the fertilized oocyte. Integration of these fragments at a random position within
the mouse genome allows the generation of mouse lines that overexpress proteins
encoded by these transgenes.
Other genome engineering objectives such as abolishing the expression of a gene
(a gene knock-out) require the targeted modification of a defined DNA sequence.
This can be achieved by introducing an extrachromosomal genetic construct into
mouse embryonic stem cells, which acts as a substrate for homologous recombi-
nation with the genomic locus of choice. Successfully engineered stem cell clones
are subsequently used to generate chimeric founder animals for establishing a new
transgenic mouse line.
Gene knock-out eliminates the expression of genes in all embryonic and adult tis-
sues, however, the complete disruption of certain genes elicits a lethal phenotype.
As an alternative, conditional gene knock-out has been introduced, which abrogates
gene expression in a limited subset of tissues. Here, a functionally important seg-
ment of a gene is flanked by recognition sites for the site-specific recombinase Cre
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(loxP sites). The expression of Cre under the control of a tissue-specific promoter
is restricted to certain developmental stages and cell lineages, in which the loxP-
flanked segment is excised resulting in gene knock-out. Furthermore, conditional
transgenesis can be used to activate a traceable marker such as a fluorescent pro-
tein in precursor cells and determine the fate of their progeny cells (lineage tracing).
The general goal of this thesis was the development and validation of technologies
for engineering the mouse genome with an unprecedented degree of precision and
thereby overcoming major limitations of classic gene-targeting and conditional trans-
genesis.
Chapter 1 introduces Binary Recombinases, a class of advanced conditional trans-
genesis systems for controlling Cre expression by any pair of tissue-specific promot-
ers. Two alternative Binary Recombinases, Co-Driver and Co-InCre, were estab-
lished, which employ a sequential and a coincidental mechanism for dual-promoter
control of Cre production, respectively. The Co-Driver cascade consists of the re-
combinase Dre, which activates a Dre-dependent Cre variant, Roxed-Cre, by excis-
ing a transcriptional and translational terminator from the Cre protein-coding DNA
sequence. Co-InCre comprises two inactive Cre fragments, which reconstitute full-
length Cre upon co-expression by the means of seamless protein trans-splicing. Co-
Driver- and Co-InCre-mediated Cre activity was strictly dependent on the presence
of both binary components and facilitated highly efficient processing of reporter
genes in transfected cell lines and in cells of the developing mouse brain. Addi-
tionally, Co-Driver allowed for the first time to generate two clearly distinguishable
patterns of Cre activation by linking two tissue-specific promoters sequentially in
“forward” and “reverse” orientation.
Chapter 2 outlines experiments with the aim of harnessing the DNA double-strand
break repair machinery in mouse embryos and cultured human cells for gene knock-
out and targeted integration of transgenes. Custom-designed zinc finger nucleases
(ZFN) and transcription activator-like effector nucleases (TALEN) were microinjected
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into fertilized mouse oocytes resulting in homologous recombination between target-
ing constructs and the ROSA26 locus and mutagenesis of the prion protein gene
(Prnp) by non-homologous end joining, respectively. All engineered genetic alleles
were efficiently transmitted to the offspring of founder animals. Prion protein (PrPC)
expression was successfully eliminated in C57BL/6 mice carrying a TALEN-induced
frameshift mutation in both alleles of the Prnp gene. In a third approach in HEK293T
cells, both copies of the human PRNP gene were successfully modified by using the
clustered regularly interspaced short palindromic repeat (CRISPR) platform.
Binary recombinases and genome editing technologies enable the generation of
sophisticated conditional transgenesis models with a defined genetic background.
These models will accelerate the dissection of cell lineage relationships and will
support the functional analysis of so far elusive proteins and cell types.
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Zusammenfassung
Die Veränderung genetischer Information in Modelorganismen ist von zentraler Be-
deutung für das Erforschen molekularer Mechanismen, die physiologischen und pa-
thologischen Prozessen zu Grunde liegen. Eine Vielzahl an Technologien zur gene-
tischen Manipulation des Mausgenoms wurden über die letzen Jahrenzehnte entwi-
ckelt. Auf Grund des Erfolgs dieser Methoden ist die Labormaus heute eines der
meist verwendeten Tiermodelle.
Einer dieser Technologien ist die pronukleare Mikroinjektion von linearen rekombi-
nanten DNA Fragmenten in befruchtete Oozyten. Durch Integration dieser Fragmen-
te an zufälligen Positionen im Mausgenom können Mauslinien generiert werden,
welche Proteine mittels dieser Transgene überexprimieren.
Andere Zielsetzungen der genetischen Manipulation, wie zum Beispiel das Elimi-
nieren der Expression eines Gens (der Gen Knock-out), setzen das gezielte Mo-
difizieren bestimmter DNA Sequenzen voraus. Dies ist möglich durch das Einbrin-
gen eines künstlichen genetischen Konstrukts in murine embryonische Stammzel-
len, welches als Substrat für Homologe Rekombination mit einem ausgewählten
genetischen Lokus fungiert. Erfolgreich veränderte Stammzellklone werden dann
verwendet um Maus-Chimären für das Etablieren einer neuen Mauslinie zu erzeu-
gen.
Der Gen Knock-out eliminiert die Expression eines Gens in allen embryonalen und
adulten Geweben. Das vollständige Ausschalten bestimmter Gene führt jedoch zu
einem letalen Phänotyp. Der konditionale Gen Knock-out stellt hier eine Alternative
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dar, indem die Genexpression nur in bestimmten Geweben verhindert wird. Konditio-
nale Gen-Varianten werden dadurch erzeugt, dass wichtige funktionale Gensegmen-
te mit Erkennungssequenzen der Cre Rekombinase (loxP) flankiert werden. Mittels
eines gewebe-spezifischen Promoters wird die Expression von Cre auf bestimm-
te Entwicklungsabschnitte und Zelllinien beschränkt, in welchen das loxP-flankierte
Segment ausgeschnitten und ein Gen Knock-out hervorgerufen wird. Weiterhin kann
konditionale Transgenese dazu eingesetzt werden, um einen Marker, wie z.B. ein
fluoreszentes Protein, in Vorläuferzellen zu aktivieren und die Entwicklung ihrer Toch-
terzellen zu verfolgen (“lineage tracing”).
Das Hauptziel dieser Doktorarbeit war die Entwicklung und Validierung von Techno-
logien zur höchstpräzisen Manipulation des Mausgenoms, welche die wesentlichen
Beschränkungen von Gene-targeting und konditionaler Transgenese überwinden.
Kapitel 1 befasst sich mit Binären Rekombinasen, eine Klasse von weiterentwickel-
ten konditionalen Transgenesesystemen, welche die Kontrolle von Cre mit jeder
Kombination zweier gewebe-spezifischer Promotoren erlaubt. Die beiden alterna-
tiven Binären Rekombinasen, Co-Driver und Co-InCre wurden etabliert, welche je-
weils auf einem sequentiellen und einem simultanen Mechanismus zur Kontrolle der
Cre Produktion durch zwei Promotoren beruhen. Die Co-Driver Kaskade besteht
aus der Dre Rekombinase, welche eine Dre-abhängige Variante von Cre (Roxed-
Cre) aktiviert, indem ein Transkriptions- und Translationsterminator aus der protein-
codierenden Sequenz von Cre entfernt wird. Co-InCre ist aus zwei inaktiven Cre-
Fragmenten zusammengesetzt, welche bei gleichzeitiger Expression mittels Protein-
Trans-Splicings die ursprüngliche Proteinsequenz der Cre Rekombinase wiederher-
stellen. Co-Driver und Co-InCre Komponenten waren nur zusammen mit ihrem bi-
nären Partner aktiv und zeigten eine hohe Effizienz beim Rekombinieren von Repor-
tergenen in transfizierten Zelllinien und in Zellen des sich entwickelten Maushirns.
Zudem konnten mit Co-Driver erstmalig zwei klar unterscheidbare Cre Aktivierungs-
muster generiert werden, indem zwei gewebe-spezifische Promotoren sequentiell in
“vorwärts” und “rückwärts” Orientierung miteinander verbunden wurden.
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Kapitel 2 umfasst Experimente mit dem Ziel, die Reparatur von DNA Doppelstrang-
brüchen in Mausembryonen und humanen Zelllinien auszunützen, um Gen Knock-
outs und die gezielte Integration von Transgenen zu erreichen. Sequenzspezifische
Zinkfinger Nukleasen (ZFN) und “transcription activator-like effector” Nukleasen (TA-
LEN) wurden in befruchtete Mausoozyten mikroinjiziert, welche jeweils homologe
Rekombination zwischen Targeting-Konstrukten und dem ROSA26 Lokus und die
Mutagenese des Prion-Protein-Gens (Prnp) durch nonhomologes Endjoining indu-
zierten. Sämtliche modifizierte genetische Varianten wurden effizient an die Nach-
kommen von transgenen Gründertieren weitergegeben. In C57BL/6 Mäusen, wel-
che eine TALEN-induzierte Frameshift-Mutation in beiden Allelen des Prnp Gens
tragen, wurde die Expression des Prion-Proteins (PrPC) erfolgreich eliminiert. In ei-
nem weiteren Ansatz in HEK293T Zellen konnten mittels der “clustered regularly
interspaced short palindromic repeat” (CRISPR) Plattform beide Kopien des human
PRNP Gens modifiziert werden.
Binäre Rekombinasen und Technologien für “genome editing” ermöglichen die Ge-
nerierung von hochentwickelten konditionalen Transgenese Modellen mit einem de-
finierten genetischen Hintergrund. Diese Modelle werden die Untersuchung von Ent-
wicklungsbeziehungen verschiedener Zellstadien beschleunigen und die funktionale
Analyse von bisher rätselhaften Proteinen und Zelltypen unterstützen.
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Abbreviations
AAV adeno-associated virus
ANOVA analysis of variance
attB/attP DNA recognition sites of serine recombinases such as Bxb1
attL/attR products of recombination between attB and attP sites
BAC bacterial artificial chromosome
b3 DNA recognition site of the yeast B3 recombinase
CAG CMV early enhancer element/ chicken beta-actin promoter
Cas9 CRISPR-associated protein 9
CAT chloramphenicol acetyltransferase
CreERT2 fusion of the Cre recombinase with a mutant estrogen receptor
CRISPR clustered regularly interspaced short palindromic repeat
crRNA CRISPR RNA
DAPI 4,6-diamidino-2-phenylindole
DNA deoxyribonucleic acid
DSB double-strand break
EGFP enhanced green fluorescent protein
ES cells embryonic stem cells
frt DNA recognition sites of the yeast Flp recombinase
GPI glycosylphosphatidylinositol
HA hemagluttinin epitope tag
HEK293T human embryonic kidney cell line
hGFAP human glia-fibrillary acidic protein promoter
HR homologous recombination
kd DNA recognition site of the yeast KD recombinase
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loxP DNA recognition site of phage P1 recombinase Cre
MEF mouse embryonic fibroblasts
mRNA messenger RNA
mTagBFP blue fluorescent protein
NeuN neuronal nucleus antigen
NHEJ non-homologous end joing
NLS nuclear localization signal
PAM protospacer adjacent motif
PCR polymerase chain reaction
poly(A) polyadenylation signal
PRNP human prion protein gene
Prnp mouse prion protein gene
PrPC cellular prion protein
RNA ribonucleic acid
ROSA26 the gt(ROSA26)Sor locus on mouse chromosome 6
rox DNA recognition site of the phage D6 Dre recombinase
RVD repeat variable diresidues
S.D. standard deviation
sgRNA single-chain guide RNA
Sirpa mouse gene encoding signal regulatory protein α
SNP single nucleotide polymorphism
SSR site-specific recombinase
SV40 simian virus 40
SVZ subventricular zone
TALEN transcription activator-like effector nucleases
Thy1.2 thymocyte differentiation antigen 1.2
tracrRNA trans-activing CRISPR RNA
VZ ventricular zone
WPRE woodchuck hepatitis virus post-transcriptional regulatory element
ZFN zinc finger nuclease
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Chapter 1. Binary Recombinases for High Resolution Conditional Mutagenesis
1.1. Introduction
1.1.1. Mechanisms of site-specific recombination
Site-specific recombination is a process that involves one or two DNA substrates and
a recombinase protein that recognizes specific sites present within these substrates
and catalyzes breakage and rejoining of DNA without a requirement for DNA synthe-
sis or energy-rich nucleotide cofactors (Grindley et al., 2006). In their simplest form,
site-specific recombinase (SSR) recognition sites are 20-30 bp of double-stranded
DNA containing a pair of recognition sequences in inverted orientation flanking the
site of breakage and joining (the crossover site) in the center. These sites are typi-
cally occupied by either a recombinase dimer or two recombinase monomers.
Based on the intial orientation of the recognition sites, site-specific recombination
can result in integration, excision, or inversion of DNA segments (Grindley et al.,
2006). Integration requires recombination between two circular or a linear and a
circular DNA molecule each of which is carrying a single recognition site. Recogni-
tion sites that are located on the same DNA molecule in a head-to-tail orientation
facilitate excision of the flanked region, whereas inversion results from sites in a
head-to-head orientation.
Nearly all SSRs belong to one of two families, tyrosine recombinases and serine
recombinases. The recombination mechanism of tyrosine family SSRs such as the
phage P1 Cre and the yeast Flp recombinase in combination with their native recog-
nition sites typically favors excision over insertion reactions, while inversions of DNA
are generally reversible as long as the SSR is present. Serine family SSRs such as
ΦC31 (Streptomyces phage) and Bxb1 (mycobacteriophage) on the other hand are
capable of carrying out unidirectional excisions and inversions. This is possible due
to the processing of their attB/attP recognition sites to attL/attR sites, which are no
longer a substrate for recombination (Grindley et al., 2006).
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1.1. Introduction
1.1.2. Classic conditional transgenesis
Conditional mutagenesis in mice typically employs the Cre recombinase, which is
expressed in a spatially and temporally restricted manner (Nagy, 2000). Distinct
Cre expression profiles result from the transcriptional control exercised by regula-
tory elements of well characterized promoters that are used to drive expression of
conventional transgenes or of large fragments of genomic DNA that are routinely
used to generate bacterial artificial chromosome (BAC) transgenics (Gong et al.,
2003). Alternatively, the fidelity of expression can be assured by directly inserting
the Cre protein-coding sequence into a native gene locus using gene-targeting. Cre
driver mouse lines generated with any of these strategies can be crossed to a wide
variety of mice carrying Cre-responsive alleles. Depending on the responder allele,
the Cre driver can mediate either gene ablation through the removal of loxP-flanked
(floxed) coding sequences or gene activation caused by the removal of floxed STOP-
cassettes (Nagy, 2000). Although elegant, conditional mutagenesis approaches are
sometimes limited, as the regulatory elements of a single gene not always suffice
for directing Cre to distinct subsets of cells in complex organs such as the brain or
the immune system. One way of enhancing the specificity of conditional somatic
mutagenesis has been the development of the CreERT2 system, which allows tem-
poral regulation of recombination through timed administration of tamoxifen (Feil et
al., 1997). While this approach has allowed labeling and tracking of cells with in-
creased temporal precision, it is still limited to cell populations that can be targeted
by a single-promoter strategy.
1.1.3. Binary recombinase systems
To date two strategies have been developed to enable dual-promoter transcriptional
control of SSRs, which can be broadly summarized as binary SSRs. The Cre recon-
stitution approach is based on splitting Cre into inactive polypeptide chains, express-
ing these fragments from two individual tissue-specific promoters and allowing the
17
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assembly of active Cre in cells where the transcriptional profiles of both promoters
intersect. Several Cre reconstitution strategies have been described. Namely, the
spontaneous reassembly of Cre fragments by α-complementation (Casanova et al.,
2003), fusing Cre fragments to protein dimerization domains in order to enhance
Cre reassembly (Hirrlinger et al., 2009b,a; Jullien et al., 2003, 2007), or covalent re-
constitution of Cre with the help of split-intein-mediated protein trans-splicing (Wang
et al., 2012). All Cre reconstitution strategies strictly depend on promoters that allow
simultaneous expression of the inactive Cre fragments.
However, another intersectional dual-promoter strategy that combines two orthog-
onally active SSRs, Cre and Flp, allows promoters with non-overlapping temporal
profiles to be used for restricting reporter expression. The Cre/Flp strategy employs
reporter constructs that carry loxP- and frt-flanked STOP-cassettes in various con-
figurations (Dymecki et al., 2010) to selectively label cell sub-populations. Although
elegant, this approach is generally not applicable to generate conditional knockout
mice since conditional alleles usually only contain loxP sites that facilitate removal of
exon sequences (Nagy, 2000). Additionally, frt sites are now frequently found in con-
ditional alleles as a result of their assembly by recombineering (Madisen et al., 2010;
Skarnes et al., 2011), thus severely limiting the application of Flp-mediated condi-
tional transgenesis in the mouse and restricting its use to lineage tracing studies
using Cre/Flp-responsive reporter alleles. The phage D6 recombinase Dre (Sauer
and McDermott, 2004) faithfully processes its cognate recognition sites known as
rox sites and does not cross-react with loxP sites in transgenic mice (Anastassiadis
et al., 2009). Thus, Dre represents a potential alternative to Flp for achieving dual-
recombinase conditional transgenesis, however Cre/Dre-responsive reporter genes
have not been reported so far.
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1.2. Outline
In this chapter I describe the construction and functional validation of novel dual-
promoter-driven conditional transgenesis systems. By combining the transcriptional
profiles of two distinct promoters the expression of the site-specific recombinase
(SSR) Cre can be targeted to subsets of cells for which single promoter strategies
are not established. Throughout this chapter, I will refer to all two-component con-
ditional transgenesis systems both introduced in this study as well as the ones de-
scribed in earlier publications as Binary SSRs. Furthermore Binary SSRs will be
classified according to their mechanism of Cre activation (Figure 1.1). Sequential
binary SSRs comprise a primary SSR, a Co-Driver, which can process the protein-
coding DNA sequence and thus initiate expression of an otherwise inactive sec-
ondary SSR (the driver). Coincidental Binary SSRs such as Co-InCre on the other
hand rely on splitting Cre (or any other SSR) into inactive fragments that are ex-
pressed using two individual promoters and on generating functional Cre by a pro-
tein reconstitution mechanism.
The choice of a suitable promoter pair, which drives Binary SSR components is criti-
cal to achieve Cre expression in the cellular sub-population of interest. The targeting
strategy for certain cell types may require the pairing of two promoters, which are
active during different developmental stages and do not show any temporal overlap
of their transcriptional profiles. Coincidental Binary SSRs rely on simultaneous ex-
pression of both components for efficient Cre activation and thus exclude the use of
promoter pairs with non-overlapping transcriptional profiles. The sequential Binary
SSR approach on the other hand allows for the first time to exploit the transcriptional
domains of any given pair of promoters (with the exception of a scenario where driver
expression precedes and does not overlap with Co-Driver expression, Figure 1.1B).
I report in this chapter the construction of the first sequential Binary SSR, Co-Driver,
which is based on Dre and Roxed-Cre, a Dre-dependent Cre variant. Co-Driver ef-
ficiently recombined reporter genes when constitutively expressed in cell lines and
19
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rox site loxP site
time
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Cre-N STOP Cre-C Co-InCre-C
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Binary SSR Configuration
Figure 1.1.: Sequential and coincidental Binary SSRs. Binary SSRs can be controlled
using two distinct promoters with non-overlapping (A, B) or overlapping (C-E) temporal ex-
pression profiles. Sequential Binary SSRs such as Co-Driver can produce a final output e.g.
the excision of an arbitrary loxP-flanked sequence (grey box) in all overlapping scenarios
as well as in non-overlapping scenario (A). coincidental Binary SSRs such as Co-InCre rely
on protein reconstitution and thus on simultaneous expression of both N- and C-terminal
Cre-fragments to produce a final output (C-E).
the developing mouse neocortex. When Dre and Roxed-Cre were expressed from
two promoters with non-identical transcriptional profiles Co-Driver integrated both
tissue-specific and temporal layers of control. Co-InCre, a newly developed coin-
cidental Binary SSR incorporating highly active split-inteins showed a significant
improvement of recombination efficiency over previously published systems.
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1.3. Results
1.3.1. Dre as the optimal Co-Driver recombinase
The basic concept of the Co-Driver cascade requires the use of a highly active SSR
that will operate orthogonally with Cre. I considered SSRs to be promising Co-Driver
candidates if they fulfilled two essential conditions. First, the specificity of the SSRs
for their cognate recognition sites (and the absence of cross reactivity with other
SSR recognition sites) should have been determined previously and preferentially
also validated in a mammalian system. Second, the Co-Driver candidate and its
recognition sites should not be routinely utilized for cloning or recombineering of
transgenic constructs. Selecting SSRs by these criteria should minimize the risk of
unintended recombination events when Co-Driver is combined with currently avail-
able transgenic alleles. Following these considerations I selected four Co-Driver can-
didates including the phage recombinases Dre (Anastassiadis et al., 2009; Sauer
and McDermott, 2004) and Bxb1 (Ghosh et al., 2005, 2003; Mediavilla et al., 2000)
as well as the yeast recombinases B3 and KD (Nern et al., 2011). I excluded the
extensively characterized SSRs Flp and ΦC31 since a large number of established
mouse lines carry conditional mutagenesis cassettes, which already contain frt and
ΦC31 attB/attP recognition sites (Madisen et al., 2010; Skarnes et al., 2011).
To date, no comparative assessment of recombination efficiency of these SSRs has
been performed in a standardized mammalian system. Therefore, I systematically
compared their recombination efficiencies relative to the highly active Cre recombi-
nase. First, I designed standardized SSR overexpression constructs by fusing all the
codon-optimized SSR protein-coding sequences to an N-terminal SV40-NLS and
a HA-tag and placing them under control of a constitutively active CAG promoter
(Figure 1.2A). B3, KD, and Dre are members of the tyrosine SSR family whereas
Bxb1 is the only representative of the serine family of recombinases.
21
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1.3. Results
Figure 1.2.: Evaluation of Co-Driver candidate recombinases. (A) Diagrams of standard-
ized SSR-driver and respective reporter plasmids that are co-transfected with a constitutively
expressing mCherry plasmid into HEK293T cells. Transfected cells are mCherry+, and SSR
activity is detected for Bxb1 using an inverted ZsGreen reporter or a STOP-cassette-based
ZsGreen reporter for KD, B3 and Dre. Arrowheads indicate the orientation of individual SSR
recognition sites.(B) HEK293T were transfected with a constitutive mCherry plasmid, a SSR-
specific ZsGreen-fluorescent reporter constructs and either adding (+ SSR, top panel) or
omitting (- SSR, bottom panel) a constitutive SSR expressing plasmid. Transfected SSRs
and cognate reporters, Bxb1/attB, attP, KD/kd , B3/b3, Dre/rox , and Cre/loxP are indicated
on top. Fluorescent microscopy images for mCherry and ZsGreen fluorescence as well as
Nomarski light microscopic images of transfected HEK293T cells are shown.
As my intent was to exploit the DNA inversion mechanism of Bxb1 to construct a
Bxb1/Cre SSR cascade, I assessed the efficiency of Bxb1 in the context of a fluores-
cent reporter construct carrying a reverse-complementary ZsGreen protein-coding
sequence flanked by Bxb1 recognition sites (Figure 1.2A). Conversely, the DNA
excision activity of the three tyrosine recombinases was assessed using reporter
constructs carrying ZsGreen preceded by a STOP-cassette (Madisen et al., 2010)
flanked by the cognate recognition sites of the respective SSR. In order to ascer-
tain SSR activity, HEK293T cells were transfected with a constitutively expressing
mCherry plasmid, SSR drivers, and their respective reporters and individual trans-
fections were initially assessed by fluorescence microscopy (Figure 1.2A). In the
absence of SSRs none of the reporter constructs produced any visible ZsGreen
signal in transfected mCherry+ cells, while co-transfection of the respective SSR re-
sulted in strong ZsGreen expression for all Co-Driver candidates with the exception
of KD (Figure 1.2B).
Having established the basic functionality of all Co-Driver candidate ZsGreen-reporter
pairs (except KD) I compared recombination efficiencies of the candidate SSRs by
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Figure 1.3.: Recombination efficiency of Co-Driver candidates. HEK293T were ana-
lyzed by flow cytometry 24h after transfection with (A) a mCherry or ZsGreen single color
control plasmid, (B) with Cre and a loxP-reporter, or (C) Co-Driver candidates. Numbers
within histograms represent the percentage of transfected cells showing recombination ac-
tivity. Insets, scatter plots showing living cells and gating for mCherry+ cells (red rectangle).
FI, relative fluorescence intensities in arbitrary units. (D) Quantification of recombination ef-
ficiency. Bars represent the percentage of cells showing recombination activity in subsets of
mCherry+ cells (gating within the mCherry+ gate is shown right to bar graph). Average data
of three independent experiments with standard deviation and normalized to 100% Cre av-
erage recombination efficiency are shown. n.d., not detectable. Statistics: two-way ANOVA
with Bonferroni post hoc test; n.s., not significant; *P<0.05; **P<0.01; ***P<0.001.
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employing flow cytometric measurement of single-cell mCherry and ZsGreen fluo-
rescence intensities (Figure 1.3). In transfected HEK293T cells that constitutively
expressed either mCherry or ZsGreen, no crosstalk between mCherry and ZsGreen
fluorescence was detected (Figure 1.3A). Next I performed co-transfections of a con-
stitutively active mCherry plasmid with either a loxP-ZsGreen reporter alone or in
combination with Cre (Figure 1.3B). All transfected cells were detected by mCherry
fluorescence (24 h post-transfection) while recombination activity of the SSR was in-
dicated by ZsGreen fluorescence in cells of the mCherry-positive population. In the
absence of Cre less than 0.5% of mCherry+ cells showed ZsGreen fluorescence con-
firming the tight control of ZsGreen expression by the loxP-flanked STOP cassette.
When Cre was added to the transfections over 85% of transfected cells showed
recombination activity.
For the evaluation of Co-Driver candidates, Cre was used as a reference for re-
combination efficiency and the performance of other SSRs is expressed as percent-
age of Cre efficiency. This definition of recombination efficiency is used for all flow
cytometric analyses throughout this chapter. All Co-Driver candidate reporter con-
structs showed a tight control of ZsGreen expression similar to the Cre-reporter
(Figure 1.3C). When Co-Driver candidates were co-transfected with their respec-
tive reporters Dre showed the highest recombination efficiency with a percentage of
ZsGreen-positive cells as high as Cre, while B3 and Bxb1 were less efficient (Fig-
ure 1.3C). KD activity was undetectable confirming the initial microscopic analysis.
In order to obtain a detailed profile of Co-Driver candidate performances I determine
recombination efficiencies in subsets of cells with overall low, medium, and high
expression levels. I defined three equally sized gates within the mCherry+ gate
covering the full range of mCherry fluorescence intensities for all SSR transfections
(Figure 1.3D). Again, Dre recombination levels were comparable to Cre in all sub-
populations including mCherrylow cells, while B3 reached only about 50% of Cre
activity in this population. Bxb1-mediated inversion of the ZsGreen reporter was
only 20% as efficient than Cre-mediated STOP-cassette excision in mCherrylow cells.
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These results prompted me to consider Dre as the optimal Co-Driver of all SSRs
tested for constructing a sequential binary recombinase system.
1.3.2. A Dre-responsive Cre driver design
Having selected Dre as the Co-Driver SSR, I evaluated several rox-flanked STOP-
cassette designs with the aim to tightly control Cre expression in the absence of
Dre. I adapted two STOP-cassette configurations that were shown previously to
completely block transgene expression and at the same time facilitated efficient
transgene reactivation upon the removal of the STOP-cassette by Cre recombina-
tion. The 3× poly(A) STOP cassette incorporates STOP codons in all three reading
frames followed by three consecutive SV40 poly(A) sequences and is part of the
Ai6 and Ai14 conditional reporter alleles (Madisen et al., 2010). The CAT-poly(A)
STOP cassette is composed of the chloramphenicol acetyltransferase (CAT) gene
and a poly(A) signal and has been shown to tightly control multi-copy transgenes
(Araki et al., 1995). Both rox-flanked STOP-cassettes were cloned upstream of
Cre (Figure 1.4A) and each of these constructs together with constitutive mCherry
plasmid, Cre-inducible ZsGreen reporter and either adding or omitting a constitutive
Dre expression construct was transfected into HEK293T (Figure 1.4B). I observed
substantial levels of loxP recombination events in the absence of Dre regardless of
which rox-flanked STOP cassette was present upstream of Cre (Figure 1.4B and
Figure 1.5).
I hypothesized that the transcriptional termination by the upstream STOP cassettes
is incomplete thus allowing sufficient translation of Cre for loxP recombination to oc-
cur. Therefore, I devised a strategy that would interrupt Cre expression at both the
transcriptional and translational level. In the Roxed-Cre construct (Figure 1.4A), the
Cre open reading frame is interrupted by the 3× poly(A) STOP cassette between
amino acids 59 and 60. Thus Roxed-Cre generates an inactive N-terminal Cre frag-
ment (Jullien et al., 2003, 2007; Hirrlinger et al., 2009b; Wang et al., 2012) in the
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absence of Dre recombination (and in the case of transcriptional read-through the
also inactive C-terminal Cre fragment). Once the rox-flanked STOP cassette is re-
moved a Cre variant with an 11 amino acid insertion resulting from translation of
the remaining rox-site is expressed. In the absence of Dre, Roxed-Cre reduced
unintended loxP recombination below detectable levels in all mCherry+ cells, while
appearing to be equally efficient as Cre when Dre was added to Roxed-Cre transfec-
tions (Figure 1.5).
In transgenic mice, Cre is typically employed to recombine hemizygous reporter
genes or homozygous loxP-flanked conditional alleles. It has been shown that while
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Figure 1.4.: Dre-dependent activation of Cre. (A) Diagram depicting Dre-dependent Cre
driver candidates 5’ 3× poly(A), 5’ CAT-poly(A), and Roxed-Cre. (B) Fluorescence micro-
scopic analysis 24h after transfection of HEK293T with Cre driver candidates alone (top
panel, - Dre) or in combination with Dre (bottom panel, + Dre).
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Figure 1.5.: Quantitative assessment of Dre-dependent Cre driver candidates. (A) Rep-
resentative flow plots 24h after transfection of HEK293T cells with a loxP-flanked ZsGreen
reporter, Cre-Driver candidates and either omitting (top row) or adding (bottom row) Dre.
(B) Quantification of recombination activity of Cre driver candidates with or without Dre Co-
Driver. Bars represent the percentage of transfected cells showing recombination activity.
Average data of three independent experiments are shown with standard deviation and nor-
malized to 100% Cre average recombination efficiency.
Cre maintains high activity on both plasmid-based and chromatin targets other re-
combinase systems such as FLP/frt are significantly less efficient in processing the
latter (Andreas et al., 2002). In order to assess Co-Driver performance in an experi-
mental environment that closely resembles in vivo conditions I established a mouse
embryonic fibroblast (MEF) cell line that carries a single-copy Cre-inducible ZsGreen
reporter (MEF-Ai6 derived from hemizygous Ai6 mice (Madisen et al., 2010), Fig-
ure 1.6A). MEF-Ai6 displayed green fluorescence with uniform intensity 72 hours af-
ter Co-Driver transfection (Figure 1.6B) as expected for a ROSA26-targeted reporter
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Figure 1.6.: MEF-Ai6 - a cell line harboring a single-copy Cre-responsive fluorescent
reporter. (A) MEFs derived from hemizygous Ai6 reporter mice (MEF-Ai6) express ZsGreen
from the single copy Ai6 transgene upon STOP-cassette excision by Cre (WPRE, woodchuck
hepatitis virus post-transcriptional regulatory element). (B) Fluorescence microscopy analy-
sis of MEF-Ai6 72h after transfection with either both or single Co-Driver components, Dre
and Roxed-Cre. Nuclei of individual transfected cells were identified using DAPI staining.
(Soriano, 1999). As expected from the observations with a plasmid-based Cre re-
porter in HEK293T, transfections of MEF-Ai6 with single Co-Driver components did
not result in detectable ZsGreen fluorescence.
When MEF-Ai6 transfected with Cre were analyzed by flow cytometry ZsGreen-
positive cells showed a homogeneous fluorescent intensity consistent with the mi-
croscopic observations (Figure 1.7A). Flow cytometric analysis of MEF-Ai6 72h post-
transfection confirmed that only combined but not individual Co-Driver modules, Dre
and Roxed-Cre, induce ZsGreen expression (Figure 1.7B). The correct processing
of the Ai6 allele was also clearly evidenced by PCR analysis (Figure 1.7C).
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Figure 1.7.: Quantitative analysis of Co-Driver activity in the MEF-Ai6 reporter cell
line. (A) mCherry and ZsGreen (induced by transfection of Cre) single color controls for flow
cytometric analysis of transfected MEF-Ai6. Recombination activity of paired or single Co-
Driver components, Dre and Roxed-Cre, in MEF-Ai6 72 h after transfection was assessed
by (B) flow cytometric quantification of ZsGreen-positive cells (percentage shown in flow
plots) and (C) by PCR analysis of the Ai6 reporter gene for Cre-induced excision of the
STOP-cassette. Primer binding sites are located outside of the loxP-flanked STOP-cassette.
Excision of the STOP-cassette is detected by the presence of a 0.4 kb PCR fragment, while
a larger-sized PCR fragment of 1.2 kb is generated from the unmodified Ai6 gene.
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1.3.3. Co-InCre - seamless Cre reconstitution
Besides my attempts to identify the optimal sequential binary SSR configuration I
was also interested in constructing a coincidental binary SSR with high recombi-
nation efficiency. All previously published coincidental Binary SSRs (Jullien et al.,
2007; Hirrlinger et al., 2009b; Wang et al., 2012) as well as the sequential Co-Driver
system generate Cre-variants with insertions of non-native amino acid sequences in-
between Cre amino acids 59 and 60. Although this has not been studied in detail for
most Binary SSRs, these insertions together with low efficiency of Cre reconstitution
potentially have a negative effect on the activity of the respective Cre variants. There-
fore an alternative reconstitution domain providing fast kinetics as well as seamless
reassembly of native Cre would be highly desirable.
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Figure 1.8: Co-InCre - a coinciden-
tal Binary SSR based on split-
inteins. (A) Diagram depicting
the configuration of the N-terminal
and C-terminal Co-InCre fragments,
which facilitate Cre reconstitution by
seamless protein-trans-splicing. (B)
Fluorescence microscopy images of
HEK293T 24 h after transfection with
a constitutively active mCherry plas-
mid, a Cre-inducible ZsGreen reporter
and either combined or individual Co-
InCre components.
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Here, I capitalized on the recently described gp41-1 split-intein (Carvajal-Vallejos
et al., 2012; Dassa et al., 2009) to construct Co-InCre (Figure 1.8A). Co-InCre re-
constitutes Cre by protein-trans-splicing akin to the previously described split-intein-
split-Cre (Wang et al., 2012). gp41-1 exhibits the highest trans-splicing activity at
37°C of all split-inteins described to date and does not require any native extein se-
quences to catalyze this reaction (Carvajal-Vallejos et al., 2012). Initial fluorescence
microscopy analysis of transfected HEK293T cells showed Cre activity only when
both Co-InCre N- and C-terminal fragments were present. Single components did
not elicit any detectable recombination-induced ZsGreen reporter expression (Fig-
ure 1.8B). These observations could be confirmed by flow cytometry (Figure 1.9).
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Figure 1.9.: Flow cytometric analysis of Co-InCre recombination activity. (A) Flow cy-
tometric analysis 24 h after transfection of HEK293T with a constitutively active mCherry
plasmid, a Cre-inducible ZsGreen reporter and either combined or single Co-InCre compo-
nents. (B) Quantification of Co-InCre recombination efficiency in HEK293T. Average data of
three independent experiments are shown with standard deviation and normalized to 100%
Cre average recombination efficiency.
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Co-transfection of Co-InCre components resulted in a high percentage of recombination-
positive cells with over 80% of the efficiency of Cre, while single Co-InCre N or
Co-InCre C transfections showed less than 1% of ZsGreen-positive cells. High ac-
tivity as well as low background recombination levels of single Co-InCre modules
was also observed in transfected MEF-Ai6 cells (Figure 1.10) that were analyzed
by microscopy, flow cytometry, and a PCR indicating the excision of the Ai6 STOP
cassette.
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Figure 1.10.: Co-InCre-mediated recombination of the single-copy Ai6 reporter gene.
MEF-Ai6 were analyzed 72h after transfection with either both or single Co-InCre modules.
(A) Fluorescence microscopy images, nuclei of individual transfected cells were identified
using DAPI staining. (B) PCR analysis of the Ai6 reporter gene. Primer binding sites are
located outside of the loxP-flanked STOP-cassette. Excision of the STOP-cassette is de-
tected by the presence of a 0.4 kb PCR fragment, while a larger-sized PCR fragment of 1.2
kb is generated from the unmodified Ai6 gene. (C) Flow cytometric analysis showing the
percentage of recombination-positive MEF-Ai6 cells.
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1.3.4. Co-Driver & Co-InCre are highly efficient binary SSRs
Having established that both Co-Driver and Co-InCre are obligate binary SSRs I
went on to evaluate their performance in relation to Cre and other binary SSR sys-
tems. I first asked how efficiently the Cre variant translated from Dre-processed
Roxed-Cre (CreRox60-70), the final output of the Co-Driver cascade, would process
the Ai6 reporter gene. In transfected MEF-Ai6, CreRox60-70 (expressed from a
construct mimicking complete processing of Roxed-Cre plasmids by Dre) showed a
30-40% lower recombination activity than native Cre (Figure 1.11). Since the Co-
Driver strategy (Figure 1.12A) seems to achieve tight control of Cre expression at
the expense of reduced Cre activity I considered an alternative SSR cascade that
would yield native Cre upon primary SSR activity and thus potentially higher binary
recombination efficiency.
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Figure 1.11.: Effect of translated rox-site in the Co-Driver component Roxed-Cre. (A)
Amino acid changes introduced in CreRox60-70 (the resulting Cre variant expressed from
Dre-processed Roxed-Cre). (B) Flow cytometric analysis of CreRox60-70 SSR activity in
MEF-Ai6 cells. (C) Quantification of CreRox60-70 recombination efficiency. Average data of
three independent experiments are shown with standard deviation and normalized to 100%
Cre average recombination efficiency.
34
1.3. Results
Here, I capitalized on the unidirectional inversion mechanism of the serine recombi-
nase Bxb1 (Figure 1.12A). I designed a Bxb1-responsive Cre expression construct
based on the reverse complementary (rc) Cre DNA sequence flanked by Bxb1 attB
and attP recognition sites in head-to-head orientation. Once rcCre is placed down-
stream of a promoter Cre recombinase can only be expressed upon Bxb1-mediated
inversion of the Cre protein-coding sequence into the correct transcriptional orienta-
tion.
After having constructed Co-Driver, Bxb1-rcCre, and Co-InCre I also cloned the pre-
viously published coincidental Binary SSRs Split-Cre (Hirrlinger et al., 2009b, based
on Cre complementation) and split-intein-split-Cre (Wang et al., 2012, based on
protein-trans-splicing) into my standard expression vector (Figure 1.12B). Thus sim-
ilar expression levels for all binary components should be achieved allowing the
unbiased comparison of the recombination efficiencies of all systems. All Binary
SSRs and native Cre were transfected into MEF-Ai6 and recombination efficiency
was assessed using flow cytometry (Figure 1.12C). Similar to the comparison of Co-
Driver SSR candidates, I analyzed subsets of mCherry+ MEF-Ai6 with low, medium,
and high mCherry fluorescent intensities (Figure 1.12D).
Not surprisingly, none of the binary SSRs reached the recombination efficiency
of Cre in mCherrylow or mCherrymed cell populations, however there were signifi-
cant differences in performance between the individual systems (Figure 1.12D). In
mCherrylow cells, Co-Driver and Bxb1-rcCre showed about 20% of Cre efficiency,
which was similar to split-intein-split-Cre and slightly above Split-Cre. Remarkably,
Co-InCre was more than twice as active as any other binary SSR reaching more than
50% of Cre efficiency. Co-InCre also showed the highest performance in mCherrymed
cells with about 80% of Cre efficiency. Here, Co-Driver activity was superior to Split-
Cre, while being slightly lower than Bxb1-rcCre and split-intein-split-Cre. Thus, a
considerable gain in efficiency at low expression levels could be achieved by the
seamless protein trans-splicing of Co-InCre.
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Figure 1.12.: Recombination efficiency of Co-Driver and Co-InCre. (A) Diagrams de-
picting the sequential Binary SSR cascades of Co-Driver and Bxb1-rcCre. Rectangles with
arrows represent expression constructs, rounded rectangles represent proteins. (B) Illustra-
tions of coincidental Binary SSRs. Cre reconstitution domains are shown in different shades
of blue for each system and references for earlier published systems are indicated. (C)
MEF-Ai6 were transfected with a plasmid for constitutive mCherry expression and either
two plasmids for the expression of both binary SSR modules or a single Cre plasmid. Rep-
resentative flow plots 72 h post-transfection show the percentage of transfected cells with
recombination activity. Insets show gating for transfected cells. (E) Recombination efficiency,
defined as ratio of mCherry+ cells showing ZsGreen-expression, was determined in subsets
of mCherry+ cells with low, medium (med), or high mCherry FI (gating within the mCherry+
gate is shown in the graph). Binary SSRs with sequential or coincidental mode of action
are color-coded in shades of red, or blue, respectively. Average data of three independent
experiments are shown with standard deviation and normalized to 100% Cre recombination
efficiency. Statistics: two-way ANOVA with Bonferroni post-hoc test; n.s., not significant; *p
< 0.05; **p < 0.01; ***p < 0.001.
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Bxb1-rcCre on the other hand only permitted an increased SSR activity relative to
Co-Driver in cells with higher expression levels. In cells with the highest levels of
mCherry fluorescent intensity basically all cells expressed ZsGreen as a result of Bi-
nary SSR activity with the exception of Split-Cre indicating that Cre activation mech-
anisms based on by protein-trans-splicing or excision of an internal STOP cassette
are generally superior to Cre complementation.
1.3.5. Binary SSR activity in the developing mouse neocortex
The utility of SSRs for in vivo conditional transgenesis depends on their functionality
within rapidly changing cellular environments during organogenesis or differentia-
tion processes on-going during adulthood. In the developing mouse neocortex, het-
erogeneous populations of progenitor cells residing in the ventricular (VZ) and the
subventricular zone (SVZ) start to produce neurons around embryonic day (E)10.5.
Corticogenesis proceeds in an “inside-out” fashion, i.e. neocortical layer VI is estab-
lished first, followed by layers V, IV and lastly layers II/III (Greig et al., 2013). After
neurogenesis is completed around E16.5, progenitors start to generate astrocytes
and oligodendrocytes (Greig et al., 2013; Kriegstein and Alvarez-Buylla, 2009).
Between E12.5 and E16.5, VZ progenitor cells can be transiently transfected us-
ing in utero electroporation of mouse embryos (Saito and Nakatsuji, 2001; Tabata
and Nakajima, 2001). Here, progenitors receive a limited number of plasmid copies,
which, upon cell division, are inherited by daughter cells. While gene expression
from introduced plasmid DNA is remarkably stable in postmitotic cells, it is rapidly
lost in dividing progenitors, probably due to the successive loss of the extrachromo-
somal plasmids with each cell division. As a result neural cells differentiating shortly
after electroporation will show the highest level of transgene expression while those
born later only show low levels or no expression at all. Neurons born before the time
point of electroporation will not receive any plasmid DNA and as a consequence will
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not express the transgene. Depending on the embryonic stage at which electropo-
ration is performed the progeny of the transfected progenitors will populate specific
cortical layers and express one or multiple introduced transgenes in the adult brain
(Saito and Nakatsuji, 2001; Tabata and Nakajima, 2001; Langevin et al., 2007).
To evaluate the full recombination potential of the novel binary SSRs in vivo, CAG-
driven Co-Driver or Co-InCre plasmids were electroporated together with a CAG-
driven EGFP plasmid into the embryonic (E14.5) brains of Ai14 tdTomato reporter
mice (Madisen et al., 2010) (Figure 1.13A). All in utero electroporations were per-
formed by Hendrik Wildner at the Institute of Neuropharmacology, University of
Zurich. I identified electroporation-positive brain areas in postnatal mice (P9-P10,
Figure 1.13B) and imaged coronal brain sections for EGFP+ and tdTomato+ cells us-
ing confocal microscopy (Figure 1.13C-F). Confirming my previous observations in
transfected MEF-Ai6 cells, single binary SSR modules (Figure 1.13C, E) did not trig-
ger any detectable tdTomato expression over a time period of more than two weeks
following electroporation. Brains of mice electroporated with binary Co-Driver or Co-
InCre showed extensive tdTomato-fluorescence in the transfected hemispheres with
the vast majority of positive cells being found in upper cortical layers (Figure 1.13C,
E). High magnification images revealed that tdTomato+ cells substantially outnum-
bered those that were EGFP+ (Figure 1.13D) indicating that cells, which had re-
ceived a number of plasmid copies below the threshold for EGFP detection, were
nevertheless able to produce amounts of Cre that were sufficient for the processing
of the Ai14 reporter gene. In all mice analyzed, gross morphology of the cortex
appeared normal. Fluorescently labeled neurons projected locally to neurons of
deeper cortical layers as well as through the corpus callosum (Figure 1.13D) to-
wards distal regions in the contralateral hemisphere. Thus, Co-Driver and Co-InCre
activity was well tolerated by neuronal populations and their precursor cells in the
developing mouse brain.
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Figure 1.13.: Co-Driver and Co-InCre trigger efficient recombination in the developing
mouse brain. (A) Diagrams depicting plasmid combinations introduced into the embry-
onic brain of Ai14 reporter by in utero electroporation (Ai14 reporter gene is shown below
mouse embryo, WPRE, woodchuck hepatitis virus post-transcriptional regulatory element).
(B) Coronal sections of fluorescence-positive brain areas (white dashed line) were prepared
from postnatal day 9-10 (P9-P10) mice. (C-F) Maximum intensity projections (MIP) of
electroporation-positive brain areas. (C) Electroporations of combined and single Co-Driver
components, Dre and Roxed-Cre. Fluorescent signals are merged with phase-contrast im-
ages of brain sections. (D) High magnification MIP of recombination-positive areas in the
cortex and in the corpus (c.) callosum. (E) Electroporation of combined and individual Co-
InCre modules. (F) Control electroporation using full-length Cre recombinase. Scale bar for
panels (C), (E), and (F), 500 µm. Scale bars for panel (D), 20 µm.
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1.3.6. Sequential expression of Co-Driver modules in the mouse
neocortex
In a final series of experiments, I asked whether I could manipulate the output of Co-
Driver, i.e. the timing and cell-type specificity of Cre recombination, by producing
Dre and Roxed-Cre from distinct tissue-specific expression constructs. To address
this question, I cloned Dre and Roxed-Cre into a human glia-fibrillary acidic protein
(hGFAP)-promoter (Zhuo et al., 1997) cassette and the Thy1.2 expression cassette
(Caroni, 1997) to generate hGFAP-Dre, hGFAP-Roxed-Cre, Thy1.2-Dre, and Thy1.2-
Roxed-Cre constructs (Figure 1.14). I also attempted to track the activity of the Dre-
driving promoter in the adult brain to gain insights into the individual contribution of
the hGFAP and Thy1.2 expression profiles to the final Co-Driver output. Therefore,
I fused Dre to the porcine teschovirus-1 (P)2A sequence (Szymczak et al., 2004)
and the blue fluorescent protein, mTagBFP (Subach et al., 2008). This strategy
should allow blue-fluorescent labeling of cells, which express Dre at the time point
of analysis in parallel with assessing Co-Driver-mediated processing of the Ai14
reporter gene.
hGFAP-Cre transgenic mice express Cre in radial glia, the principal VZ precursor
cells, between E13-E17 and in the adult brain in astrocytes but not in neurons or
oligodendrocytes (Malatesta et al., 2003). Since radial glia give rise to neurons,
astrocytes, and oligodendrocytes, activation of a Cre-dependent reporter allele in
hGFAP BGHpA
Roxed-Cre
Dre P2A BFP
Roxed-Cre
Ia Ib II/IV
Thy1.2 expression vector
Dre P2A BFP
hGFAP expression vector
Figure 1.14.: Construction of human (h)GFAP and Thy1.2 Co-Driver expression vec-
tors. Promoter sequences are indicated by arrows, other sequences by grey boxes, and
exons are denoted by roman numerals.
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radial glia results in labeling of all three cell lineages in the adult brain. In the postna-
tal mouse neocortex, Thy1.2-driven fluorescent proteins can be detected in neurons
throughout cortical layers II-VI (Feng et al., 2000) and two lines of Thy1.2-brainbow
mice showed expression in astrocytes (Livet et al., 2007). For a large number of
transgenic lines, Thy1.2-driven transgenes have been reported to reach detectable
expression levels in the postnatal brain (Caroni, 1997; Feng et al., 2000; Kelley et
al., 1994). However, several lines of Thy1.2-Cre mice already showed reporter gene
activation during embryonic development (Campsall et al., 2002).
In a first step, I assessed the expression profiles of single Thy1.2- and hGFAP-driven
Roxed-Cre plasmids by combining each of them with the continuously expressing
CAG-Dre construct (Figure 1.15). In the postnatal brains of Ai14 mice that were
electroporated at E14.5 with CAG-Dre, Thy1.2-Roxed-Cre and CAG-EGFP, recombi-
nation was restricted to NeuN+ cortical neurons, which typically also exhibited EGFP
fluorescence (Figure 1.15B). Combining CAG-Dre with hGFAP-Roxed-Cre resulted
in a more extensive pattern of recombination within and beyond the area of EGFP+
cells. Here, I observed tdTomato-labeling of NeuN+ neurons and NeuN- cells mor-
phologically resembling astrocytes in the cortex and tdTomato+ NeuN- cells in prox-
imity of the corpus callosum (Figure 1.15C).
In a final series of experiments the Co-Driver pairs, hGFAP-Dre with Thy1.2-Roxed-
Cre (hGFAP⇒ Thy1.2) and Thy1.2-Dre with hGFAP-Roxed-Cre (Thy1.2⇒ hGFAP),
were introduced into the embryonic mouse brain. Confocal imaging of postnatal
coronal brain sections consistently showed reporter gene activation by both Co-
Driver pairs. However, there was a remarkable difference in the lineage identity
and radial positions of tdTomato+ cells relative to EGFP+ cells for hGFAP⇒ Thy1.2
and Thy1.2 ⇒ hGFAP electroporations, respectively (Figure 1.16). In hGFAP ⇒
Thy1.2-electroporated brains the vast majority of tdTomato+ cells stained positive
for NeuN (Figure 1.17) and large numbers of these neurons either showed EGFP
fluorescence themselves or occupied similar radial positions relative to their EGFP+
neighbors (Figure 1.16B).
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Figure 1.15.: Cell type specificity of human GFAP and Thy1.2 constructs. (A) Embryos
carrying the Ai14 reporter gene were electroporated with constitutively expressing EGFP
and Dre plasmids in combination with (B) Thy1.2-Roxed-Cre or (C) hGFAP-Roxed-Cre. Rep-
resentative low magnification single-plane confocal images of fluorescence-positive areas
within the cortex and additionally for (B) in proximity to the corpus (c.) callosum of postnatal
day (P)10 mice are shown (top rows within each panel). High magnification maximum in-
tensity projections (MIP) (bottom rows within each panel) show tdTomato-positive cells and
staining for neuronal nuclei (NeuN) within the cortex. Arrow heads denote tdTomato- fluo-
rescent cells with positive NeuN-staining. Arrows denote tdTomato-positive cells that are
negative for NeuN. Scale bar low magnification, 200 μm; high magnification, 20 μm.
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Figure 1.16.: Sequential expression of Co-Driver components in the developing
mouse neocortex. (A) E14.5 embryos carrying a single-copy Cre-inducible tdTomato
reporter gene (Ai14) were electroporated with a constitutively expressing EGFP plas-
mid and either hGFAP-Dre with Thy1.2-Roxed-Cre (white rectangles) or Thy1.2-Dre with
hGFAP- Roxed-Cre (gray rectangles). (B) Representative single-plane confocal images of
fluorescence-positive areas within the cortex and MIP of areas in proximity to the corpus (c.)
callosum of post-natal day (P)10 mice are shown (top panel, hGFAP-Dre with Thy1.2-Roxed-
Cre electroporations; bottom panel, Thy1.2-Dre with hGFAP-Roxed-Cre electroporations).
Arrow heads denote cells within the cortex that show both EGFP and tdTomato fluorescence,
arrows denote cells with single tdTomato fluorescence. Scale bars, 100mm. (C) Quantifi-
cation of EGFP-positive cells (left), tdTomato-positive cells (middle) and tdTomato/EGFP
double-positive cells (right) in coronal brain sections. Average data of three animals and
three coronal sections per animal with standard deviation are shown. Statistics: unpaired
Student’s t-test; ***P < 0.001.
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Thy1.2 ⇒ hGFAP on the other hand targeted tdTomato expression predominantly
to EGFP- cells with tdTomato+ NeuN+ neurons occupying positions closer to the
pial surface and tdTomato+ NeuN- non-neuronal cells residing also in lower cortical
layers and in the white matter proximal to EGFP+ fibers of callosal projection neurons
(Figure 1.16B, Figure 1.17).
While both hGFAP- and Thy1.2-constructs seemed to reliably produce sufficient
amounts of Dre I was unable to detect BFP fluorescence in postnatal brains indi-
cating that at the time of analysis the respective activity of neither promoter was
sufficient to generate detectable amounts of BFP. In order to substantiate the quali-
tative assessment of Cre recombination patterns, I quantified the numbers of EGFP+
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Figure 1.17.: Neuronal marker expression in cells labeled by sequential Co-Driver acti-
vation. Representative high magnification MIP of electroporation-positive areas are shown.
Arrow heads denote tdTomato-fluorescent cells with positive NeuN-staining. Arrows denote
tdTomato-positive cells that are negative for NeuN. Scale bar, 20 μm.
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cells, tdTomato+ cells, and EGFP+ tdTomato+ cells in electroporation-positive coro-
nal brain sections that were randomly selected along the rostral-caudal brain axis (3
brains for each Co-Driver pair with 3 sections per brain, Figure 1.16C). Cell counts
per coronal section were similar for EGFP+ cells (hGFAP⇒ Thy1.2, 359 ± 130 and
Thy1.2⇒ hGFAP, 391 ± 75) and tdTomato+ (120 ± 40 and 117 ± 32), while there was
a significantly higher number of cells showing cytoplasmic co-localization of EGFP
and tdTomato in hGFAP⇒ Thy1.2 brain sections (96 ± 36 and 18 ± 7). Considering
that expression of detectable levels of EGFP is restricted to cells born shortly after
in utero electroporation was performed (Langevin et al., 2007) these observations
suggest that the Thy1.2 ⇒ hGFAP Co-Driver pair targeted reporter gene activation
mainly to cells that were born later relative to the tdTomato+ cells observed as a
result of hGFAP⇒ Thy1.2 Co-Driver activity.
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1.4. Discussion
1.4.1. Implementation of sequential lineage tracing
The principal aim of this work was to design and validate binary SSR systems that
can integrate the transcriptional profiles of a wide range of promoters and thus
hold the potential to significantly increase the resolution of genetic lineage tracing.
Co-Driver demonstrates for the first time the implementation of the sequential lin-
eage tracing concept by using a cascade of two orthogonally active SSRs, which
we termed sequential binary SSR. This concept relies on exploiting the temporal
activity profiles of two individual promoters to create a genetic record in a distinct
sub-population of a cell lineage.
The generation of a high fidelity binary SSR system requires the design of two mod-
ules that can only produce the desired output in combination but not individually.
I challenged the individual Co-Driver modules Dre and Roxed-Cre in several bio-
logical systems such as transfected cell lines with plasmid-based or chromosomal
Cre-dependent fluorescent reporters and in the developing brains of Cre reporter
mice without detecting any spurious recombination events caused by either Dre or
Roxed-Cre. Thus Co-Driver is essentially an obligate binary SSR, with production
of functional Dre solely depending on the expression profile of the Dre-driving pro-
moter, while active Cre is only produced when two conditions are fulfilled, 1) the
Roxed-Cre gene has been processed by Dre and 2) the Roxed-Cre-driving promoter
is transcriptionally active.
Tissue-specific promoters and expression cassettes harbor regulatory elements that
exercise control over the cell-type specificity as well as the timing of gene expres-
sion. I could show that Co-Driver integrates both tissue-specific and temporal layers
of control when Dre and Roxed-Cre are expressed from two promoters with non-
identical transcriptional profiles. This directional mechanism of integrating transcrip-
tional activities of two individual promoters was evident in the developing mouse
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neocortex. Here, the combination of hGFAP and Thy1.2 expression constructs tar-
geted activation of a Cre reporter gene to distinct cell populations depending on
which expression construct harbored Dre or Roxed-Cre, respectively. While hGFAP-
dependent Thy1.2-Roxed-Cre expression restricted reporter gene expression to neu-
rons that were born shortly after these constructs were introduced into precursors by
in utero electroporation, Thy1.2-dependent hGFAP-Roxed-Cre expression resulted
in reporter gene activation in later-born neurons as well as cells of the glial lineages.
1.4.2. Novel binary SSRs & the established toolkit for mouse
transgenesis
In terms of versatility, Co-Driver combines the advantages of two classes of previ-
ously published binary SSR systems. Co-Driver relies exclusively on Cre-dependent
alleles to generate a binary output akin to Cre reconstitution systems (Hirrlinger et
al., 2009b; Wang et al., 2012) thus making it compatible with a plethora of available
Cre reporter lines (Madisen et al., 2010; Soriano, 1999; Livet et al., 2007; Schep-
ers et al., 2012), diphtheria toxin-based responder mice for conditional cell ablation
(Buch et al., 2005; Wu et al., 2006), and mice that harbor conditional knockout al-
leles (Skarnes et al., 2011). However, unlike these complementation systems that
function best when similar amounts of the two inactive Cre precursor polypeptides
are expressed, the Co-Driver cascade of two highly active SSRs should better tol-
erate a mismatch of transcriptional levels between the two driving promoters in a
manner similar to Cre/Flp systems (Dymecki et al., 2010). Conversely, the Cre/Flp
approach facilitates intersectional labeling of cells but relies on purpose-designed
dual-stop-cassette reporters and thus cannot be combined with currently available
Cre-responsive alleles.
In addition to Co-Driver, I have developed and characterized two additional obligate
binary SSR systems. First, a binary SSR cascade could also be constructed us-
ing the alternative SSR pair Bxb1/Cre, which generates native Cre recombinase
51
Chapter 1. Binary Recombinases for High Resolution Conditional Mutagenesis
upon Bxb1-mediated inversion of a reverse-complementary Cre expression cassette.
Thus we provide evidence that construction of sequential binary SSRs is a gener-
ally applicable concept for potentially any combination of SSRs, which exhibit high
individual recombination efficiencies and do not cross-react with each other’s recog-
nition sites. Linking SSRs in series could for example be used to connect several
SSR-based genetic logic circuits (Bonnet et al., 2013; Siuti et al., 2013) to obtain
higher order logic devices for synthetic biology applications in bacteria and mam-
malian cells.
Second, I have constructed Co-InCre, a coincidental binary SSR system employ-
ing highly active split-inteins to reconstitute a native Cre polypeptide from N- and
C- terminal precursors upon their simultaneous expression. Co-InCre showed un-
precedented activity particularly in low-expressing transfected cells with a 2.5-fold
increase in recombination efficiency of a genomic target relative to other binary
SSRs tested. The improvement in recombination efficiency of Co-InCre over the
recently published DnaE-based split-intein-split-Cre (Wang et al., 2012) most likely
results from the combined effects of higher expression levels facilitated by mam-
malian codon-optimized Cre (Shimshek et al., 2002) in combination with seamless
and faster protein-splicing activity of the gp41-1 split-intein (Carvajal-Vallejos et al.,
2012). In combination with simultaneously active promoters, Co-InCre most likely
provides faster kinetics by reconstituting Cre on a protein level than sequential bi-
nary SSRs, which rely on two individual recombinases and thus on two subsequent
cycles of transcription and translation.
1.4.3. Considerations for generating binary SSR-transgenic
animals
Since its discovery, Cre recombinase has been unrivaled in creating tissue-specific
driver lines and most complications observed in Cre-mediated conditional transgene-
sis seem to be related to the choice of promoters and design of expression cassettes
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rather than intrinsic Cre SSR activity (Schmidt-Supprian and Rajewsky, 2007). My
aim was to generate binary SSRs with the highest possible activity and therefore we
focused on optimizing recombination efficiency in standardized model systems that
allowed direct comparison with Cre. This strategy should result in dual-promoter-
driven conditional transgenic animals that match the advantageous characteristics
of many Cre driver lines. However, just as in the case of Cre, not every promoter
combination will result in informative recombination patterns. Conversely, for cer-
tain populations of cells a strategy incorporating binary SSRs expressed from two
strong yet intersectional promoters might be superior to Cre being controlled by a
single promoter that is specific but low in transcriptional output.
The need for identifying cell sub-populations with an increased resolution is high-
lighted by the continuous improvements of histological methods (Gerner et al., 2012)
and flow cytometry (Bendall et al., 2011) with the goal to increase the number
of markers that can be analyzed simultaneously. I expect that high-resolution lin-
eage tracing will complement these efforts with its unique capacity to create genetic
records of developmental transitions. This will facilitate the inference of relationships
between precursor and differentiated cells or cells that undergo transdifferentiation
processes, which is difficult to conclude from immunodetection methods capturing
only the current state of expressed markers. For certain biological questions tem-
poral control of binary SSR function might be required. Ligand-dependent variants
of all Co-Driver and Co-InCre components can be created with suitable solutions re-
ported in the form of CreERT2 (Feil et al., 1997), DrePBD* (Anastassiadis et al.,
2009), Split-CreERT2 (Hirrlinger et al., 2009a), and more recently trimethoprim-
controlled destabilized Cre (Sando et al., 2013). Performing binary SSR-based
lineage tracing requires the generation of mice that, including the Cre-responsive
gene, harbor at least three transgenes. Recent advances in genome editing tech-
nologies (see also Chapter 2 of this thesis) such as combinations of ZFN (Cui et al.,
2011; Hermann et al., 2012; Meyer et al., 2010) or TALEN (Wang et al., 2013a) with
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plasmid-based targeting constructs promise the rapid generation of animals with tar-
geted integration of Co-Driver or Co-InCre components into genomic loci providing
suitable expression profiles. Potentially, a binary SSR founder animal can be pro-
duced in one step by CRISPR/Cas9-mediated multiplexed genome editing in the
mouse embryo (Yang et al., 2013).
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Gene synthesis and template plasmids
Codon-optimized SSRs Bxb1, B3 and KD (Genscript) and gp41-1 and DnaE split-
inteins (IDT) were gene-synthesized. DreO was a generous gift from C. Monetti.
For the construction of Co-InCre expression plasmids codon-optimized Cre (iCre,
Shimshek et al., 2002) was split into a N-terminal (aa 19-59) and a C-terminal (aa
60-343) fragment. Amino acid sequences for gp41-1N and gp41-1C split-intein
fragments (Dassa et al., 2009) were back-translated using Emboss Backtranseq
(http://www.ebi.ac.uk/Tools/st/emboss_backtranseq/) with mouse codon usage and
fused to N- and C-terminal iCre fragments respectively.
The Roxed-Cre expression plasmid was constructed by introducing a rox-flanked
STOP cassette (based on the STOP cassette of the Ai6 targeting construct, Madisen
et al., 2010, Addgene plasmid 22798) in between iCre codons 177 (aa 59) and 180
(aa 60). A single nucleotide (G) was introduced 5’ of the rox-site to create an in-
frame insertion of 33 bp into the iCre open reading frame upon Dre recombination.
Golden Gate cloning
All constructs for constitutive mammalian expression were assembled using Golden
Gate cloning (Engler et al., 2008) of PCR products into a pCAG-T7 destination
vector. The standard pCAG-T7 destination vector is based on the plasmid pCAG-
RabZFN-L (a generous gift by R. Kühn, Meyer et al., 2012). The RabZFN-L CDS
was excised using BglII and SacI. A BglII-Esp3I-LacZ-Esp3I-SacI fragment was gen-
erated using PCR with primer overhangs from pTAL4 (Cermak et al., 2011), digested
with BglII and SacI and ligated with the linearized pCAG-T7 backbone generating the
pCAG-T7 destination vector.
Esp3I digestion of the pCAG-T7 destination vector excises the LacZ cassette and
generates a 3’ GTGG overhang downstream of the CAG/T7 promoter and a 5’ GTCA
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overhang upstream of the polyadenylation signal. Single or multiple inserts for
golden gate cloning into pCAG-T7 destination were generated by PCR using primers,
which add Esp3I recognition sites and appropriate overhangs to the 5’ and 3’ ends
of the PCR products. Primers were designed in a way that Esp3I digestion of PCR
products always generates a 5’ CACC overhang on the first insert and 3’ CAGT
overhang on the last insert, which each are compatible with the overhangs in the
pCAG-T7 destination vector. Additional 4 bp overhangs required for the ligation of
multiple inserts to each other are designed in a way that the 3’ overhang of the first
insert is compatible with the 5’ overhang of the second insert and so on. Addition-
ally, 4 bp overhangs for linking inserts 1 with 2 and 2 with 3 and so on were selected
by the following design rules to avoid incorrect assembly of multiple fragments. All
overhangs (including the overhangs compatible with the destination vector) should
differ from each other in at least two subsequent bases and overhangs should be
non-palindromic. PCR fragments for golden gate assembly were amplified using the
proofreading polymerase Herculase (Agilent) and purified using either the QIAquick
PCR Purification Kit or the QIAquick Gel Extraction Kit (both Qiagen).
Golden gate reactions were set up with (1) 75 ng or 150 ng of pCAG-T7 destina-
tion vector, (2) insert(s) in a 2:1 molar ratio to the destination plasmid, (3) 1x T4
ligase buffer (NEB), (4) T4 ligase (400 U, NEB), (5) Esp3I (10 U, Thermo Scientific).
Golden Gate reactions were incubated in a thermocycler with the following program,
(37°C/5 min, 16°C/10 min) 10-50 cycles, 50°C/5 min, 80°C/5 min.
Standard cloning
hGFAP and Thy1.2 expression constructs were assembled using standard cloning
techniques. hGFAP expression constructs are based on hGFAP-fLuc (Cho et al.,
2009, Addgene plasmid 40589). The luciferase polyadenylation signal (pA) cassette
was excised from hGFAP-fLuc using the restriction enzymes HindIII and BamHI. A
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HindIII-EcoRI-Dre-P2A-BFP-pA-BglII insert was created by PCR with primer over-
hangs from the template pCAG-T7-Dre-P2A-BFP, digested with HindIII and BglII,
and cloned into the HindIII/BamHI linearized hGFAP backbone to create hGFAP-
Dre-P2A-BFP. Subsequently Dre-P2A-BFP-PA was excised using EcoRI and SalI
and a EcoRI-Roxed-Cre-SalI fragment was inserted to create hGFAP-Roxed-Cre.
Thy1.2 expression constructs are based on Thy1 promoter construct (Feng et al.,
2000, Addgene plasmid 20736). The Thy1 promoter construct was linearized us-
ing XhoI and XhoI-flanked Dre-P2A-BFP or a SalI-flanked Roxed-Cre fragment was
inserted to create Thy1.2-Dre-P2A-BFP and Thy1.2-Roxed-Cre, respectively.
All plasmids that were submitted for public distribution to Addgene are shown in
Table A.1 in the Appendix.
Transformation of E. coli and plasmid purification
Ligation reactions were desalted using drop dialysis with membrane filters (25 mm,
pore size 0.025 µm, Millipore) on ddH2O. Electrocompetent E. coli (Top10 Elec-
trocomp, Life Technologies) were transformed using a MicroPulser electroporation
apparatus (Biorad) and electroporation cuvettes (1 mm, Cell Projects). Bacteria
were plated on Luria-Bertani (LB) agar (Sigma) plates with the appropriate antibiotic
(Ampicillin, 100 µg/ml; Kanamycin, 50 µg/ml; Spectinomycin, 50 µg/ml; Tetracycline
10 µg/ml) and if blue-white selection was required additionally with 40 µg/ml Xgal
(5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside, Sigma). Plasmids were puri-
fied from 2-5 ml bacterial culture (in LB, Sigma) using the QIAprep Spin Miniprep Kit
and from 50-100 ml culture using the Plasmid Midi Kit (both Qiagen).
Animals
Ai6 and Ai14 mice (Madisen et al., 2010) were purchased from Jackson Laboratories,
USA and CD1 mice were purchased from Charles River, Germany. All animals were
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maintained in temperature- and light-controlled rooms (12 light/12 dark, light on from
6:00 a.m.) with food and water ad libidum. All experiments including laboratory
animals were approved by the Cantonal Veterinary Office of Zurich. The protocol of
animal handling and treatment was in accordance with Swiss Federal and Cantonal
regulations as well as the internal guidelines of the University of Zurich.
Cell-lines and Transfection
MEF-Ai6 were derived from hemizygous Ai6 reporter mice (Madisen et al., 2010)
and immortalized using standard methods (Xu, 2005). HEK293T and MEF-Ai6
were cultured in Opti-MEM and DMEM, respective, each with the addition of 10%
fetal bovine serum (FBS), 1% Glutamax, and Penicillin/Streptomycin (all Gibco).
HEK293T and MEF-Ai6 were transfected in a 6 well format using X-tremeGene 9
(Roche) in a 4:1 transfection reagent/DNA ratio. Individual combinations of pCAG-
T7 plasmids encoding recombinases reporters were adjusted to a total DNA amount
of 1 µg using pUC57 as an inert carrier plasmid. The specific amounts of plasmids
transfected into HEK293T were 50 ng for mCherry, 100 ng each for all plasmids en-
coding SSRs, Dre-dependent Cre variants, or coincidental SSR components, and
250 ng for all ZsGreen-based SSR reporter plasmids and for single color ZsGreen
and mCherry control transfections. Transfections of MEF-Ai6 included 50 ng each
for all types of plasmids.
For quantifications, transfections of each distinct combination of plasmids were re-
peated three times with each replicate experiment including independent DNA prepa-
rations for each plasmid, independent transfection reagent/medium preparations
and independently seeded cell populations.
For MEF-Ai6, Cre-mediated excision of the Ai6 stop cassette was detected using
genotyping PCR with the primers Ai6-F, TTT TCC TAC AGC TCC TGG GC; Ai6-R,
GGC ATT AAA GCA GCG TAT CC.
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Flow Cytometry
HEK293T and MEF-Ai6 cells were trypsinized and collected in PBS with 10% fetal
bovine serum (FBS) 24h and 72h after transfection, respectively. Cells were ana-
lyzed on a BD LSRII Fortessa. ZsGreen fluorescent protein was excited using a
488 nm laser and detected using a 525/50 filter. mCherry fluorescent protein was
excited using a 561 nm laser and detected using a 610/20 filter. Single color con-
trols are shown in Supplementary Figure 8. For HEK293T, a minimum of 20.000
and for MEF-Ai6, a minimum of 5.000 mCherry-positive events were recorded. Data
analysis was performed using FlowJo software and flow plots were processed using
Adobe Illustrator.
in utero Electroporation
Uteri of timed-pregnant mothers (CD1, 14.5 days after mating with Ai14-homozygous
males) anaesthetized with isoflurane in an oxygen carrier (Merial Animal Health)
were exposed through a 2 cm incision in the ventral peritoneum. Embryos were
lifted through the incision and placed on humidified gauze pads. DNA (0.5 µg of
each recombinase plasmid and 1 µg of EGFP plasmid) was injected through the
uterine wall into the telencephalic vesicle using pulled borosilicate needles and a
Femtojet microinjector (Eppendorf). Electric pulses were applied using 5 mm plat-
inum tweezers electrodes (CUY650P5, Nepagene) and an ECM-830 BTX square
wave electroporator (BTX, Gentronic, Inc.). Uterine horns were then placed back
into the abdominal cavity and the abdomen wall and skin were sutured using surgi-
cal needle and thread.
Histology, Immunohistochemistry, and Fluorescence Imaging
In utero electroporated Ai14-hemizygous mice were sacrificed at P9-10 and per-
fused with ice-cold 4% PFA in PBS. Brains were harvested and post-fixed in 4%
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PFA in PBS for at least 4h on ice. Whole-mount brains were visually inspected
using an Olympus SZX12 stereo microscope equipped with epi-fluorescence illu-
mination and brains with similar-sized areas of EGFP fluorescence were selected
for further analyses. 50-60 µm-thick coronal brain sections were prepared using a
VT 1000S vibratome (Leica), mounted (Dako Fluorescence Mounting Medium) and
imaged using a Fluoview FV10i confocal microscope (Olympus).
Immunostainings were performed by permeabilizing and blocking free floating brain
sections in PBS with 1% bovine serum albumin (BSA, Sigma) and 0.5% Triton X-
100 (Sigma) at 4°C over night. Primary and secondary antibodies were diluted in
PBS with 0.5% BSA and 0.25% Triton X-100 and brain slices were incubated with
primary antibody at 4°C for 48h and with secondary antibody for 24h. Slices were
washed with PBS with 0.5% BSA and 0.25% Triton X-100 in-between incubations
and with PBS prior to mounting. A mouse monoclonal anti-NeuN antibody (1 µg/ml,
clone A60, Millipore) and a goat anti-mouse Alexa Fluor 647 secondary antibody
(Life Technologies) were used for immunostainings.
Images were processed using ImageJ or Imaris (Bitplane Scientific Software) and
panels were arranged using Adobe Illustrator.
Quantifications and Statistical Analysis
Recombination efficiency was determined as the percentage of mCherry-positive
cells showing ZsGreen fluorescence. Cre recombination efficiency served as a stan-
dard and all replicates were divided by mean Cre recombination efficiency thus
transforming data to percentage of Cre recombination efficiency. Standard devia-
tion (S.D.) was calculated for transformed replicates and is shown as error bars in
bar graphs. Two-way ANOVA with Bonferroni post-hoc test was used to compare
multiple means. The number of EGFP+ cells and tdTomato+ cells per coronal brain
sections was determined in a single confocal plane and for each fluorescent channel
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individually using the automatic spot detection function with default parameters (es-
timated xy diameter = 12.4 µm) implemented in Imaris (Bitplane Scientific Software).
The spot detection threshold was manually set using the “quality filter” and detected
spots were manually curated to eliminate spots marking false-positive detected cell
bodies and add spots for false-negative undetected cell bodies. Based on the prox-
imity of individual spots marking EGFP+ and tdTomato+ cells, respectively, EGFP+
tdTomato+ cells were annotated manually and EGFP/tdTomato co-localization was
validated in an overlay image of the green and red fluorescence channels (the work-
flow is outline in the Appendix, Figure A.1). Average numbers of cells were calcu-
lated for three mice per group and three coronal sections per mouse. Student’s t-test
(two-tailed) was used to compare two means. For all statistical analyses, a p-value
of less than 0.05 was considered significant.
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2.1. Introduction
2.1.1. The cellular prion protein & its physiological functions
The cellular prion protein, PrPC, is a highly conserved and ubiquitously expressed
glycosylphosphatidylinositol (GPI)-anchored extracellular protein (Aguzzi et al., 2008).
The protein-coding sequence of mouse PrPC (254 amino acids) is incorporated into
a single exon of the Prnp gene located on chromosome 2. Nascent PrPC contains an
N-terminal secretory signaling peptide (aa 1-22) and a C-terminal membrane anchor
region (aa 232-254), which are both cleaved off during export and GPI-anchoring of
PrPC to the cell surface. Mature PrPC consists in principle of two structurally distinct
domains, the N-terminal flexible tail (aa 23-123) and the C-terminal globular domain
(aa 124-231) (Riek et al., 1996; Hornemann et al., 1997). Within the flexible tail
two charged clusters (CC1 and CC2) flank five octapeptide repeats (ORs) and are
followed by the hydrophobic core (HR). The globular domain is comprised of three
α-helices and two β-strands. In prion diseases, also known as transmissible spongi-
form encephalopathies, PrP C is converted into PrPSc, a misfolded conformer, which
forms extracellular aggregates (Aguzzi et al., 2008).
In the mouse, Prnp mRNA expression was detected as early as embryonic day 8.5
(Miele et al., 2003) and abundance of both Prnp mRNA and protein increases post-
natally throughout most regions of the brain (Linden et al., 2008). In adult animals,
PrPC is detected in a multitude of cells in neural and non-neural tissues (Linden
et al., 2008) indicating important functions of PrPC across different organ systems.
Despite extensive efforts revealing the physiological role of PrPC has proven diffi-
cult. Several Prnp-/- mouse lines created independently by classic gene-targeting
(see below) have been subjected to phenotypic analysis however many functions
attributed to PrPC based on these experiments are not well understood on a mecha-
nistic level and have often been disputed in subsequent studies (Steele et al., 2007;
Striebel et al., 2013). The most striking phenotype of Prnp-/- mice is their resistance
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to prion disease showing that the cellular prion protein is absolutely required for dis-
ease progression (Büeler et al., 1993). One of the best documented physiological
roles of PrPC has been demonstrated in the peripheral nervous system. Here, PrPC
expressed on neurons plays a role in long-term maintenance of the myelin sheath
as aged Prnp-/- mice and mice with conditional neuronal ablation of Prnp suffer from
a chronic demyelinating polyneuropathy (Bremer et al., 2010).
2.1.2. Gene-targeting & the implications for mouse genetics
Over the past 20 years, gene-targeting based on homologous recombination in
mouse embryonic stem (ES) cells has been the core technology for introducing a
wide variety of modifications into the mouse genome (Capecchi, 2005). In ES cells,
homologous recombination between a target locus and a targeting vector carrying
the investigator-defined gene modification occurs at a low frequency. Thus ES cell
clones carrying the desired modification are enriched by a positive-negative regimen
(Capecchi, 2005). Successfully targeted clones are then injected into a mouse blas-
tocyst and these manipulated embryos are transferred to a pseudo-pregnant foster
mother. Offspring are chimeric mice, which have a tissue composition that is par-
tially derived from the engineered ES cells. Germline-competent chimeric founders
can then be used to established a mouse line carrying the desired gene modification
in all cells.
Gene-targeting has proven successful with the generation of several 1000 mouse
lines harboring targeted gene modifications. However, using these mice as genetic
models is often accompanied by several challenges due to the technical limitations
in manipulating ES cells. Most notably, the derivation of highly germline-competent
ES cells has for a long time been restricted to non-standard mouse strains such as
129 and has only recently been successfully adapted for the widely used C57BL/6
strain (Poueymirou et al., 2007). As a result chimeric founders were typically exten-
sively backcrossed to C57BL/6 mice with the goal to generate congenic mice that
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carry the intended genetic modification but are otherwise genetically highly similar or
identical with wild-type C57BL/6 mice. In many cases such as congenic Prnp-/- mice
long stretches of ES cell-derived genomic DNA flank the modified locus and can har-
bor several 100 polymorphic genes. Some single nucleotide polymorphisms (SNPs),
which co-segregate with the Prnp-/- allele might affect the expression levels or the
function of flanking gene products. These unintended genetic alterations could con-
found functions attributed to PrPC based on the phenotype of Prnp-/- mice. Nuvolone
et al., 2013 have recently shown that the hyperphagocytic phenotype observed in
Prnp-/- mice is not related to the ablation of PrPC but the presence of a 129-derived
variant of the Sirpa (signal regulatory protein α) gene. Similarly, additional polymor-
phic flanking genes could be responsible for other disputed Prnp-/- phenotypes such
as susceptibility to experimentally induced seizures (Striebel et al., 2013). Thus a
Prnp-/- mouse with a pure C57BL/6 genetic background would be highly desirable for
avoiding genetic confounders in the search for the physiological functions of PrPC.
2.1.3. Genome Editing Technologies
Nucleases with protein-based DNA recognition domains. Zinc fingers and tran-
scription activator-like effectors are currently the most widely used modular DNA-
binding protein domains for the construction of designer nucleases. Zinc finger nu-
cleases (ZFN) incorporate Cys2His2 zinc finger modules, which are derived from nat-
urally occurring eukaryotic transcription factors. Each zinc finger consists of about
30 amino acids forming one α-helix and two β-strands (Berg, 1988; Pavletich and
Pabo, 1991). Individual zinc fingers typically contact 3 bp in the major groove of
DNA and functional synthetic zinc finger arrays incorporate three to six modules
recognizing 9-18 bp DNA sequences (Liu et al., 1997). Several openly accessible
as well as proprietary libraries of natural and artificial zinc finger modules recogniz-
ing the majority of the 64 possible nucleotide triplets have been established (Carroll,
2014; Urnov et al., 2010). Zinc finger arrays with custom specificities can be pro-
duced by modular assembly of one-finger (Carroll et al., 2006; Wright et al., 2006)
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or two-finger modules (Moore et al., 2001; Doyon et al., 2008) with predefined bind-
ing characteristics or by selection-based methods such as the Oligomerized Pool
Engineering (OPEN) protocol (Maeder et al., 2009).
The DNA-binding domains of transcription activator-like effector nucleases (TALEN)
are derived from transcriptional activators that plant-pathogenic bacteria of the genus
Xanthomonas introduce into host cells to facilitate infection (Bogdanove and Voytas,
2011). TALE specificity is mainly determined by a series of repeat domains 33-35
amino acids in length, which contain so called repeat variable diresidues (RVD) in
positions 12 and 13. Residue 13 of each RVD contacts a single DNA base pair
with standard RVDs HD recognizing C:G, NG recognizing T:A, NN recognizing G:C
and NI recognizing A:T (Boch et al., 2009; Moscou and Bogdanove, 2009). TALE
recognition sites are commonly 15-21 bp in length with an additional preferred T in
position 0, which is recognized by a cryptic module in the TALE N-terminus (the last
base pair of a target site is recognized by a partial repeat, referred to as half-repeat).
The repetitive nature of TALE domains presents a technical challenge for assem-
bling custom arrays but several molecular cloning techniques have been introduced
that allow rapid construction of custom TALENs (Cermak et al., 2011; Reyon et al.,
2012; Briggs et al., 2012; Schmid-Burgk et al., 2013).
Both ZFN and TALEN function as pairs with scission of a DNA double strand per-
formed by the dimerizing Fok I cleavage domain (Li et al., 1992), which is fused to
the C-terminus of each ZFN and TALEN monomer (Kim et al., 1996; Christian et al.,
2010). An important parameter for productive FokI dimerization is the size of the
spacer between nuclease monomer binding sites. For ZFN a spacer of 5 or 6 bp
is required, while the the truncated TALEN architecture introduced by Miller et al.,
2011 tolerates 12-20 bp with an optimum at 14-16 bp. FokI domains have been engi-
neered to function as heterodimers (Miller et al., 2007) with the aim to substantially
reduce dimerization of identical nuclease monomers, which could cause cleavage at
undesired off-target sites. Further directed evolution of FokI performed by Guo et al.,
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2010 and Doyon et al., 2011 has led to an improved activity of these heterodimeric
domains.
Programmable RNA-guided nucleases. Another addition to the collection of de-
signer nucleases originates from an adaptive immune system frequently found in
bacteria and archaea (Sorek et al., 2013). These organisms when invaded by
phages or plasmids are capable of capturing fragments of foreign DNA with a size
of approximately 20 bp and integrate these sequences known as protospacers into
their own genome to form a clustered regularly inerspaced short palindromic re-
peat (CRISPR). In the case of Type II CRISPR systems, these CRISPR loci are
transcribed into CRISPR RNA (crRNA) containing a single protospacer and part of
a repeat and a second trans-activing crRNA (tracrRNA), which is partially comple-
mentary to the repeat. Association of both crRNA and tracrRNA with the CRISPR-
associated protein (Cas)9 results in the formation of an active DNA endonucle-
ase. The Cas9-crRNA/tracrRNA complex recognizes and cleaves a 23-bp DNA
sequence, which is composed of the guide sequence, i.e. the protospacer, in the
crRNA and a 5’-NG/AG consensus sequence, which is recognized by Cas9 itself
and was termed protospacer adjacent motif (PAM) (Kim and Kim, 2014).
The RNA-guided mechanism of Cas9 DNA cleavage allows investigators to target
novel DNA sequences without the need to re-engineer proteins as it is the case
for genome editing with ZFN or TALEN. Several groups have constructed hybrids
of crRNA/tracrRNA (Hsu et al., 2013; Jinek et al., 2013), which are now generally
referred to as single-chain guide RNAs (sgRNA) and are transcribed using plasmids
containing an RNA polymerase III promoter.
Gene disruption and targeted integration. The basic principle of genome editing
is the introduction of a DNA double-strand break (DSB) at a defined target site by
using one of the designer nuclease platforms. DSBs are repaired by cells using two
alternative mechanisms (Symington and Gautier, 2011), homologous recombination
(HR) with an intact sister chromatid or homologous chromosome or non-homologous
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end joining (NHEJ). While HR typically results in faithful repair of a DSB, NHEJ is
error-prone causing small insertions and deletions in repaired genomic sequences.
Mutagenic NHEJ-repair triggered by designer nucleases within protein-coding se-
quences can introduce a frameshift mutation, which disrupts the function of a gene
(Carroll, 2014). Some frameshift mutations will additionally result in the introduc-
tion of a premature stop codon leading to production of mRNA, which is degraded
by nonsense-mediated decay (Huang and Wilkinson, 2012). Genome editing ap-
proaches aiming at gene disruption by NHEJ have so far been successful in virtually
all organisms and cell-types that are amenable to the introduction of foreign nucleic
acids (Carroll, 2014).
When designer nucleases are combined with extrachromosomal repair templates,
which are often referred to as donor constructs, the introduction of a DSB can be
exploited for the targeted insertion of exogenous DNA sequences by HR (Moehle
et al., 2007). To serve as an HR substrate donor constructs must have sufficient
homology with the target locus. Double-stranded donors typically include homology
arms with a length in the range of 800 to 4000 bp (Meyer et al., 2010; Cui et al.,
2011; Perez-Pinera et al., 2012). Single-stranded oligonucleotide donors with as
little as 40 bp total homology have also been successfully used (Chen et al., 2011).
However, partial integration is frequently reported for this type of donor (Chen et
al., 2011; Wefers et al., 2013), which typically is not the case when long double-
stranded targeting constructs are used. In general, NHEJ-mediated repair has been
observed with higher frequencies than targeted integration by HR independent of
the type of designer nuclease or donor configuration (Meyer et al., 2010, 2012; Yang
et al., 2013; Perez-Pinera et al., 2012; Bedell et al., 2012).
Genomic loci that have received special interest for nuclease-assisted targeted inte-
gration of large (> 2 kb) transgenes are the so called safe harbors, which allow stable
ubiquitous expression in the vast majority of cell types and during most developmen-
tal stages. The most frequently used safe harbor target sites are located within intron
1 of the mouse gt(ROSA26)Sor (or ROSA26) on chromosome 6 (Zambrowicz et al.,
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1997) and a locus between exon 1 and intron 1 of the human PPP1R12C gene,
which is an integration site of the human adeno-associated virus (AAV) (Samulski et
al., 1991). Both sites have been accessible to classic gene-targeting and ROSA26
has become the standard locus for the integration of reporter genes in transgenic
mice (Soriano, 1999; Madisen et al., 2010).
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2.2. Outline
In this chapter I present the development and adaptation of designer nucleases for
editing the mouse and human prion protein gene as well as the mouse ROSA26
locus. The experiments outlined here aimed at identifying designer nuclease archi-
tectures providing high DNA cleavage efficiency.
Two distinct ZFN pairs allowed the targeted integration of large reporter genes into
the ROSA26 locus directly in mouse embryos. The first Prnp knock-out mouse
with a pure C57BL/6 genetic background was generated by microinjecting embryos
with Prnp-specific TALEN pair. A CRISPR/Cas9-based approach allowed bi-allelic
modification of the human PRNP gene in HEK293T cells.
Isogenic C57BL/6 Prnp knock-out mice and PRNP knock-out HEK293T cells are
valuable model systems for dissecting the physiological function of PrPC. Impor-
tantly these two systems avoid genetic confounders present in other knock-out mice
generated by gene-targeting in mouse ES-cells. ZFN-based ROSA26 targeting sig-
nificantly accelerates the generation of mice harboring conditional alleles for tissue-
specific expression of reporters and orther transgenes. Since this approach is not
limited to mice with a particular genetic background ROSA26 targeting can also be
performed directly in C57BL/6 Prnp knock-out animals.
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2.3. Results
2.3.1. ZFN-mediated targeted integration into the ROSA26 locus
The mouse ROSA26 locus is a “safe harbor” frequently used for site-specific inser-
tion of transgenes by HR. Previous studies have demonstrated the feasibility of gene
targeting in the ROSA26 locus by use of commercially available ZFNs (Meyer et al.,
2010). In a complementary approach I investigated whether OPEN ZFNs (provided
by J. Keith Joung and Morgan Maeder, Massachusetts General Hospital) also allow
modification of the ROSA26 locus. Due to design constraints of the OPEN system
it was, however, not possible to target a ZFN pair directly to the XbaI site in the
ROSA26 locus that is frequently used to insert transgenes. Instead, two ZFN pairs
that could mediate DNA cuts in proximity of this XbaI site were used. These ZFN
pairs, 90/91 and 204/205, target the ROSA26 sequence 75 and 403 bp upstream of
the XbaI site, respectively (Figure 2.1A).
Initial experiments aiming at the selection of the most active OPEN design and opti-
mization of microinjection conditions were conducted by Pawel Pelczar and Thorsten
Buch. All microinjections shown in this chapter were performed by Pawel Pelczar.
ZFN architectures incorporated either homodimeric or first generation heterodimeric
FokI domains that were reported to reduce ZFN-induced off-target mutagenesis
(Miller et al., 2007). All ZFN pairs were in vitro transcribed and polyadenylated
to generate mRNA for cytoplasmic microinjections of zygotes.
Cytoplasmic microinjection of mRNAs encoding the OPEN 90/91 heterodimeric pair
did not result in any discernible ZFN activity either in the form of imprecise NHEJ
or through HR upon co-injecting the pRosa26.8 donor construct (Meyer et al., 2010)
that targets the XbaI site 75 bp downstream of the 90/91 cleavage site (Table 2.1).
Also cytoplasmic microinjection of mRNAs encoding the OPEN 204/205 homod-
imeric ZFN pair at a concentration of 10 ng/µl did not result in genome modification
through NHEJ. Co-injection of the same mRNAs with a newly constructed targeting
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Z20 wt 
Pup/Fetus Sequence Ins/Del 
TCTGGCCGCGCGCCCCTGCGCAACGTGGCAGGAAGCGCGCGCTG wt 
Z20 TCTGGCCGCGCGCCCCCCT:::::GTGGCAGGAAGCGCGCGCTG 8 +3 
Z23 TCTGGCCGCGCGCCCCTGCGCGACGTGGCAGGAAGCGCGCGCTG 1 +1 
ZGFP35 TCTGGCCGCGCGCCCCTGC::::::::::AGGAAGCGCGCGCTG 10 
ZGFP70 TCTGGCCGCGCGCCCCCCT:::::GTGGCAGGAAGCGCGCGCTG 8 +3 
ZGFP76 TCTGGCCGCGCGCCCCTG:::::::::GCAGGAAGCGCGCGCTG 9 
ZGFP90 TCT:::::::::::::::::::::::::::GGAAGCGCGCGCTG 27 
ZGFP103 TCTGGCCGCGCGCCCCTGC::::::::::AGGAAGCGCGCGCTG 10 
ZGFP112* TC:::::::::::::::::::::::TGGCAGGAAGCGCGCGCTG 23 
ZTOM6 TCTGGCCGCGCGCCCCTGCGCCAACGTGGCAGGAAGCGCGCGCTG +1 
ZTOM25 :::::::::::::::::::::::::::::::::::::::::::: 66 
ZTOM37 TCTGGCCGCGCGCCCCTGCG:AACGTGGCAGGAAGCGCGCGCTG 1 
ZTOM55 TCTGGCCGCGCGCCCCTGCG:::CGTGGCAGGAAGCGCGCGCTG 3 
*biallelic modification with identical 23 deletion 
A 
B 
D 
ZGFP 112 
bp 
300 
200 
500 
FspI XbaI RF RR 
474 bp 
403 bp R26 
ZFN 
204/205  
ZFN 
90/91  
ZFN 204                               ZFN 205  
75 bp 
RF + RR 
ZFN   
91  
  90 
cTGCTGCCTCctggctTCTGAGGACc
gACGACGGAGgaccgaAGACTCCTGg 
204 gCGCCCCTGCgcaacGTGGCAGGAa 
 205 cGCGGGGACGcgttgCACCGTCCTt 
Cleavage Site
C 
Figure 2.1.: OPEN ZFN-induced NHEJ repair within the ROSA26 locus. (A) Schematic
of ZFN 90/91 and 204/205 target sites within ROSA26 intron 1. RF and RR (black arrows),
ROSA26 forward and reverse primers generating a 474 bp PCR fragment used for NHEJ
analysis by FspI digestion as exemplified in (C). (B) DNA-binding sites (bold font) of individ-
ual ZFN proteins. (C) Most error-prone NHEJ repair events eliminate the FspI recognition
sequence (underlined in C) resulting in an indigestible band at 474 bp. In the majority of
founders such as Z20 both modified and wt alleles were detected, however only mutated
alleles were present in founder ZGFP112. (C) Cloning and sequencing of undigested PCR
products reveals mutations close to the ZFN204/205 cleavage site. Founder ZGFP112 car-
ried an identical Δ23 deletion in both ROSA26 alleles. ZFN 204/205 recognition sites are
highlighted in bold font and the spacer region in grey color.
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vector gtR26_EGFP containing an EGFP expression cassette and equipped with
1.4 kb and 1.8 kb long homology arms flanking the ZFN recognition site (Figure 2.2)
appeared, however, to be toxic. This toxicity also persisted upon co-injecting re-
duced concentrations (2 ng/µl) of 204/205 homodimeric mRNAs. Most importantly,
none of the experiments performed with the homodimeric pairs 90/91 and 204/205
led to any discernible activity in mouse zygotes.
Since mice showing mutagenesis of ROSA26 could not be recovered from zygotes
injected with homodimeric 90/91 and 204/205 ZFN I proceeded with generating mR-
NAs encoding the heterodimeric OPEN ZFN 204/205 pair. Cytoplasmic injections of
heterodimeric OPEN 204/205 ZFN mRNAs were well tolerated by the embryos and
led to efficient disruption of the ZFN 204/205 target sequence in a total of 12 founder
animals. Modifications of the ROSA26 target sequence was initially detected by FspI
digestion of a PCR product (Figure 2.1C) and confirmed through Sanger sequenc-
ing (Figure 2.1D). Founders carrying NHEJ-mediated disruptions were consistently
obtained across several injection sessions (Table 2.1). One of the injection series
yielded a founder in which both ROSA26 alleles had been mutated. These alleles,
which could be discriminated by a C/T SNP 33 bp upstream of the ZFN cleavage
site, contained identical 23 bp deletions (Figure 2.1C,D).
In order to investigate the potential of the 204/205 ZFN pair to recruit the HR re-
pair machinery to the ZFN cleavage site, we co-injected the ZFN mRNAs with a
linear DNA fragment of the targeting vector gtR26_EGFP. We identified 16 green-
fluorescent founder animals and could confirm that one of them carried the EGFP
cassette from the targeting vector correctly integrated into the ZFN target site. The
fidelity of integration of the targeting vector by HR was confirmed by Southern blot
analysis (Figure 2.2B) as well as by junction PCR and sequencing (Figure 2.2C, Fig-
ure 2.3). The integrated EGFP transgene was transmitted through the germ line to
the next generation and remained active in F1 offspring (Figure 2.2C, D).
In further experiments the full-length super-coiled gtR26_EGFP targeting vector was
co-injected, since vectors with super-coiled topology served as efficient donors in
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Figure 2.2.: OPEN ZFN promote ROSA26 targeting by homologous recombination. (A)
HR targeting strategy for the insertion of the targeting vector gtR26_EGFP carrying EGFP
driven by a CAG promoter into the ROSA26 locus. (B) Southern blot analyses of EcoRI
digested genomic DNA from a GFP-fluorescent animal showing site-specific integration into
the ROSA26 locus. Both 5’ and 3’ probes detect only one expected fragment in the DNA of
wild-type (wt) animal. Additional fragments detected in the DNA of targeted animal (ti) are
consistent with the integration of the CAG-EGFP cassette into one of the ROSA26 alleles.
(C) Germ line transmission of the ROSA26-CAG-EGFP allele was confirmed by junction
PCR in two F1 mice (ti allele, 3.2 kb, wt allele, 2.5 kB), one of which is depicted in (D).
Figure 2.3.: Integration of gtR26_EGFP by HR into the ROSA26 locus. The junction PCR
product shown in Figure 2.2C was cloned, partially sequenced and an alignment of the
sequencing results with the expected architecture of ROSA26 after gtR26_EGFP targeted
integration was generated.
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previous studies (Meyer et al., 2010; Cui et al., 2011). I observed a decrease in
random integration events compared to a linearized donor but failed, however, to de-
tected HR in this setup (Table 2.1). To test whether integration at the ZFN 204/205
cleavage site would allow transgene expression under the transcriptional control
of the ROSA26 promoter, co-injections of ZFN with the linear targeting construct
gtR26_tdT carrying a splice-acceptor tdTomato cassette were performed. Despite
identifying 12 pups that expressed tdTomato and several others carrying indepen-
dent NHEJ events, I could not identify any animals with homologous integration
of the gtR26_tdT vector. This result shows that in the presence of active ZFN
gtR26_tdT failed to serve as a donor construct for HR despite including homology
arms that were identical to gtR26_EGFP. The 12 tdTomato expressing mice are
most likely the result of random transgene integration and a partially active ROSA26
promoter that was included in the left homology arm of the gtR26_tdT construct.
Considering the outcome of all microinjection experiments, the percentage of foun-
der animals carrying genomic modifications resulting from OPEN ZFN activity seemed
to be significantly lower in comparison to other reports in which proprietary ZFN
technology was employed (Carbery et al., 2010; Meyer et al., 2010; Cui et al., 2011).
These studies also indicated a positive correlation between the frequency of ZFN-
induced NHEJ and HR events in mouse zygotes. Thus, an alternative highly active
(and freely accessible) designer nuclease targeting the ROSA26 locus would be
highly desirable in order to establish reliable targeted integration in mouse zygotes.
Gersbach and colleagues showed that highly efficient targeted integration can be
achieved in transfected mouse Neuro2A cells by ROSA26 ZFN that were constructed
by modular assembly (Perez-Pinera et al., 2012). This ZFN pair, designated R4/L6,
targets the standard integration site within intron 1 of ROSA26 by utilizing DNA-
binding domains of four and six individual zinc finger modules, respectively. This
pair also incorporates second generation heterodimeric FokI domains with improved
cleavage activity (Doyon et al., 2011; Guo et al., 2010). I adapted the R4/L6 ZFN
pair for microinjection of mouse embryos by cloning them into my standard pCAG-T7
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Figure 2.4.: Highly efficient induction of NHEJ repair by the ROSA26 ZFN pair R4/L6.
(A) Diagram depicting the ZFN R4/L6 target site within the ROSA26 locus and the loca-
tion of primer binding sites (F, R) utilized for detecting NHEJ events by XbaI digestion of
PCR products shown in (B). The presence of a full-length PCR product after XbaI digestion
indicates ZFN-induced mutagenesis. Stars denote founders with biallelic modifications of
the ROSA26 locus as indicated by the complete absence of a XbaI digestion product and
confirmed by Sanger sequencing in (C).
vector and in vitro synthesis of ZFN mRNAs. PCR analysis of founder animals born
after R4/L6 ZFN microinjection revealed a remarkably high rate of NHEJ-induced
mutagenesis. 20 out of 25 founders exhibited a partial (16 animals) or complete
(4 animals) loss of an XbaI site as result of ZFN R4/L6-induced NHEJ repair (Fig-
ure 2.4). Sequencing of PCR products that were fully resistant to XbaI digestion
confirmed the absence of both wild-type ROSA26 alleles in animals, #1, #10, #23
and #24. Animal #24 harbored at least three distinct ROSA26 mutations indicat-
ing that ZFN were active beyond the one-cell embryonic stage leading to a mosaic
genotype in this animal.
Having identified the highly active ZFN pair R4/L6 I attempted to target a large condi-
tional transgene to the ROSA26 locus. Therefore, the CAG promoter, a loxP-flanked
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Figure 2.5.: Targeted integration of a conditional Hygromycin-EGFP transgene
into ROSA26. (A) Targeting strategy based on ZFN R4/L6 and the donor construct
dR26_HygEGFP. Components of the targeting constructs, sizes of the insert and the
ROSA26 homology arms, and location of junction PCR primers used in (B) are shown. pA,
polyadenylation site; Hyg, Hygromycin. (B) Junction PCRs for indentifying founders with tar-
geted integration of the donor. Positive founders were identified by the presence of a PCR
product of 1 kb with primers RF + CR and a 1.8 kb PCR product with primers EF + RR.
STOP cassette containing mCherry and a polyadenylation signal, and a Hygromycin-
EGFP cassette followed by a polyadenylation signal were inserted into the ROSA26
targeting vector pzDonor-R26 (Perez-Pinera et al., 2012) thus generating the donor
construct R26_HygEGFP (Figure 2.5A). Co-injection of mouse zygotes with ZFN
R4/L6 and R26_HygEGFP resulted in the birth of 43 potential founder animals (16
of the strain C57Bl6, and 27 BDF1), out of which 13 exhibited mCherry fluorescence
indicating an integration event of the R26_HygEGFP donor. Junction PCR analyses
of the ROSA26 locus of these 13 animals revealed that 2 animals (one each of the
strains C57BL/6 and BDF1) were positive for targeted integration of R26_HygEGFP
(Figure 2.5B, Table 2.1).
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2.3.2. TALEN-mediated knock-out of Prnp in C57BL/6 mice
Targeting the ROSA26 locus with ZFN provided an experimental paradigm for opti-
mizing the parameters of genome editing in mouse zygotes as well as for establish-
ing screening methods for identifying founder animals with suitable genomic mod-
ifications. However, for editing genomic loci other than ROSA26 it seemed to be
difficult to identify suitable target sites for ZFN based on the publicly available OPEN
and modular assembly zinc finger libraries.
Earlier studies using genome editing approaches with the aim of disrupting the ex-
pression of a protein typically relied on introducing a DNA double-strand within the
genes protein coding sequence in close proximity to the start codon. Error-prone
NHEJ-repair of this double-strand break often introduces a frameshift and in some
cases a premature stop codon in the protein coding sequence of the gene of interest
(Geurts et al., 2009; Carbery et al., 2010). Depending on the nature of the intro-
duced mutation and the exon/intron architecture of a specific gene, translation of the
mRNA produced from a NHEJ-modified allele yields a non-functional or truncated
version of the native protein and mRNAs carrying premature stop codons can be
degraded by the non-sense-mediated mRNA decay pathway (Huang and Wilkinson,
2012).
The gene encoding the mouse prion protein, Prnp, consists of three exons with
exon 3 containing the complete open reading frame coding for PrPC. Thus, in order
to completely abolish PrPC expression, the introduction of a premature stop codon
close to the start of the open reading frame in exon 3 would be highly desirable. To
achieve this goal I employed a new class of designer nucleases known as TALEN
(Christian et al., 2010; Miller et al., 2011). TALEN consist of conserved N-terminal
and C-terminal domains (a FokI DNA cleavage domain is fused to the C-terminus),
which flank the main region providing DNA-binding specificity. Specific DNA se-
quences are bound by an array of repeat-variable di-residues (RVDs), with a single
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RVD recognizing an individual base of the DNA strand (Boch et al., 2009; Moscou
and Bogdanove, 2009).
For the design and construction of a TALEN pair that would specifically recognize
a DNA sequence in the Prnp open reading frame I adapted a TALEN assembly
strategy reported by Cermak et al. 2011 (Figure 2.6). This method is based on
two Golden Gate cloning steps (Engler et al., 2008) and allows the assembly of a
user-defined RVD array into a TALEN expression vector, which harbors the TALE
N-terminus and the C-terminus fused to the FokI domain. Since the original TALEN
assembly kit only included TALEN destination vectors for the expression in yeast and
plants, I developed a bi-functional TALEN expression vector, which allows production
of TALEN in transfected mammalian cells from the strong CAG promoter and in
vitro synthesis of TALEN mRNA from the T7 promoter (Figure 2.6B). To ensure
optimal dimerization and high cleavage activity of the FokI domains, CAG-T7 TALEN
expression constructs included truncated N- and C-terminal TALE domain reported
earlier by Miller et al., 2011 fused to second generation heterodimeric FokI domains
(Doyon et al., 2011; Guo et al., 2010).
The TALEN architecture introduced by Miller et al., 2011 provided the highest cleav-
age activity when the spacer region between the two TALEN monomers (where the
FokI domains dimerize) is 14-16 bp in length. Considering this parameter together
with the other TALEN design constraints (Bogdanove and Voytas, 2011) I could iden-
tify a TALEN binding site approximately 40 bp downstream of the Prnp start codon
with the left TALEN recognizing 16 bp, the right TALEN recognizing 17 bp, and a
spacer region of 16 bp (Figure 2.7A). I assembled this TALEN pair and produced
TALEN mRNAs using in vitro transcription.
TALEN mRNAs were microinjected into C57BL/6 fertilized oocytes at the concentra-
tions of 10 ng/µl and 100 ng/µl each in order to empirically determine the optimal
conditions for embryo survival and efficiency of on-target genome editing. A total
of 94 pups were born, which were analyzed for NHEJ-mediated mutagenesis us-
ing PCR and T7 endonuclease digestion (Figure 2.7B, C). Microinjections of TALEN
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Figure 2.6.: Golden Gate TALEN assembly strategy. (A) Up to 10 repeat-variable di-
residues (RVDs) are preassembled into pFUS vectors using Golden Gate cloning with the
Type II restriction enzyme BsaI. (B) Full-length TALEN are generated by inserting RVD-
arrays within pFUS vectors and the last half-repeat (within pLR) into the CAG-T7 TALEN
expression vectors with heterodimeric FokI domains (FokIELD, FokIKKR) using Golden Gate
cloning with the Type II restriction enzyme Esp3I. The assembly strategy was adapted from
Cermak et al., 2011 and the TALEN destination constructs were specifically developed for
mammalian expression and in vitro synthesis of TALEN mRNA.
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Figure 2.7.: Identification of founders with TALEN-mediated mutagenesis of Prnp. (A)
Schematic of the TALEN binding site within the Prnp protein-coding sequence. RVDs bind-
ing individual bases are color-coded (legend on the right). Analysis of genomic DNA ob-
tained from founders after microinjection of zygotes with (B) 10 ng/µl TALEN mRNAs and
(C) 100 ng/µl TALEN mRNAs for TALEN-induced error-prone NHEJ repair. A PCR was per-
formed with primers flanking the Prnp TALEN target site with subsequent T7 endonuclease
digestion of PCR products. NHEJ positive animals can be identified by the presence of T7
endonuclease digestion products.
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Figure 2.8.: Sequence analysis of TALEN-induced mutations in Prnp. (A) Founders with
mutated Prnp alleles. The Prnp start codon (bold) and TALEN binding sites (bold, yellow)
are highlighted in the wt Prnp sequence. (B) Founders TP6 and TP85 carry the Prnp alleles
Δ8 and Δ17, respectively, which introduce a premature stop codon (*) in proximity to the
Prnp start codon.
mRNAs at 10 ng/µl each resulted in 1 out of 44 newborns showing a T7 digestion
pattern indicative of mutagenesis at the TALEN target site. When TALEN mRNAs
were injected at 100 ng/µl a significantly higher number of pups (23 out of 50) were
NHEJ-positive (Figure 2.7D).
Subsequently, I determined the exact seqence of Prnp mutations present in NHEJ-
positive mice by cloning of PCR products and Sanger sequencing. Modified Prnp
alleles exhibited deletions with a size range of 1 to 17 bp within the TALEN spacer re-
gion (Figure 2.8A). Interestingly, a deletion of 8 bp (Δ8) occurred with an increased
frequency in multiple NHEJ-positive mice (5 out 18 mutated alleles) and seemed to
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be the result of microhomology-mediated end joining repair (McVey and Lee, 2008)
based on a TGTG motif within the TALEN target site. This Prnp Δ8 mutation as
well as the Prnp Δ17 mutation introduced a premature stop codon in close proximity
to the Prnp start codon and thus seemed to be promising candidates for disrupting
the expression of PrPC (Figure 2.8B). Additionally, both deletions eliminated an ad-
ditional in-frame ATG coding for methionine15, which could potentially serve as an
alternative start codon and the translation of PrPC with an N-terminally truncated
signaling peptide. Thus, founders TP6 (Δ8) and TP85 (Δ17) were bred to C57BL/6
with the goal to generate homozygous Prnp Δ8 and Δ17 mice in the F2 generation.
The code determining the nucleotide specificity of TALEN RVDs has been estab-
lished both by experimental (Boch et al., 2009) and bioinformatic (Moscou and Bog-
danove, 2009) means. However the overall DNA binding specificity of TALEN pro-
teins remains poorly characterized and TALENs might introduce DNA double-strand
breaks at unintended off-target sites. These off-target mutations, if passed on un-
detected to the offspring of Prnp Δ8 and Δ17 founders, might elicit phenotypes
erroneously attributed to the ablation of Prnp. Therefore I screened a limited num-
ber of off-target sites for NHEJ-mediated mutagenesis. I first used the TAL Effector-
Nucleotide Targeter tools (Doyle et al., 2012) to predict the most likely off-target sites
for both TALEN monomers within the mouse genome based on sequence similarity
to the Prnp TALEN target site. I selected 12 off-target sites at which both TALEN
monomers would bind with a spacer length allowing productive FokI dimerization
(Figure 2.9A). Four of these sites seemed to be located within repetitive regions of
the mouse genome preventing the design of suitable primers for PCR-based anal-
ysis of off-target TALEN cleavage. The remaining 8 off-target sites were probed
for TALEN-induced mutagenesis using T7 endonuclease digestion of PCR products
(Figure 2.9B). None of the investigated genomic loci, both in the Prnp Δ8 and the
Δ17 founder, showed a T7 digestion pattern that would indicate NHEJ-mediated
mutagenesis at the predicted off-target sites.
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Figure 2.9.: Analysis for off-target cleavage of Prnp-TALEN. (A) Predicted off-target sites
(OT) based on binding specificities of individual RVDs within the in Prnp-TALEN. Lower
scores indicate a higher probability of binding for a TALEN monomer. OTs in bold font
could be analyzed by PCR, suitable primers could not be designed for other OTs. (B) T7
endonuclease digestion of PCR products generated from OTs indicated above gels and
Prnp as a digestion positive control (lower gel undigested PCR products). Analysis was
performed for founders carrying Prnp Δ8 and Δ17 alleles, respectively and C57BL/6 mice.
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Figure 2.10.: Ablation of PrPC expression in PrnpΔ8/Δ8 mice. (A) Hemizygous PrnpΔ8/wt
were bred and the offspring (F2 generation) was genotyped. PrnpΔ8/Δ8mice can be identi-
fied by a single PCR product smaller in size compared to the PCR product amplified from
Prnpwt/wt genomic DNA. Multiple bands are detected for PrnpΔ8/wt mice. (B) Genotypes
were confirmed by direct sequencing of PCR products. Exemplary sequencing results for
mice F2-8 (Prnpwt/wt) and F2-9 (PrnpΔ8/wt) are shown. (C) Western blot analysis of PrPC
expression in the cortex of a PrnpΔ8/Δ8 animal (Δ8) using antibodies POM19 and POM13
with epitopes in the c-terminal globular domain of PrPC. C57BL/6 (wt) and Zurich I PrnpO/O
(ZH1) serve as controls. (D) Analysis of PrPC expression in cortex, spinal cord, and cere-
bellum using antibodies POM1 (globular domain) and POM2 (N-terminal octarepeat region,
OT).
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At the time of writing, homozygous Prnp Δ17 mice were not yet available and thus
only the characterization of homozygous Prnp Δ8 is reported. Once germ line
transmission of the Δ8 allele was confirmed, PrnpΔ8/wt were bred and the offspring
were genotyped (Figure 2.10A, B). Using PCR, gel electrophoresis, and sequenc-
ing, I could identify 5/9 mice with a PrnpΔ8/Δ8 genotype. Genomic DNA of one of
these PrnpΔ8/Δ8 animals was subjected to whole-genome SNP scanning (provided
by Taconic) to confirm it’s C57BL/6J genetic background. The interrogation of 1459
SNPs distributed across the 19 autosomes and the X chromosome showed that
based on these markers the PrnpΔ8/Δ8 mouse was genetically indistinguishable from
a wt C57BL/6J animal (Appendix, Table A.2).
PrPC expression levels in the central nervous system of a PrnpΔ8/Δ8 animal were de-
termined using western blot (Figure 2.10C, D). Protein extracts from the cortex, the
cerebellum, and the spinal cord were probed using a panel of antibodies (POM19,
POM13, POM1, and POM2), which bind to distinct epitopes in the N-terminal flexible
tale and the C-terminal globular domain of PrPC. PrPC could not be detected in any
of the PrnpΔ8/Δ8 tissues providing strong evidence that the premature stop codon
present in the Δ8 allele is sufficient to completely suppress the translation of PrPC
and is not permissive for the production of truncated PrPC.
Prnp knock-out mice generated by classic gene-targeting in mouse ES-cells such
as Zurich I carry a transgenic cassette integrated into Prnp locus. These exogenous
DNA sequences can be used for genotyping by designing primers that are specific
for the Zurich I but not the wt Prnp allele. However, since the Prnp Δ8 allele only dif-
fers from the wt allele by the loss of 8 base pairs, I evaluated alternative genotyping
strategies based on the size difference of PCR products (Figure 2.11). Here, I took
advantage of high-resolution capillary electrophoresis. First, I assessed the preci-
sion of size calling for single PCR products generated from PrnpΔ8/Δ8 and Prnpwt/wt
genomic DNA. I compared two PCRs with primers flanking the Prnp TALEN target
site that produce PCR bands from wt Prnp with a length of 86 bp and 356 bp, respec-
tively (Figure 2.11A). Both PCRs allowed discriminating PrnpΔ8/Δ8 and Prnpwt/wt mice
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based on the detected sizes of the PCR products, however size calling was more
precise for the 86 bp PCR compared to the 356 bp PCR. Hemizygous PrnpΔ8/wt mice
could be easily discriminated from the homozygous genotypes by the presence of
multiple PCR bands present in both PCRs.
Next, I attempted to genotype newborn mice and again compared the two PCR
approaches. These mice were the offspring of three different breeding schemes,
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Figure 2.11.: High-resolution genotyping of Prnp Δ8 mice. (A) Evaluation of the resolu-
tion of Qiaxcel capillary electrophoresis using two PCRs that generate products with the
expected sizes of 86 bp and 356 bp for wt Prnp, respectively. Genomic DNA of Prnpwt/wt,
PrnpΔ8/Δ8, and PrnpΔ8/wt mice previously genoptyped by gel electrophoresis was used (8
PCR reactions/genotype, insets show Qiaxcel virtual gel images). bp, base pairs. (B) Sizes
of PCR products for mice with unknown genotype. Individual animals with single-product
PCRs are shown and color-coded according to the genotypes of their parents.
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PrnpΔ8/wt × Prnpwt/wt , PrnpΔ8/wt × PrnpΔ8/wt , or PrnpΔ8/wt × PrnpΔ8/Δ8 (Figure 2.11B).
The sizes of single PCR bands formed two clearly distinguishable clusters around
85 bp and 80 bp for the shorter PCR fragments, while the sizes of the longer PCR
products were difficult to discriminate due to low resolution (Figure 2.11B). Impor-
tantly, all mice originating from PrnpΔ8/wt × Prnpwt/wt breedings were correctly geno-
typed either as Prnpwt/wt (85 bp cluster) or as PrnpΔ8/wt , while the offspring of the
PrnpΔ8/wt × PrnpΔ8/Δ8 breeding was either PrnpΔ8/wt or PrnpΔ8/Δ8 (80 bp cluster).
Thus genotyping of Prnp Δ8 mice can be performed reliably using PCR combined
with capillary electrophoresis.
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2.3.3. CRISPR-mediated knock-out of PRNP in HEK293T cells
Having succeeded to generate a C57BL/6 Prnp-/- mouse using TALEN-mediated
genome editing, I attempted to genetically ablate PRNP in the widely used human
embryonic kidney cell line HEK293T. While in mice gene knock-out can be achieved
by modifying one allele in microinjected embryos and subsequent breeding to ho-
mozygosity, all copies of a gene need to be mutated in a single HEK293T cell in
order to establish a clonal PRNP knock-out cell line.
Genome editing based on CRISPR/Cas9 has been shown to be highly efficient in
modifying a number of human genes in cell lines (Cho et al., 2013; Jinek et al., 2013;
Mali et al., 2013; Cong et al., 2013) making this technology the ideal choice for
genetic ablation of PRNP in HEK293T cells. Additionally, the simple construction of
CRISPR guide RNA expression plasmids offers a significant advantage over TALEN
and ZFN when simultaneous editing of multiple genomic targets is required.
Since the complete PRNP protein-coding sequence is located within a single exon,
I devised two alternative strategies for PRNP knock-out (Figure 2.12). First, a
CRISPR guide RNA target site (PRNP1) in close proximity to the PRNP start codon
was identified (Figure 2.12A). Cas9-mediated cleavage and NHEJ-repair at this site
can be exploited for the introduction of a premature stop codon analogous to the
TALEN-based knock-out strategy in mouse embryos. An alternative strategy was
based on simultaneously cleaving two target sites, which would allow the complete
excision of the PRNP protein-coding sequence. For this purpose a second guide
RNA (PRNP2) targeting the PRNP stop codon was designed, which can be com-
bined with PRNP1 targeting the start codon (Figure 2.12A).
Guide RNAs PRNP1 and PRNP2 were cloned into expression constructs that fa-
cilitate gRNA expression in vivo using the RNA polymerase III–dependent U6 pro-
moter (Addgene plasmid 43860, J.K. Joung lab, unpublished). HEK293T cells were
then transfected with a Cas9 plasmid and either single or combined PRNP-targeting
guide RNA constructs (Figure 2.12B). Both single PRNP1 and PRNP2 guide RNA
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AGAGCAGTCATTATGGCGAACCTTGGCTG
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wt  GCAGTCATTATGGCGAACCTTGGCTG…        …TTCATCTTCCTGATAGTGGGATGAGGAAGGTCT
1  GCAGTCATTATGGCGAA-------------(Δ751)--------------------ATGAGGAAGGTCT
2  GCAGTCATTATGGCGAA-------------(Δ751)--------------------ATGAGGAAGGTCT
3  GCAGTCATTATGG-----------------(Δ762)---------------------------AGGTCT
4  GCAGTCATTATGGCGAA-------------(Δ751)--------------------ATGAGGAAGGTCT
5  GCAGTCATTATGGCGAA-------------(Δ750)-------------------GATGAGGAAGGTCT
7  GCAGTCATTATGGCGAA-------------(Δ764)--------------------------------T
8  GCAGTCATTATGGCGAA-------------(Δ750)-------------------GATGAGGAAGGTCT
10  GCAGTCATTATGGCGAA-------------(Δ750)-------------------GATGAGGAAGGTCT
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B
C
HEK293T - 48h post-transfection
Figure 2.12.: Strategies for genetic ablation of PRNP in HEK293T. (A) The CRISPR
guide RNAs PRNP1 and PRNP2 target sequences in proximity to the start and the stop
codon (bold font, gRNA binding site in blue) of the PRNP protein-coding sequence, respec-
tively. PAM, protospacer-adjacent motif (highlighted red on sequence). (B) Genomic DNA
was extracted from HEK293T 48h after transfection with indicated plasmids and was ana-
lyzed by PCR and T7 endonuclease assay for NHEJ repair. In case of co-transfection of
Cas9 with PRNP1 and PRNP2 a PCR product with an approximate size of 350 bp indicates
excision of the DNA sequence flanked by both guide RNAs. (C) Cloning and sequencing
of PCR products confirms the presence of large deletions within the PRNP open reading
frame.
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Figure 2.13.: Optimization of CRISPR-mediated editing of PRNP. (A) Titration of plas-
mids encoding Cas9-2A-EGFP and guide RNA PRNP1 and comparison of X-tremeGENE 9
and Lipofectamine 2000 transfection reagents. NHEJ repair within PRNP is detected using
PCR and T7 endonuclease digestion. (B) Quantification of the intensity of T7 endonuclease-
digested PCR products to determine gene modification efficiency (blue bars). The percent-
age of Cas9-expressing cells was monitored by flow cytometric measurement of EGFP fluo-
rescent intensity in single cells (light grey bars). The percentage of viable transfected cells
was assessed using a co-transfected constitutively expressing mCherry plasmid (dark grey
bars).
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transfections resulted in efficient mutagenesis at their respective target sites as re-
vealed by PCR and T7 endonuclease digestion. When PRNP1 and PRNP2 were
combined, the same PCR with primers located outside of the PRNP protein coding
sequence showed an additional product 750 bp shorter in length the expected full-
length 1100 bp PCR product. Cloning and sequencing of this shorter PCR product
confirmed the presence of several distinct PRNP variants with an almost complete
lack of the protein-coding sequence.
Thus both the single- and the dual-guide RNA strategy showed potential for achiev-
ing PRNP knock-out in HEK293T cells. However, since introduction of an early stop
codon was sufficient to ablate expression of the mouse prion protein and the pre-
sumably lower risk of off-target Cas9 cleavage, I focused on the single PRNP1 guide
RNA strategy for generating HEK293T clones with suitable biallelic mutations. Next I
optimized Cas9/guide RNA transfection conditions to achieve high modification rates
of PRNP along with optimal survival of transfected cells. I compared the transfec-
tion reagents X-tremeGENE 9 (Roche) and Lipofectamine 2000 (Life Technologies)
each with three different dosages of Cas9 and guide RNA plasmids (Figure 2.13).
Here, a Cas9-2A-EGFP plasmid was used to achieve stochiometric co-expression
of Cas9 and EGFP. Thus, EGFP fluorescent intensity served as a surrogate mea-
surement for Cas9 expression levels in individual cells. Additionally, I co-transfected
a constant amount of a constitutively expressing mCherry plasmid for identifying all
transfected cells independent of their Cas9/EGFP expression levels and assessed
the percentage of mCherry+ and EGFP+ cells using flow cytometry. As expected,
both transfection methods showed a clear positive correlation between amount of
DNA transfected and the percentage of EGFP+ cells as well the rate of PRNP
modification, which was measured by PCR and T7 endonuclease digestion (Fig-
ure 2.13B). The highest gene modification rate of approximately 20% was observed
when Lipofectamine 2000 combined with the highest recommended DNA amount
was employed. Importantly, these high amounts of Cas9 and PRNP1 guide RNA
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Figure 2.14.: Single cell sorting of HEK293T transfected with Cas9 and PRNP1 guide
RNA. (A) Sorting strategy for viable EGFP+ HEK293T 48h after transfection. (B) PRNP
gene modification efficiency was assessed using PCR and digestion of PCR products with
the restriction enzyme StyI (location of restriction site relative to PRNP1 binding site shown
on top). The intensity of the undigested band (310 bp) indicates the frequency of NHEJ
repair within PRNP.
had no effect on the percentage of mCherry+ , i. e. viable transfected, cells as com-
pared to mCherry-only transfections. Thus Cas9/PRNP1-mediated DNA-cleavage
within PRNP allows high gene modification rates without eliciting detectable levels
of cytotoxicity in transfected HEK293T cells.
Having established the optimal transfection conditions for Cas9-mediated editing of
PRNP, I transfected HEK293T with Cas9-2A-EGFP and PRNP1 and performed sin-
gle cell FACS in collaboration with Hitoshi Takizawa (Division of Hematology, USZ)
48h after transfection (Figure 2.14). Since optimization experiments had shown that
EGFP fluorescent intensity correlates with Cas9 expression levels and thus with
PRNP modification efficiency I reasoned that sorting viable EGFP+ HEK293T would
enrich cells with NHEJ-modified PRNP alleles and thus increase the probability of
identifying individual clones carrying biallelic PRNP mutations. Single EGFP+ cells
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were sorted into 96 well plates and 105 EGFP+ cells were sorted into DNA lysis
buffer for analysis of PRNP modification efficiency. For this purpose and the sub-
sequent screening of individual HEK293T clones, I identified the restriction enzyme
StyI, which recognizes and cleaves a DNA sequence, which partially overlaps with
the Cas9/PRNP1 cleavage site and the PAM consensus sequence (Figure 2.14B).
As expected, StyI digestion of a PRNP-specific PCR product showed that sorting of
H1 F1 C1 G2F2E2
C4 F5G4
B7 F8 C8
C11B11 B12
StyI
HEK293T - 14 days after clonal selection
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Figure 2.15.: Identification of HEK293T with biallelic modification of PRNP. Analysis of
96 HEK293T PRNP knock-out candidates by PCR and StyI restriction digest 14 days after
clonal selection of single cells transfected with Cas9 and PRNP1 guide RNA. 15 clones
show PCR products completely resistant to StyI digestion indicating biallelic modification of
PRNP.
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     GCAGTCATTATGGCGAACCTTGGCTGCTGGATGCTGGT       wt 
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C1   GCAGTCATTATGGC----------TGCTGGATGCTGGT       10 
     GCAGTCATTATGGCGAA-----GCTGCTGGATGCTGGT       5 
C4   GCAGTCATTATGGCGAA--------------TGCTGGT       14 
     GCAGTC---------------GGCTGCTGGATGCTGGT       15 
E2   GCAGTCATTATGGC----------TGCTGGATGCTGGT       10 
     GCAGTCATT------------------TGGATGCTGGT       18 
F2   GCAGTCATTATGGCGAA-----GCTGCTGGATGCTGGT       5 
     GCAGTCATTATGGC----------TGCTGGATGCTGGT       10 
F5   GCAGTCATTATGGCATTAAATGCCATAATTTAATGCCAGTTG   5 +25
 
     GCAGTCATTATGGCATTAAATGCCATTATTTAATGCCAGTTG   5 +25
 
H1   GCAGTCATTATGGCGAATCCAGCATTATGGCTGCTGGATGCT   3 +10
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wt MANLGCWMLVLFVATWSDLGLC...*
Δ1 MANLAAGCWFSLWPHGVTWAS...* 
Δ11 MAKDAGSLCGHME*
Δ5 MAKLLDAGSLCGHME*
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Figure 2.16.: HEK293T PRNP knock-out candidates. (A) Deletions (red on grey back-
ground) and insertions (blue background) detected HEK293T cells with biallelic modifica-
tions of PRNP (start codon in bold font). (B) Clones carrying mutations that introduce
frameshifts and premature stop codons in both PRNP alleles. Mutated amino acids in red,
stop codon,*, numbers indicate distance from initial methionine.
EGFP+ Cas9/PRNP1 transfected cells resulted in a 2.5-fold increase of PRNP mod-
ification rate within this pooled cell population as compared to unsorted transfected
cells.
Following single cell sorting, individual clones were expanded for 14 days and screened
for biallelic mutagenesis of PRNP by PCR and StyI digestion (Figure 2.15). Of the
96 expanded clones analyzed, 15 exhibited PCR products completely resistant to
StyI digestion indicating the absence of wt PRNP in these cell populations. The ma-
jority of cell populations showed a partial StyI digestion pattern, which is consistent
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with either the modification of a single PRNP allele in a clonal population of cells or
an oligoclonal mixture of cells with several possible combinations of modified and
unmodified PRNP alleles.
In order to select HEK293T PRNP knock-out candidates I determined the precise
mutations in 7 out of 15 biallelicly modified clones by cloning of PCR products and
Sanger sequencing (Figure 2.16). Sequencing confirmed the absence of wt PRNP
for all clones analyzed. With the exception of clone H1, where only one PRNP
mutation could be identified, all Cas9/PRNP1-modified HEK293T carried two distinct
PRNP alleles with short deletions or insertions in proximity to the PRNP start codon
(Figure 2.16A). Sequence analysis revealed the presence of premature stop codons
in both modified PRNP protein coding sequences of clones B7, C1, F2, F5, H1
(Figure 2.16B). Premature stop codons could be detected as early as 6 amino acids
downstream of the initial methionine (clone F5, both Δ5 +25 alleles), however some
mutations such as Δ1 present in clone B7 result in a frameshift that allows translation
of relatively long polypeptides (96 amino acids in the case of Δ1) before termination.
By coincidence clones C1 and F2 carried the same combination of a Δ5 and a Δ10
PRNP.
At the time of writing analysis of PrPC expression in clones F2, F5, and H1 was on-
going (clone B7 was excluded from the analysis due to a growth defect and atypical
cell morphology) in order to confirm PRNP knockout for these three candidates.
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2.4. Discussion
2.4.1. Potential & limitations of genome editing
The results presented in this thesis clearly show that all three genome editing tech-
nologies, ZFN, TALEN, and CRISPR, can achieve high levels of gene modification
in the mouse zygote as well as in standard cell lines such as HEK293T. The cur-
rently available genome editing technologies provide sufficiently high rates of NHEJ-
mediated repair to ablate genes in any organism that can be manipulated by the intro-
duction of foreign nucleic acids. For the mouse and the human genome libraries of
TALEN and CRISPR guide RNAs targeting several 1000 protein-coding genes have
been synthesized (Kim et al., 2013; Koike-Yusa et al., 2013; Shalem et al., 2014;
Wang et al., 2014). These developments establish high-throughput gene-knockout
as a valuable alternative to whole-genome siRNA screens, where protein production
is typically reduced but not completely eliminated (Mohr et al., 2010). Additionally,
the relatively simple construction of a large number of CRISPR guide-RNAs makes
this technology the ideal choice for multiplexed genome editing, i.e. the simultane-
ous editing of multiple loci in the same cell or embryo (Wang et al., 2013b; Niu et al.,
2014).
I have also shown that targeted integration can be achieved in mouse zygotes that
were micro-injected with designer nucleases and an HR donor construct. This ap-
proach has several advantages over gene-targeting in mouse ES cells such as a
shorter time-frame and a better cost efficiency for generating germline-competent
founders as well as the freedom of introducing gene modification in any strain of
mice. Genome editing in mouse embryos excels at introducing precise changes,
such as SNPs, into genes of interest since introducing a selectable marker is not
required for identifying correctly targeted alleles (Chen et al., 2011; Wefers et al.,
2013).
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The results presented here demonstrate the feasibility of integrating large trans-
genes into defined genomic loci directly in mouse zygotes but also illustrate the
need for improving the efficiency of this approach. Not surprisingly, designer nucle-
ases achieving higher cleavage efficiencies also warrant more robust HR-mediated
integration of a donor, which became apparent when I compared OPEN and MA
ZFNs targeting ROSA26. These experiments also suggest that a variety of donors
with different configurations, in particular the length of homology arms, can serve as
HR repair templates. Ultimately, the frequency of targeted integration events is lim-
ited by the endogenous double-strand break repair machinery of mammalian cells,
which initiates NHEJ rather than HR by default. Could the repair pathway choice be
skewed towards HR by inhibiting components of the NHEJ pathway? Experiments
in Drosophila (Beumer et al., 2008) and C. elegans (Morton et al., 2006) have shown
that knocking-out ligase IV, a key component of the NHEJ pathway, significantly im-
proved the HR/NHEJ ratio, however in mice the loss of ligase IV is embryonically
lethal (Frank et al., 1998). RNAi screens have identified several additional mem-
bers of the NHEJ pathway as potential targets for increasing HR repair frequency
(Słabicki et al., 2010; Certo et al., 2011). These observations raise the possibility of
transient NHEJ-inhibition in mouse embryos. This could be achieved by co-injecting
siRNA against one or a combination of these targets together with designer nucle-
ases and targeting constructs or by bath application of small-molecule inhibitors
while embryos are in culture.
None of the three genome editing systems offers perfect recognition of a DNA target
sequence and cleavage at unintended off-targets has to be taken into consideration.
Potential off-target sites can be identified by sequence similarity to the main target
site with online resources available for ZFN (Cradick et al., 2011), TALEN (Doyle
et al., 2012), and CRISPR (Hsu et al., 2013). With an increasing number of de-
signer nucleases being subjected to high-throughput analysis of binding specificity
(Pattanayak et al., 2011, 2013; Guilinger et al., 2014) a continuing improvement of
these computational tools can be expected.
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If off-target cleavage occurs in a founder animal unintended mutations can be elimi-
nated by successively back-crossing fertile founders and their offspring to wild-type
mice (as long as off-target sites are not genetically linked to the modified gene of in-
terest). The absence of off-target cleavage at a limited number of interrogated sites
in the genome of C57BL/6 Prnp-/- confirms the general view that heterodimeric TAL-
ENs are highly specific for their target (Carroll, 2014). A recent study by Guilinger
et al., 2014 suggests that TALEN specificity can be further increased by mutating
positively charged amino acids in the TALE N- and C-terminus.
For CRISPR/CAS9 two strategies have been suggest to reduce off-target cleavage.
First, a CAS9 nickase has been introduced, which can only trigger a double-strand
break in combination with two guide RNAs that bind on opposite DNA strands in
close proximity to each other (Ran et al., 2013). Second, it has been suggested
that truncated guide-RNAs (18 bp instead of the canonical 20 bp) show an improved
ratio of on-target over off-target cleavage (Fu et al., 2014).
2.4.2. Re-evaluating the functions of PrPC in health and disease
Prnp-/- mouse lines have been crucial models for investigating putative physiological
functions of PrPC. However, several studies have produced contradictory findings
with regard to whether the ablation or PrPC is underlying the phenotypic changes
in these mice (Steele et al., 2007). Recent studies have highlighted the influence
of polymorphic genes flanking the Prnp-/- alleles on phenotypes such as increased
phagocytosis (Nuvolone et al., 2013) and seizure sensitivity (Striebel et al., 2013).
Most likely there are more cases in which a function attributed to PrPC is actually
performed by a protein encoded by one of the Prnp flanking genes. Experimen-
tal strategies such as comparing phenotypes in several strains of Prnp-/- mice with
distinct genetic backgrounds and rescue experiments including Prnp-/- mice inter-
crossed with a PrPC -overexpresing line such as tga20 (Fischer et al., 1996) allow to
some extend to control for genetic confounders (Bremer et al., 2010; Striebel et al.,
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2013). However, wild-type and Prnp-/- mice with in principal identical genetic back-
grounds such as the C57BL/6 Prnp-/- presented in this thesis are advantageous for
studying more subtle phenotypes.
Comparing phenotypes in C57BL/6 wild-type and Prnp-/- mice can potentially help
to clarify disputed roles of PrPC in diverse physiological processes such as synaptic
transmission (Collinge et al., 1994; Lledo et al., 1996) or autophagy (Oh et al., 2008;
Korom et al., 2013) and pathological conditions such as toxicity of Aβ aggregates
(Laurén et al., 2009; Calella et al., 2010) or neuroinflammation (Tsutsui et al., 2008,
Kana et al., unpublished).
Membrane-bound PrPC is indispensable for prion replication (Büeler et al., 1993).
However it is currently unknown whether proteins other than PrPC might modulate
the rate of prion replication. Once the knockout of human PrPC in HEK293T cells
is confirmed mouse PrPC could be introduced into these cells. HEK293T cells ex-
pressing mouse but not human PrPC could serve as a safe model system (avoiding
human prions) for performing an unbiased human transcriptome siRNA knockdown
screen to unravel potential modulators of prion replication. In case a “druggable”
modulator is identified these findings could path the way to therapeutically slowing
the progression of human prion diseases.
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2.5. Methods
ZFN construction
Zinc finger proteins binding target sites 75 and 403 bp upstream of the XbaI site
within the ROSA26 intron 1 were selected using the previously described OPEN
method (Maeder et al., 2008). Selected zinc fingers were cloned as XbaI-BamHI
fragment into either the expression vectors pST1374 or pMLM290/pMLM292 that
express homo- or heterodimeric ZFNs, respectively (Miller et al., 2007). In both
ZFN expression vectors, the CMV promoter was replaced by a CMV early enhancer
element/chicken beta-actin promoter (CAG) promoter (Okabe et al., 1997). ROSA26
ZFN R4 and L6 (Perez-Pinera et al., 2012) were inserted into the standard pCAG-T7
expression vector using Golden Gate cloning.
TALEN construction
The TALEN expression vector pCAG-T7-TALEN(Sangamo)-Destination was derived
from the yeast TALEN expression vector pTAL4 (Cermak et al., 2011). Two PCR frag-
ments were generated from pTAL4. The first fragment included a truncated TALEN
N-terminus (153 aa), followed by a Esp3I-flanked LacZ cassette flanked and trun-
cated TALEN C-terminus (63 aa). TALEN truncations correspond to the TALEN ar-
chitecture described by Sangamo Biosciences (Miller et al., 2011). A 5’ BglII site and
a 3’ BamHI site were added to the fragment by primer overhangs. The second PCR
fragment included the wt FokI domain flanked by a 5’ BamHI site and 3’ SacI site.
The plasmid pCAG-RabZFN-L (a generous gift by R. Kühn, Meyer et al., 2012) was
linearized using BglII (3’ of T7 promoter) and SacI (5’ of polyadenylation signal) and
the pCAG-T7 backbone was gel-purified. Both BglII-TALE-LacZ-BamHI and BamHI-
FokI-SacI fragments were ligated in a single reaction with the pCAG-T7 backbone to
generate pCAG-T7-TALEN(Sangamo)-Destination. TALEN expression vectors with
second generation heterodimeric FokI domains (Doyon et al., 2011; Guo et al., 2010)
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were generated by excising the wt FokI domain from pCAG-T7-TALEN(Sangamo)-
Destination using BamHI and SacI and inserting BamHI/SacI-flanked FokI-ELD and
FokI-KKR fragments that were generated by PCR from the plasmids pCMV-RosaR4
KKR and pCMV-RosaL6 ELD (Addgene plasmids 37198, 37198, Perez-Pinera et
al., 2012). TALEN expression plasmids described in this thesis are available on
Addgene (Table A.1 in the Appendix).
The Prnp TALEN target site was identified using the TAL Effector Nucleotide Tar-
geter 2.0 (https://tale-nt.cac.cornell.edu/, Doyle et al., 2012). A Prnp-specific TALEN
pair was assembled using the Golden Gate TALEN and TAL Effector Kit (Cermak
et al., 2011) and the here described heterodimeric pCAG-T7-TALEN(Sangamo)-
Destination vectors.
Cas9 and guide RNA construction
The codon-optimized Cas9 protein coding DNA sequence was created by gene syn-
thesis (Genscript). The expression plasmid pCAG-T7-Cas9-P2A-EGFP for simul-
taneous production of Cas9 and EGFP was generated using Golden Gate cloning
of two PCR products. The first PCR construct included Cas9 with a C-terminal fu-
sion of a partial P2A sequence, the second product consisted of the remaining P2A
sequence fused to the N-terminus of EGFP.
U6-promoter driven specific guide RNA plasmids were constructed using the vec-
tor MLM3636 (Addgene plasmid 43860, J.K. Joung lab, unpublished). Target se-
quences for guide RNAs 20 bp in length were identified using the http://crispr.mit.edu/
design tool. For construction of the MLM3636-based guide RNA plasmids PRNP1
and PRNP2, following single-stranded oligos were synthesized (Microsynth), PRNP1-
top, ACA CCG CAG TCA TTA TGG CGA ACC TG, PRNP1-bottom, AAA ACA GGT
TCG CCA TAA TGA CTG CG, PRNP2-top, ACA CCA TCT TCC TGA TAG TGG
GAT GG, PRNP2-bottom, AAA ACC ATC CCA CTA TCA GGA AGA TG. To generate
double-stranded oligos with a 5’ ACAC and a 3’ AAAA overhang, 1 nmol each of top
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and bottom oligo were mixed with NEB buffer 2 (final volume 100 µl) and incubated
in a water bath under slow cooling from 95°C to room temperature. Double-stranded
oligos were ligated into MLM3636 using Golden Gate cloning.
In vitro mRNA synthesis
Template plasmids for mRNA synthesis were linearized and purified (QIAquick PCR
Purification Kit, Qiagen). pCAG-T7-based TALEN and ZFN plasmids were linearized
using SacI and OPEN ZFN plasmids were linearized using PmeI.
In vitro mRNA transcription, capping and polyadenylation, was performed using the
mMESSAGE mMACHINE T7 Ultra Kit. Prior to injection the mRNAs were purified us-
ing the NucAway Spin Columns (Ambion). mRNA quality was verified by denaturing
gel electrophoresis and concentration was quantified using spectrophotometry.
Construction of ROSA26 targeting vectors
Targeting vector GTR26204/205 includes a 1.4 kB 5’ ROSA26 homology arm and
a 1.8 kB 3’ ROSA26 homology arm flanking a central SwaI restriction site. An ex-
pression cassette consisting of a 1.6 kB CAG promoter/enhancer followed by the
720 bp EGFP coding region and the 531 bp rabbit beta-globin polyadenylation
site was inserted by blunt cloning into the SwaI site to generate targeting vector
GTR26204/205-CAG-EGFP. To generate targeting vector GTR26204/205-SA-tdTom
a cassette including the 104 bp Ad2 splice-acceptor followed by a 590 bp triple-
STOP-pCMV-IRES fragment, the 1.4 kB tdTomato coding region and the 256 bp TK
polyadenylation signal was PCR-amplified from pXLBluescriptII PTS tdTomato (gift
of J. Ruiz and K. Rector) using primers AGG GCG CAG TAG TCC AGG GTT TCC
and GGC TAT GGC AGG GCT TGC CGC C with Pfu polymerase and cloned into the
SwaI site of the gtR26-204/205 targeting vector. To generate a linear fragment all
GTR26204/205 -based targeting vectors were PacI digestion prior to microinjection.
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Targeting vector dR26_HygEGFP is based on pDonor MCS Rosa26 (Addgene plas-
mid 37200, Perez-Pinera et al., 2012). pDonor MCS Rosa26 was linearized us-
ing XbaI, a CAG-T7-Esp3I-LacZ-Esp3I-pA fragment was excised from pCAG-T7-
Destination using SpeI and ligated into to pDonor MCS Rosa26 to generated dR26-
Destination. A loxP-mCherry-pA-loxP-HygromcinEGFP-pA cassette was introduced
into dR26-Destination to generate dR26_HygEGFP.
Animals
Females and males of BDF1 (B57BL/6 x DBA/2), C57BL/6, and CD1 mice were
purchased from a commercial breeder (Charles River, Germany). All animals were
maintained in temperature- and light-controlled rooms (12 light/12 dark, light on from
6:00 a.m.) with food and water ad libidum. All experiments including laboratory
animals were approved by the Cantonal Veterinary Office of Zurich. The protocol of
animal handling and treatment was in accordance with Swiss Federal and Cantonal
regulations as well as the internal guidelines of the University of Zurich.
Embryo Collection, Culture and Manipulation
B6D2F1 or C57BL/6 female mice underwent ovulation induction by intra peritoneal
(i.p.) injection of 5 IU pregnant mare’s serum gonadotrophin (PMSG; Folligon – In-
terVet, Switzerland), followed by i.p. injection of 5 IU human chorionic gonadotropin
(hCG; Pregnyl – Essex Chemie, Switzerland) 48 h later. For the recovery of zygotes,
the B6D2F1 and C57BL/6 females were mated with the males of the same strain im-
mediately after the administration of hCG. All zygotes were collected from oviducts
24 h after the hCG injection and were then freed from any remaining cumulus cells
by a 1-2 min treatment of 0.1% hyaluronidase (Sigma) dissolved in M2 medium.
Mouse embryos were cultured in M16 (Sigma) medium at 37°C and 5% CO2. For
micromanipulation the embryos were transferred into M2 medium (Sigma).
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Cytoplasmic and pronuclear microinjections
All microinjections were performed using a microinjection system comprised of an
inverted microscope equipped with Nomarski optics (Nikon, Japan), set of microma-
nipulators (Narashige, Japan) and a FemtoJet microinjection unit (Eppendorf, Ger-
many). ZFN mRNAs were injected into the cytoplasm whereas the DNA expression
constructs and DNA targeting fragments were injected into the male pronuclei; in
experiments where mRNA and DNA were co-injected the RNA DNA mixture was
first injected into the male pronucleus and subsequently into the cytoplasm upon the
withdrawal of the microinjection capillary. Specific concentrations of injected mRNAs
and DNA constructs are compiled in Table 1.
Embryo Transfer
Embryos that survived the microinjection were transferred on the same day into
the oviducts of 8-16 weeks old pseudopregnant CD-1 females (0.5 days post coitus)
that have been mated with sterile TgV males (Haueter et al., 2010) on the day before
embryo transfer. Pregnant females were allowed to deliver and raise their pups or
were sacrificed at 14-16 days post embryo transfer so that the developing fetuses
could be removed for analysis.
Transfection and single cell sorting of HEK293T
HEK293T were transfected in 6-well format with 1.8 µg of pCAG-T7-Cas9-P2A-
EGFP and 0.6 µg of PRNP1 guide RNA. Cells were trypsinized 48h after transfec-
tion, washed with PBS and respuspended in PBS with 10% FBS. Sorting of single
EGFP+ HEK293T into individual wells containing culture medium (96 well format)
was performed using a BD FACSAria III with a 100 µm diameter nozzle. EGFP
fluorescence was excited using a 488 nm laser and detected using a 530/30 filter.
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ROSA26 NHEJ and targeted integration detection assays
Genomic DNA was extracted from mouse biopsies or fetal tissue using a buffer con-
taining 10 mM Tris-HCl pH 9, 50 mM KCl, 0.45% Nonidet p40, 0.45% Tween 20
and Proteinase K. Extracts were subjected to Phenol/Chloroform/Isoamyl alcohol
purification, precipitated with Isopropanol, and dissolved in EB buffer (Qiagen). For
detecting NHEJ repair at the ROSA26 locus, primers RF (GCC GCC CAC CCT CCC
CTT CCT C) and RR (CGC CTA CT CCA CTG CAG CTC CC) were used to amplify
a 474 bp fragment covering the ZFN204/205 target site and primers RF4 (AAG TTG
AGT CCA TCC GCC GGC) and RR4 (AAA TAC TCC GAG GCG GAT CAC AAG C)
were used to amplify a 748 bp fragment covering the ZFN R4/L6 target site. 25 µl of
each PCR product were digested with FspI (ZFN204/205) or XbaI (ZFN R4/L6) and
subsequently resolved on a 2% agarose gel. Samples including undigested PCR
fragments were cloned into pGEM-T easy (Promega) for Sanger sequencing.
Targeted integration of donor vectors was assessed by junction PCR and Southern
blotting. In case of ZFN204/205 –mediated ROSA26 targeting primers GF (GCC
GGG ATC ACT CTC GGC ATG) and RR2 (CAC CAC TGG CTG GCT AAA CTC
TGG) amplified the 3’ junction that is specific for the integration of GTR26-204/205-
CAG-EGFP. For targeted integration of dR26_HygEGFP into the ZFN R4/L6 site,
primers RF3 (CTG ATT GGC TTC TTT TCC TCC CGC C) with CR (GAA CAT ACG
TCA TTA TTG ACG TCA ATG GGC) for the 5’ junction and RR3 (ATT GGG GGA
GGA GAC ATC CAC CTG GAA ACC) with EF (CCT ACG GCG TGC AGT GCT TCA
GC) for the 3’ junction were used.
For Southern Blot analysis of ZFN204/205 targeting experiments 10 μg of genomic
DNA were digested overnight at 37°C with EcoRI, resolved on a 0.7% agarose gel,
and transferred to nylon membranes. Membranes were heat-fixated at 65°C for
1 h and incubated with prehybdrization solution over night at 65°C. The Rosa 26
5’ probe, a 695 bp EcoRI/PacI fragment, was generated from the "Orkin" plasmid.
The ROSA26 3’ probe, a 615 bp, EcoRI fragment, was generated from plasmid
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pCRII-Rosa 3’. Hybridization probes were heat denatured, labeled with P32 marked
dCTP (Perkin Elmer) using the Ladderman Labelling Kit (Takara). The labeled probe
was purified with illustra MicroSpin S-200 HR columns (GE Healthcare) and heat-
denatured probe in hybridization buffer was added to the membranes for overnight
rotation at 65°C. Membranes were washed three times (5 min) using 2x SSC. The
membranes were exposed for at room temperature 1-3 days and imaged using a
Storm 840 phospho-imager (Molecular Dynamics). Digital images of Southern Blots
were processed with ImageJ.
Prnp TALEN on- and off-target NHEJ analysis
TALEN-induced mutagenesis of Prnp was analyzed using primers PrnpF (AGA TGT
CAA GGA CCT TCA GCC) and PrnpR (TAT GGG TAC CCC CTC CTT GG). For ini-
tial screening of founders for NHEJ activity, PCR products (356 bp) were subjected to
heteroduplex formation using the following conditions in a thermocycler, 95°C 2 min,
95°C to 85°C (-2°C/s), 85°C to 25°C (-0.1°C/s) and digested by T7 endonuclease
(NEB) for 20 min at 37°C. Digestion products were resolved on a 2% agarose gel.
For Sanger sequencing PCR products were cloned into pGEM-T easy (Promega).
Prnp Δ8 and Δ17 were genotyped using primers PrnpF/R or primers generating
a shorter (86 bp) PCR fragment, PrnpF2 (ATC ATG GCG AAC CTT GGC T) and
PrnpR2 (GGC TTT GGC CGC TTT TTG C) and PCRs were resolved on a 3%
agarose gel or by Qiaxcel capillary electrophoresis (Qiagen).
Potential off-target sites for the Prnp TALEN pair were identified using TAL Effector
Nucleotide Targeter 2.0 (https://tale-nt.cac.cornell.edu/, Doyle et al., 2012). Sites
with a high predicted probably of binding of the left and the right TALEN with a
spacer length that would allow efficient FokI dimerization were prioritized. Off-target
sites were screened using T7 endonuclease digestion of PCR products generated
with the following primers,
OT1 | GGAGACTAAGTGGGTGATGTTGT | AGGTGATGATTCACTGTGAGCTT
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OT2 | CTAAGACCCTTGGGTCCATAAGC | GACATAGAAGGCCAATCTGACCA
OT3 | TCAAATCCAACTACCAGGGTCTG | GTGGGGTATCACAGTATCCTTCC
OT4 | CTGTCCTGGTTTGTTTAAGTGGC | AAGATCTTCTCAGCAGGCTTTCA
OT6 | AACTGTGGTCAAAGATGGAAGGA | CCCGTGCATAGGGATCAGAATTA
OT7 | CAATGCTTTTAGAGGAATGGCCC | CTGACACCTGTATCTTTGACCCA
OT11 | GAAGATGTGCACAAGGAAAGGAC | GAGACCACAGCCAATTAGACACT
OT12 | TGACACTGTTTTGCTAGGTCTGA | ATGTGAATGTGGGTATTCTGCCT.
PRNP CRISPR NHEJ analysis
CRISPR-mediated editing of PRNP was analyzed by PCR using the primers PRNP-
F (TGC TTCA GAG AAG TAC AGG GTG) and PRNP-R (ATG AAC TCA ATC AAA
GGG GGC T) for transfections of guide RNAs PRNP1 or PRNP2 (or the combination
of both) or by primers PRNP-F2 (TGG AGC AGG AGA AAG AGT TGT GT) and
PRNP-R2 (CAG TGT TCC ATC CTC CAG GCT TC) specific for the PRNP1 target
site. NHEJ-induced mutagenesis was analyzed using T7 endonuclease digestion
for PRNP1 and PRNP2 target sites or by StyI digestion for the PRNP1 target site.
Densities of digested and undigested PCR bands resolved on 1.5% or 2% agarose
gels were integrated using ImageJ. Gene modification efficiency was derived from
integrated band densities for T7 endonuclease digested products as described by
Guschin et al., 2010 using the following equation , % gene modifcation = 100× (1−√
1−
∑
cleaved bands∑
all bands ). For StyI digested PCR products, gene modification efficiency
was calculated by % gene modification = 100× uncleaved band∑ all bands .
Protein Analysis
Homogenates of mouse cortex, cerebellum and spinal cord were prepared in PBS,
0.05% sodium deoxycholate, and 0.05% Nonidet P-40. Protein concentration was
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determined using the bicinchoninic acid assay (BCA, Pierce). Samples were pre-
pared in loading buffer (NuPAGE, Life Technologies) and boiled at 95°C for 10 min.
Proteins (17 µg per lane) were separated on a 12% Bis-Tris polyacrylamide gel (Nu-
PAGE, Life Technologies) and blotted onto a nitrocellulose membrane (Whatman).
Membranes were blocked with PBS with 0.1% Tween 20 and 5% Top block (LuBio
Science). Primary antibodies were diluted in PBS with 0.1% Tween 20 and 1% Top
block. Mouse monoclonal antibodies were anti-PrPC antibodies (produced in-house)
POM1 (280 ng/ml), POM2, POM13, and POM19 (all 400 ng/ml) and anti-actin an-
tibody clone C4 (Millipore, 125 ng/ml). Membranes were incubated with primary
antibodies at 4°C over night and subsequently washed with BS with 0.1% Tween 20
and 1% Top block. Membranes were incubated with a HRP-conjugated goat anti-
mouse secondary antibody (Life Technologies, 1:17000) at room temperature for
one hour. Blots were developed using Luminata Crescendo reagent (Millipore) and
were exposed using a Stella detector (Raytest).
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Table A.1.: Plasmids that were generated in this thesis and are publicly available on
www.addgene.org.
Plasmid Addgene ID
pCAG-T7-TALEN(Sangamo)-Destination 37184
pCAG-T7-TALEN(Sangamo)-FokI-KKR-Destination 40131
pCAG-T7-TALEN(Sangamo)-FokI-ELD-Destination 40132
pCAG-Golden-Gate-Esp3I-Destination 51278
pCAG-NLS-HA-Dre 51272
pCAG-NLS-HA-B3 51270
pCAG-NLS-HA-Bxb1 51271
pCAG-roxSTOProx-ZsGreen 51273
pCAG-b3STOPb3-ZsGreen 51266
pCAG-attBr-ZsGreen-attP 51265
pCAG-loxPSTOPloxP-ZsGreen 51269
pCAG-Roxed-Cre 51273
pCAG-attBr-Cre-rc-attP 51264
Thy1.2-NLS_HA_Dre-P2A-BFP 51275
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hGFAP-NLS-HA-Dre-P2A-BFP 51277
hGFAP-Roxed-Cre 51263
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Figure A.1.: Imaris workflow for counting fluorescent cells following in utero electroporation
of Co-Driver.
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1 rs3683945 1 3201415 AA AA BB AA AA AA 1 1 Symbol Definition
2 rs6269442 1 3495168 BB AA BB AA AA AA 1 1
3 rs13475701 1 4538744 AA BB BB AA AA AA 1 1 AA Homozygous for Allele1
4 rs13475706 1 5917284 AA BB AA AA AA AA 1 1 AB Heterozygous 1/2
5 rs3684358 1 8111551 AA AA BB BB BB BB 1 1 BB Homozygous for Allele2
6 rs3716083 1 9092463 AA BB AA BB BB BB 1 1
7 rs3722996 1 11348581 AA AA BB AA AA AA 1 1 1 Homozygous for C57BL/6J SNP
8 rs13475729 1 12981709 AA AA AA BB BB BB 1 1 0.5 Heterozygous for C57BL/6J SNP and non-C57BL/6J SNP
9 rs3671256 1 16443156 BB BB BB AA AA AA 1 1 0 Homozygous for non-C57BL/6J SNP
10 rs13475745 1 17512198 AA BB BB BB BB BB 1 1 NC=no call
11 rs13475750 1 19680103 BB BB BB AA AA AA 1 1
12 rs6404446 1 20994482 AA AA AA BB BB BB 1 1
13 mCV23695025 1 22386585 BB AA BB AA AA AA 1 1
14 rs6173215 1 22977896 AA BB BB AA AA AA 1 1
15 mCV24784983 1 25471405 AA BB BB AA AA AA 1 1
16 rs6166266 1 26136349 AA AA BB AA AA AA 1 1
17 rs3677683 1 27510356 BB BB BB AA AA AA 1 1
18 rs3695988 1 29990732 BB AA BB AA AA AA 1 1
19 rs4137502 1 31102378 BB BB AA BB BB BB 1 1
20 rs3707642 1 32799125 AA AA AA BB BB BB 1 1
21 rs3681732 1 34414162 BB AA BB AA AA AA 1 1
22 rs3683997 1 36198091 BB BB AA BB BB BB 1 1
23 rs4222295 1 39320203 BB AA AA BB BB BB 1 1
24 gnf01.036.770 1 40297949 AA BB AA BB BB BB 1 1
25 rs13475827 1 41262551 AA BB BB BB BB BB 1 1
26 rs13475834 1 42789902 BB AA BB AA AA AA 1 1
27 CEL-1_44668113 1 44668113 AA AA BB AA AA AA 1 1
28 rs13475847 1 46277649 BB AA BB AA AA AA 1 1
29 rs13475851 1 47845326 AA BB BB AA AA AA 1 1
30 CEL-1_49993068 1 49993068 AA BB AA BB BB BB 1 1
31 rs3724092 1 50613798 AA BB AA BB BB BB 1 1
32 rs13475866 1 51771264 BB AA AA BB BB BB 1 1
33 rs6183203 1 53853346 BB AA BB BB BB BB 1 1
34 rs6386920 1 54482766 AA BB AA AA AA AA 1 1
35 rs3723035 1 55942220 BB AA BB BB BB BB 1 1
36 rs13475881 1 58775689 BB AA AA AA AA AA 1 1
37 rs6353774 1 60126995 BB AA BB BB BB BB 1 1
38 rs3716105 1 61943426 AA BB AA AA AA AA 1 1
39 rs6322485 1 63649681 AA BB AA BB BB BB 1 1
40 rs6395308 1 65272783 BB BB BB BB BB BB 1 1
41 rs13475902 1 66810982 BB AA AA AA AA AA 1 1
42 rs6288543 1 68917890 AA AA AA BB BB BB 1 1
43 rs6312657 1 69408967 BB AA BB AA AA AA 1 1
44 rs6191076 1 72377589 AA AA BB AA AA AA 1 1
45 rs13475919 1 73407862 BB BB AA BB BB BB 1 1
46 rs3713616 1 74900046 BB AA BB AA AA AA 1 1
47 rs13475931 1 76832354 BB AA AA AA AA AA 1 1
48 gnf01.075.385 1 78359030 AA AA AA BB BB BB 1 1
49 rs13475939 1 79202787 AA AA AA BB BB BB 1 1
50 mCV23431007 1 80839073 BB BB BB BB BB BB 1 1
51 rs13475946 1 81235702 AA BB BB BB BB BB 1 1
52 gnf01.079.218 1 82668689 BB AA BB AA AA AA 1 1
53 rs3723062 1 85865441 AA BB AA BB BB BB 1 1
54 UT_1_89.100476 1 87104170 BB AA BB AA AA AA 1 1
55 rs6195073 1 88494443 BB AA AA AA AA AA 1 1
56 rs13475980 1 91575836 AA AA BB BB BB BB 1 1
57 rs6268443 1 93319361 BB BB BB AA AA AA 1 1
58 rs6157345 1 95497940 BB AA AA AA AA AA 1 1
59 rs3726669 1 96875139 AA BB BB BB BB BB 1 1
60 rs13476003 1 97677389 BB AA AA AA AA AA 1 1
61 rs13476012 1 99797518 BB AA AA AA AA AA 1 1
62 rs6368370 1 101749052 AA BB BB BB BB BB 1 1
63 CEL-1_103251925 1 103251925 BB AA AA BB BB BB 1 1
64 CEL-1_105423103 1 105423103 BB AA AA BB BB BB 1 1
65 rs13476036 1 106831730 BB AA AA AA AA AA 1 1
66 rs3685919 1 109634975 AA AA AA BB BB BB 1 1
67 rs13476050 1 110616212 BB BB BB AA AA AA 1 1
68 rs3726043 1 111780707 BB BB BB AA AA AA 1 1
69 rs13476061 1 113899609 BB BB AA AA AA AA 1 1
70 mCV24201027 1 115751113 BB BB AA BB BB BB 1 1
71 rs3674655 1 117379659 AA AA AA BB BB BB 1 1
72 rs3695581 1 118500635 BB BB AA BB BB BB 1 1
73 rs3678634 1 120380872 AA BB AA BB BB BB 1 1
74 rs3717360 1 122796548 BB BB BB AA AA AA 1 1
75 rs3694822 1 123642529 AA AA AA BB BB BB 1 1
76 rs4137908 1 125475941 AA AA BB BB BB BB 1 1
Highlighted region indicates the region 25 MBp on either side of 
the known chromosomal modification
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77 rs6228473 1 126460218 AA AA AA BB BB BB 1 1
78 rs13476104 1 128094625 AA AA BB BB BB BB 1 1
79 rs3699561 1 130962369 AA AA BB BB BB BB 1 1
80 rs3724826 1 131376437 BB BB AA AA AA AA 1 1
81 rs13476119 1 134099450 AA AA BB AA AA AA 1 1
82 rs8250053 1 135044501 BB AA BB AA AA AA 1 1
83 rs6279930 1 137268795 BB AA AA AA AA AA 1 1
84 gnf01.137.841 1 138089211 AA AA BB AA AA AA 1 1
85 rs13476141 1 140472264 BB AA BB AA AA AA 1 1
86 rs6382880 1 142470600 BB AA BB AA AA AA 1 1
87 rs13476152 1 144012938 BB AA BB AA AA AA 1 1
88 rs3672697 1 145088382 BB BB AA BB BB BB 1 1
89 rs13476163 1 146776886 BB AA AA AA AA AA 1 1
90 rs6411476 1 148913234 AA BB BB BB BB BB 1 1
91 rs6393307 1 150967309 BB BB BB BB BB BB 1 1
92 CEL-1_152747565 1 152747565 AA BB BB BB BB BB 1 1
93 rs13476187 1 154187910 BB BB BB BB BB BB 1 1
94 UT_1_113.684537 1 156044150 AA BB BB AA AA AA 1 1
95 rs3719034 1 157158100 BB AA BB BB BB BB 1 1
96 rs6387609 1 157898706 AA BB AA AA AA AA 1 1
97 rs3693161 1 160294867 BB AA BB BB BB BB 1 1
98 rs13476208 1 162037129 AA BB BB AA AA AA 1 1
99 UT_1_167.58185 1 164012960 BB BB BB BB BB BB 1 1
100 rs13476219 1 166263327 BB BB BB BB BB BB 1 1
101 rs6399765 1 167289594 BB BB BB BB BB BB 1 1
102 rs13476229 1 169381101 AA BB AA BB BB BB 1 1
103 rs8245216 1 171312251 AA AA AA BB BB BB 1 1
104 rs13466711 1 172206556 BB BB BB AA AA AA 1 1
105 rs3707910 1 172614886 AA AA AA BB BB BB 1 1
106 rs3669108 1 174667766 BB BB BB AA AA AA 1 1
107 rs3700831 1 176145762 BB BB BB AA AA AA 1 1
108 CEL-1_178482360 1 178482360 BB BB BB BB BB BB 1 1
109 rs13476265 1 179633768 AA BB BB BB BB BB 1 1
110 rs13474399 1 180675247 AA AA AA AA AA AA 1 1
111 rs13476272 1 181495101 BB BB BB BB BB BB 1 1
112 rs13476273 1 182175880 BB BB BB BB BB BB 1 1
113 rs6157620 1 183197685 AA AA AA BB BB BB 1 1
114 mCV22849619 1 186531848 BB BB BB AA AA AA 1 1
115 rs3667164 1 188355284 BB BB BB AA AA AA 1 1
116 rs13476300 1 190164592 AA AA AA BB BB BB 1 1
117 rs13476313 1 194054190 BB BB AA BB BB BB 1 1
118 mCV24145570 1 195161421 BB BB AA BB BB BB 1 1
119 rs3713997 2 3181746 AA BB BB BB BB BB 1 1
120 rs6213083 2 3972678 NC NC NC BB NC NC NA NA
121 rs4136817 2 4258057 AA BB BB BB BB BB 1 1
122 rs3678168 2 5606042 BB AA BB BB BB BB 1 1
123 rs6359983 2 6694892 AA AA AA AA AA AA 1 1
124 gnf02.006.767 2 9780767 BB BB BB BB BB BB 1 1
125 rs6240512 2 10929543 AA BB BB BB BB BB 1 1
126 rs6172408 2 12582823 AA AA AA AA AA AA 1 1
127 rs6287980 2 13669366 BB BB BB BB BB BB 1 1
128 CZECH-2_15618849 2 15618849 BB BB BB BB BB BB 1 1
129 rs6402127 2 17856135 BB BB BB BB BB BB 1 1
130 rs13476366 2 19454722 AA AA AA AA AA AA 1 1
131 rs3674936 2 20427488 BB AA BB AA AA AA 1 1
132 rs6404309 2 23451610 BB BB BB BB BB BB 1 1
133 rs6286688 2 24495175 BB BB BB BB BB BB 1 1
134 rs13476391 2 26055543 AA AA AA AA AA AA 1 1
135 rs13476399 2 28249160 BB AA AA AA AA AA 1 1
136 rs3154953 2 30147850 AA BB BB BB BB BB 1 1
137 rs6186876 2 31660228 BB BB BB BB BB BB 1 1
138 CEL-2_32981944 2 32981944 BB BB BB BB BB BB 1 1
139 gnf02.035.469 2 33954610 AA AA AA AA AA AA 1 1
140 rs6260403 2 35804961 AA AA AA AA AA AA 1 1
141 rs13476439 2 38071109 AA BB AA BB BB BB 1 1
142 rs13476454 2 41244144 BB AA BB AA AA AA 1 1
143 rs13476467 2 44361765 AA BB AA BB BB BB 1 1
144 rs13476472 2 45653218 BB AA BB AA AA AA 1 1
145 rs6265423 2 47124603 AA AA BB AA AA AA 1 1
146 rs6250599 2 48633486 AA AA AA AA AA AA 1 1
147 CEL-2_50605053 2 50605053 AA BB AA BB BB BB 1 1
148 rs3725341 2 51425686 BB AA BB AA AA AA 1 1
149 rs13476503 2 53143600 AA BB AA BB BB BB 1 1
150 rs3718711 2 56489184 BB AA BB AA AA AA 1 1
151 rs3672719 2 58142938 AA BB AA BB BB BB 1 1
152 rs13476530 2 59956872 AA BB BB BB BB BB 1 1
153 rs4223189 2 61738719 BB AA AA AA AA AA 1 1
154 CEL-2_63143553 2 63143553 BB AA AA AA AA AA 1 1
155 rs6222797 2 65057687 BB AA AA AA AA AA 1 1
156 rs13476553 2 66906537 BB AA BB AA AA AA 1 1
157 rs6381994 2 68188374 AA AA AA AA AA AA 1 1
158 rs4136610 2 70090167 BB AA AA BB BB BB 1 1
159 rs3664661 2 71492729 BB AA AA BB BB BB 1 1
160 CEL-2_73370728 2 73370728 BB AA BB AA AA AA 1 1
161 rs13476580 2 74776032 AA AA BB BB BB BB 1 1
162 gnf02.076.311 2 77549169 BB AA AA BB BB BB 1 1
163 CEL-2_79237503 2 79237503 BB AA AA BB BB BB 1 1
164 rs3722345 2 80509747 AA BB BB AA AA AA 1 1
165 rs3667007 2 82000176 BB AA AA BB BB BB 1 1
166 rs8273639 2 84666393 AA BB BB AA AA AA 1 1
167 rs3689658 2 85572783 BB AA AA BB BB BB 1 1
168 rs13476621 2 87247149 AA BB BB AA AA AA 1 1
169 rs6404809 2 88899373 BB AA BB BB BB BB 1 1
170 rs13476636 2 91539303 AA BB AA AA AA AA 1 1
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171 rs13476639 2 92720804 AA AA BB AA AA AA 1 1
172 rs13476649 2 95929798 BB AA BB BB BB BB 1 1
173 rs6316774 2 96787868 AA BB AA BB BB BB 1 1
174 rs6378047 2 99378126 AA AA AA BB BB BB 1 1
175 rs6406705 2 100253963 AA AA AA AA AA AA 1 1
176 rs13476666 2 101217024 BB BB BB AA AA AA 1 1
177 gnf02.102.146 2 103792940 AA BB AA AA AA AA 1 1
178 rs13476689 2 107356662 AA BB BB AA AA AA 1 1
179 rs13476691 2 108396162 AA BB AA AA AA AA 1 1
180 rs13476698 2 111095530 AA BB AA AA AA AA 1 1
181 CEL-2_111981058 2 111981058 AA AA BB BB BB BB 1 1
182 rs4138562 2 114161459 BB BB BB AA AA AA 1 1
183 rs3699172 2 115671423 BB BB AA AA AA AA 1 1
184 rs13476723 2 117074373 BB AA BB BB BB BB 1 1
185 rs8279354 2 118948317 BB BB BB AA AA AA 1 1
186 rs3658927 2 120726441 BB BB BB AA AA AA 1 1
187 rs3723643 2 122067606 AA BB BB AA AA AA 1 1
188 rs6228179 2 123216313 BB BB BB AA AA AA 1 1
189 rs6401493 2 125046796 BB BB BB AA AA AA 1 1
190 gnf02.126.027 2 127549770 AA AA BB BB BB BB 1 1
191 rs3661596 2 129893838 BB BB BB AA AA AA 1 1
192 rs3665528 2 130762932 BB BB AA BB BB BB 1 1
193 rs4223511 2 131742558 AA BB AA BB BB BB 1 1
194 rs13476783 2 133610154 AA BB BB BB BB BB 1 1
195 CEL-2_135876979 2 135876979 BB BB BB BB BB BB 1 1
196 rs8246404 2 136627476 AA BB BB BB BB BB 1 1
197 rs6158085 2 138928693 BB BB BB BB BB BB 1 1
198 rs13476807 2 140555557 AA AA AA AA AA AA 1 1
199 rs13476810 2 142149749 BB BB BB BB BB BB 1 1
200 rs13476817 2 144125632 AA BB BB BB BB BB 1 1
201 rs6363071 2 145784318 AA BB BB AA AA AA 1 1
202 rs6209325 2 147807884 AA BB BB AA AA AA 1 1
203 rs6246342 2 149614906 AA AA AA AA AA AA 1 1
204 gnf02.149.271 2 151100533 BB AA AA AA AA AA 1 1
205 rs6247960 2 152642098 BB AA AA BB BB BB 1 1
206 rs6376291 2 154204634 BB AA AA AA AA AA 1 1
207 rs13476860 2 156330826 BB BB BB AA AA AA 1 1
208 rs3695266 2 158068522 BB BB BB AA AA AA 1 1
209 rs13476874 2 159733176 BB AA AA BB BB BB 1 1
210 rs3664408 2 161443571 BB BB BB AA AA AA 1 1
211 rs3671849 2 163215888 BB AA AA BB BB BB 1 1
212 rs13476889 2 164370875 BB AA BB AA AA AA 1 1
213 rs13476895 2 166374505 AA AA BB BB BB BB 1 1
214 CEL-2_168586738 2 168586738 BB BB BB AA AA AA 1 1
215 rs3726974 2 169905098 AA AA AA BB BB BB 1 1
216 rs13476917 2 171452147 AA AA AA BB BB BB 1 1
217 rs13476928 2 174162530 BB BB AA AA AA AA 1 1
218 rs13476932 2 174923839 BB BB AA AA AA AA 1 1
219 rs13476934 2 178315515 AA AA BB BB BB BB 1 1
220 rs6187766 2 179210967 BB BB BB AA AA AA 1 1
221 rs3679483 2 179814463 BB BB BB AA AA AA 1 1
222 rs13476950 3 3793662 BB AA AA BB BB BB 1 1
223 rs13476953 3 4378945 AA BB BB AA AA AA 1 1
224 rs13476957 3 5656063 AA BB BB AA AA AA 1 1
225 rs13476963 3 7703356 BB AA AA BB BB BB 1 1
226 rs13476969 3 9744167 AA BB BB BB BB BB 1 1
227 rs13476973 3 11073596 AA BB BB BB BB BB 1 1
228 rs6248752 3 12161848 BB BB BB AA AA AA 1 1
229 rs13476985 3 14943619 BB AA AA BB BB BB 1 1
230 rs3659988 3 16122429 AA BB BB AA AA AA 1 1
231 gnf03.015.035 3 17691447 BB BB AA AA AA AA 1 1
232 mCV24211562 3 18932166 AA BB AA AA AA AA 1 1
233 rs6235984 3 21215374 AA AA AA AA AA AA 1 1
234 rs13477019 3 23589162 X AA AA AA BB BB BB 1 1
235 rs3715834 3 26405124 BB AA BB AA AA AA 1 1
236 rs13477030 3 27365675 AA BB BB BB BB BB 1 1
237 rs3660588 3 30094761 AA BB BB AA AA AA 1 1
238 rs13477043 3 31257023 BB BB AA BB BB BB 1 1
239 gnf03.030.222 3 33096061 BB AA BB AA AA AA 1 1
240 rs4223883 3 33860283 BB AA AA AA AA AA 1 1
241 rs6246699 3 36110851 BB AA BB AA AA AA 1 1
242 rs6274061 3 38689460 AA BB AA BB BB BB 1 1
243 rs6324747 3 39835273 BB BB BB AA AA AA 1 1
244 rs3661720 3 41838640 BB BB AA AA AA AA 1 1
245 rs13477083 3 43361057 AA AA BB AA AA AA 1 1
246 CEL-3_45598106 3 45598106 BB BB AA BB BB BB 1 1
247 CEL-3_46558020 3 46558020 AA AA AA AA AA AA 1 1
248 rs13477097 3 48335184 BB AA AA BB BB BB 1 1
249 rs4139913 3 50623988 BB AA BB BB BB BB 1 1
250 rs6241331 3 52675823 BB BB AA AA AA AA 1 1
251 rs6335414 3 53103565 BB BB BB AA AA AA 1 1
252 rs4223969 3 55143939 AA BB BB AA AA AA 1 1
253 rs13477126 3 56753970 AA AA AA AA AA AA 1 1
254 rs6301139 3 58612475 NC BB BB NN NC NC NA NA
255 rs13477138 3 60037290 AA AA AA BB BB BB 1 1
256 rs13477143 3 61103349 BB BB BB AA AA AA 1 1
257 rs13477154 3 63787516 AA AA AA BB BB BB 1 1
258 rs6212539 3 65222079 AA BB BB BB BB BB 1 1
259 gnf03.063.824 3 66994152 BB AA BB BB BB BB 1 1
260 rs13477178 3 70089276 AA AA BB AA AA AA 1 1
261 rs6198234 3 70361430 BB BB BB AA AA AA 1 1
262 rs6264454 3 71858927 AA AA BB BB BB BB 1 1
263 rs13477201 3 75852874 AA BB BB BB BB BB 1 1
264 rs13477210 3 77646357 BB BB AA AA AA AA 1 1
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265 rs13477217 3 79085242 AA AA BB AA AA AA 1 1
266 rs13477218 3 80321582 BB AA BB AA AA AA 1 1
267 rs13477224 3 81758272 BB AA BB AA AA AA 1 1
268 rs13477233 3 83880528 AA AA AA BB BB BB 1 1
269 rs3719390 3 85880745 BB BB BB AA AA AA 1 1
270 rs6376008 3 87149248 AA BB AA BB BB BB 1 1
271 rs13477251 3 89418525 BB AA AA BB BB BB 1 1
272 rs6211610 3 90650953 AA AA BB BB BB BB 1 1
273 rs13477261 3 92344335 BB BB AA AA AA AA 1 1
274 rs13477268 3 93549679 AA AA AA AA AA AA 1 1
275 rs13477272 3 95678878 BB BB BB AA AA AA 1 1
276 rs3022964 3 97282711 BB AA AA AA AA AA 1 1
277 rs3726226 3 98954988 BB BB BB AA AA AA 1 1
278 rs3162061 3 100657788 AA AA AA BB BB BB 1 1
279 rs4138887 3 102619416 AA AA BB AA AA AA 1 1
280 rs3701653 3 103564280 BB BB AA AA AA AA 1 1
281 rs13477309 3 105788245 BB AA AA BB BB BB 1 1
282 rs3702359 3 107508882 AA BB BB AA AA AA 1 1
283 rs13477321 3 109585764 AA BB AA BB BB BB 1 1
284 rs3676545 3 110649631 BB BB BB AA AA AA 1 1
285 rs3698700 3 112624069 AA AA AA BB BB BB 1 1
286 rs3710419 3 116000138 AA BB BB BB BB BB 1 1
287 gnf03.119.970 3 116888086 AA BB BB AA AA AA 1 1
288 rs3708412 3 118002787 BB BB BB AA AA AA 1 1
289 CEL-3_120379605 3 120379605 BB AA AA BB BB BB 1 1
290 rs3659836 3 122002332 BB AA AA AA AA AA 1 1
291 rs13477379 3 123230785 AA BB BB BB BB BB 1 1
292 rs13477385 3 125504930 BB BB BB AA AA AA 1 1
293 rs3671119 3 126894715 BB BB BB AA AA AA 1 1
294 rs3670168 3 128820535 AA AA AA BB BB BB 1 1
295 rs13477404 3 130952894 BB AA BB AA AA AA 1 1
296 rs13477408 3 132189425 BB BB AA BB BB BB 1 1
297 CEL-3_133070717 3 133070717 AA AA AA AA AA AA 1 1
298 rs13477421 3 134785250 AA BB BB BB BB BB 1 1
299 rs3676039 3 136766271 BB AA AA BB BB BB 1 1
300 rs13477439 3 138624013 AA BB BB BB BB BB 1 1
301 rs13477448 3 140515828 AA AA AA BB BB BB 1 1
302 rs3090379 3 142598970 BB BB BB BB BB BB 1 1
303 rs6290401 3 143193940 BB BB BB BB BB BB 1 1
304 rs6407142 3 143619317 AA AA AA BB BB BB 1 1
305 rs3710548 3 146841800 BB BB BB AA AA AA 1 1
306 rs3657112 3 148942421 AA AA AA BB BB BB 1 1
307 rs13477487 3 150745214 AA AA AA BB BB BB 1 1
308 rs13477494 3 152154652 BB AA AA BB BB BB 1 1
309 rs13477506 3 155444424 AA BB BB AA AA AA 1 1
310 gnf03.160.599 3 157755333 AA BB BB BB BB BB 1 1
311 CEL-3_159340478 3 159340478 AA BB BB AA AA AA 1 1
312 rs3695715 4 3649824 BB BB BB AA AA AA 1 1
313 gnf04.002.008 4 5013576 AA AA BB AA AA AA 1 1
314 gnf04.002.599 4 5606396 AA AA BB AA AA AA 1 1
315 rs3660863 4 7127435 AA AA AA BB BB BB 1 1
316 UT_4_10.84692 4 10825412 BB BB AA BB BB BB 1 1
317 rs13477568 4 13764168 AA AA AA BB BB BB 1 1
318 mCV22939387 4 15321444 AA AA AA AA AA AA 1 1
319 rs6287606 4 18045313 BB BB AA BB BB BB 1 1
320 CEL-4_19508304 4 19508304 BB BB BB AA AA AA 1 1
321 rs13477596 4 20665789 AA AA AA BB BB BB 1 1
322 gnf04.019.134 4 22305486 BB BB BB AA AA AA 1 1
323 mCV22919271 4 24149712 BB BB AA AA AA AA 1 1
324 rs13477617 4 27105003 BB BB AA AA AA AA 1 1
325 rs3701432 4 29487208 BB BB BB AA AA AA 1 1
326 CEL-4_30653207 4 30653207 BB BB AA AA AA AA 1 1
327 rs3663744 4 31215491 AA AA AA BB BB BB 1 1
328 rs3674908 4 32441103 AA AA AA BB BB BB 1 1
329 rs13477643 4 35074381 BB BB AA BB BB BB 1 1
330 rs3719299 4 36221145 AA AA BB BB BB BB 1 1
331 rs3684104 4 38414337 BB BB BB AA AA AA 1 1
332 rs13477662 4 39882315 BB BB BB AA AA AA 1 1
333 CEL-4_40541402 4 40541402 AA AA BB AA AA AA 1 1
334 rs3698283 4 42429891 BB AA AA BB BB BB 1 1
335 rs13477676 4 44111689 BB AA AA AA AA AA 1 1
336 rs13477681 4 45420449 BB BB BB AA AA AA 1 1
337 rs3663355 4 47358427 BB AA AA AA AA AA 1 1
338 rs3676423 4 51035410 BB AA AA BB BB BB 1 1
339 rs13477709 4 52679398 AA BB BB AA AA AA 1 1
340 rs3677770 4 53964528 AA AA AA BB BB BB 1 1
341 rs6239799 4 55765284 BB BB BB AA AA AA 1 1
342 rs13477726 4 57030578 BB AA AA AA AA AA 1 1
343 rs3712541 4 59103430 AA AA AA BB BB BB 1 1
344 rs3690581 4 61034761 AA AA AA BB BB BB 1 1
345 rs6254381 4 62013092 AA AA AA AA AA AA 1 1
346 rs13477749 4 64811196 AA BB AA AA AA AA 1 1
347 rs3710245 4 68727690 BB AA AA AA AA AA 1 1
348 rs13477765 4 69553312 BB AA AA AA AA AA 1 1
349 rs6222684 4 70467819 BB AA AA AA AA AA 1 1
350 rs13477774 4 71868643 BB AA AA AA AA AA 1 1
351 rs13477785 4 74403260 AA AA BB BB BB BB 1 1
352 rs3708471 4 75144974 BB BB AA AA AA AA 1 1
353 CEL-4_77952063 4 77952063 AA BB AA AA AA AA 1 1
354 rs4139273 4 79969982 AA AA BB BB BB BB 1 1
355 rs3676928 4 81040027 AA AA BB BB BB BB 1 1
356 rs3699276 4 81462943 BB BB AA AA AA AA 1 1
357 rs3711477 4 84506191 BB BB BB AA AA AA 1 1
358 rs6209043 4 88269130 AA AA AA BB BB BB 1 1
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359 rs13477838 4 89450763 BB AA AA BB BB BB 1 1
360 rs6271003 4 91308682 BB AA AA AA AA AA 1 1
361 rs3659791 4 94278186 BB AA AA BB BB BB 1 1
362 rs13477860 4 95674511 BB AA AA AA AA AA 1 1
363 rs13477866 4 97650355 BB AA AA AA AA AA 1 1
364 rs13477873 4 99775886 BB AA AA BB BB BB 1 1
365 rs6315002 4 101395000 BB AA AA BB BB BB 1 1
366 rs13477883 4 102307704 BB AA AA BB BB BB 1 1
367 rs6324470 4 104323754 BB BB BB AA AA AA 1 1
368 rs6226080 4 107056497 AA AA AA BB BB BB 1 1
369 rs3710617 4 108380717 BB AA AA AA AA AA 1 1
370 rs3709486 4 109968331 BB AA AA BB BB BB 1 1
371 rs6381371 4 114381685 BB AA AA BB BB BB 1 1
372 rs3692563 4 116737689 AA AA AA BB BB BB 1 1
373 rs3675629 4 119404209 AA AA AA BB BB BB 1 1
374 rs13477952 4 121322200 AA BB BB AA AA AA 1 1
375 rs13477959 4 122566268 AA AA AA BB BB BB 1 1
376 rs13477965 4 125082422 BB AA AA BB BB BB 1 1
377 gnf04.123.367 4 126400415 BB AA AA BB BB BB 1 1
378 rs6355837 4 128083691 BB BB BB AA AA AA 1 1
379 UT_4_132.137715 4 131705391 BB BB BB AA AA AA 1 1
380 rs3663950 4 134187547 BB BB AA AA AA AA 1 1
381 rs13478002 4 135132664 BB AA AA BB BB BB 1 1
382 rs4224864 4 136662000 BB AA AA BB BB BB 1 1
383 rs3688566 4 140026440 BB BB BB AA AA AA 1 1
384 rs3719891 4 140961583 AA AA BB AA AA AA 1 1
385 rs3023025 4 141638718 BB AA AA AA AA AA 1 1
386 rs6230717 4 145785696 BB AA BB AA AA AA 1 1
387 rs6268364 4 149902058 BB BB AA AA AA AA 1 1
388 rs13478089 4 152316000 AA AA AA BB BB BB 1 1
389 rs13478068 4 153104114 BB BB BB AA AA AA 1 1
390 rs6279100 4 154069720 BB AA BB AA AA AA 1 1
391 mCV24244050 5 3061523 BB BB AA AA AA AA 1 1
392 rs13478092 5 3601413 BB BB AA AA AA AA 1 1
393 rs13478094 5 4310159 BB BB AA BB BB BB 1 1
394 rs3664617 5 4474737 BB BB BB AA AA AA 1 1
395 rs6402980 5 5438798 AA BB AA BB BB BB 1 1
396 rs6307393 5 7652759 BB AA AA AA AA AA 1 1
397 rs13478110 5 9748059 BB AA AA AA AA AA 1 1
398 rs3714258 5 11417181 AA BB AA BB BB BB 1 1
399 rs3687916 5 13389454 AA BB AA BB BB BB 1 1
400 rs6353097 5 13875606 BB AA AA AA AA AA 1 1
401 rs3692039 5 16224015 BB AA AA AA AA AA 1 1
402 rs6234642 5 17667733 BB AA AA AA AA AA 1 1
403 rs13478133 5 19993162 AA AA BB AA AA AA 1 1
404 rs13478139 5 21398479 BB BB AA AA AA AA 1 1
405 rs6349956 5 23273638 AA AA BB AA AA AA 1 1
406 CEL-5_24211033 5 24211033 AA BB BB BB BB BB 1 1
407 rs13478154 5 25501830 BB BB BB AA AA AA 1 1
408 rs3696671 5 26095730 BB BB BB AA AA AA 1 1
409 rs3680434 5 27162034 BB AA AA BB BB BB 1 1
410 rs13469943 5 29486094 BB BB BB AA AA AA 1 1
411 rs3700706 5 31071103 BB BB BB AA AA AA 1 1
412 rs13459085 5 33353887 AA BB BB AA AA AA 1 1
413 rs3673363 5 33963604 AA BB BB AA AA AA 1 1
414 rs6341620 5 35567326 AA AA AA BB BB BB 1 1
415 rs6256504 5 38327673 BB AA AA AA AA AA 1 1
416 rs13478205 5 39608047 BB BB AA AA AA AA 1 1
417 rs6215373 5 42914749 AA AA AA BB BB BB 1 1
418 rs13478223 5 43971357 BB AA AA BB BB BB 1 1
419 rs3659933 5 44700900 NC NC NC BB NC NC NA NA
420 CEL-5_45872918 5 45872918 BB AA AA BB BB BB 1 1
421 rs6192958 5 47975043 AA BB BB AA AA AA 1 1
422 rs3714001 5 49310150 BB BB AA AA AA AA 1 1
423 rs3660964 5 51028268 AA AA BB BB BB BB 1 1
424 rs3664008 5 52283097 BB BB BB AA AA AA 1 1
425 mCV23125912 5 53853311 AA BB AA BB BB BB 1 1
426 CEL-5_56167948 5 56167948 BB AA BB AA AA AA 1 1
427 rs3090667 5 58891807 AA AA AA BB BB BB 1 1
428 rs6354160 5 60155561 BB BB BB AA AA AA 1 1
429 rs6187409 5 61437749 BB BB BB AA AA AA 1 1
430 mCV23386455 5 62818443 BB BB BB AA AA AA 1 1
431 rs4225248 5 65265514 BB BB BB AA AA AA 1 1
432 rs13478309 5 65750331 BB AA AA BB BB BB 1 1
433 gnf05.061.650 5 65952319 AA AA AA BB BB BB 1 1
434 rs3695107 5 69049778 AA AA BB BB BB BB 1 1
435 rs6340166 5 71436027 BB BB AA BB BB BB 1 1
436 rs6161105 5 73093296 BB BB BB AA AA AA 1 1
437 mCV22996021 5 75065363 BB BB AA BB BB BB 1 1
438 rs13478337 5 76181811 AA BB BB BB BB BB 1 1
439 rs13478352 5 79902641 AA AA BB BB BB BB 1 1
440 rs3721607 5 81282125 BB BB BB AA AA AA 1 1
441 rs3667334 5 81819770 BB BB BB AA AA AA 1 1
442 rs13459087 5 85884364 BB BB BB AA AA AA 1 1
443 CEL-5_87173557 5 87173557 BB BB BB AA AA AA 1 1
444 gnf05.084.686 5 88364567 BB BB BB AA AA AA 1 1
445 rs3673049 5 88498569 AA AA AA BB BB BB 1 1
446 rs13478388 5 89674255 AA BB BB AA AA AA 1 1
447 rs6232866 5 90936845 BB BB BB AA AA AA 1 1
448 rs13478402 5 93496397 AA AA AA BB BB BB 1 1
449 CEL-5_93945748 5 93945748 AA AA AA BB BB BB 1 1
450 rs3661241 5 95154383 AA AA AA BB BB BB 1 1
451 rs3705458 5 96618852 AA AA AA BB BB BB 1 1
452 rs13478433 5 101291108 AA BB BB BB BB BB 1 1
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453 rs13478451 5 106102700 BB BB BB AA AA AA 1 1
454 rs13459186 5 107435156 AA AA BB BB BB BB 1 1
455 UT_5_110.343536 5 108678291 AA BB BB BB BB BB 1 1
456 gnf05.106.197 5 109421273 BB BB BB AA AA AA 1 1
457 rs13478473 5 111603432 AA AA BB AA AA AA 1 1
458 gnf05.110.207 5 113532900 BB BB AA AA AA AA 1 1
459 rs13478483 5 115405250 AA AA AA BB BB BB 1 1
460 CEL-5_117374791 5 117374791 AA AA AA BB BB BB 1 1
461 rs8239888 5 119078055 BB BB AA AA AA AA 1 1
462 rs13478496 5 119747337 BB BB AA AA AA AA 1 1
463 rs13478501 5 121338564 AA AA BB BB BB BB 1 1
464 rs3671202 5 122343598 BB BB BB AA AA AA 1 1
465 gnf05.120.129 5 123654667 AA AA BB BB BB BB 1 1
466 rs13478518 5 125334324 BB AA BB AA AA AA 1 1
467 rs13478527 5 126818001 BB BB AA AA AA AA 1 1
468 gnf05.124.386 5 127936509 AA BB BB BB BB BB 1 1
469 rs13478540 5 131766121 AA AA AA AA AA AA 1 1
470 rs13478546 5 133978719 BB AA AA BB BB BB 1 1
471 rs4225536 5 135836567 BB BB BB AA AA AA 1 1
472 rs6298689 5 137173297 AA BB AA AA AA AA 1 1
473 rs3656197 5 139206611 AA AA AA BB BB BB 1 1
474 rs13478574 5 141567331 BB AA AA AA AA AA 1 1
475 rs3718776 5 147051702 AA AA AA BB BB BB 1 1
476 rs3661828 6 3167392 AA AA AA BB BB BB 1 1
477 rs13478602 6 3547547 AA AA AA BB BB BB 1 1
478 rs6172481 6 4362632 BB BB BB AA AA AA 1 1
479 rs3699833 6 6161470 BB BB BB AA AA AA 1 1
480 rs13478617 6 7747436 AA AA AA AA AA AA 1 1
481 rs13478621 6 8907544 BB AA AA AA AA AA 1 1
482 rs13478626 6 9890882 BB AA AA AA AA AA 1 1
483 rs13478631 6 11055603 BB AA AA AA AA AA 1 1
484 rs3678711 6 14045168 AA BB BB AA AA AA 1 1
485 rs13478641 6 15816033 BB AA AA BB BB BB 1 1
486 rs3655269 6 17715100 AA AA AA BB BB BB 1 1
487 rs13478649 6 18376687 BB AA AA AA AA AA 1 1
488 rs13478656 6 21755667 AA AA AA BB BB BB 1 1
489 rs3684494 6 24248321 BB AA BB BB BB BB 1 1
490 rs3671709 6 25646449 BB BB AA BB BB BB 1 1
491 rs13478677 6 27804113 BB AA BB AA AA AA 1 1
492 gnf06.026.418 6 29269458 AA AA AA BB BB BB 1 1
493 rs13478697 6 32730020 BB BB BB AA AA AA 1 1
494 rs13478705 6 34409100 BB AA AA BB BB BB 1 1
495 rs3704635 6 36040358 AA AA AA BB BB BB 1 1
496 rs6330932 6 37461200 AA AA AA AA AA AA 1 1
497 rs13478719 6 38474383 BB BB AA BB BB BB 1 1
498 gnf06.037.785 6 40733942 BB BB AA BB BB BB 1 1
499 rs13478727 6 43778689 BB BB BB AA AA AA 1 1
500 rs6238771 6 45234635 AA BB AA AA AA AA 1 1
501 rs13478732 6 45420260 AA BB AA AA AA AA 1 1
502 rs13478745 6 48964507 BB AA AA BB BB BB 1 1
503 rs4139698 6 49813889 BB BB AA AA AA AA 1 1
504 rs13478753 6 51145321 AA BB BB AA AA AA 1 1
505 rs13478761 6 53702681 AA BB AA BB BB BB 1 1
506 rs6355719 6 56316458 AA BB BB BB BB BB 1 1
507 CEL-6_57082524 6 57082524 AA AA AA BB BB BB 1 1
508 rs13478780 6 59609561 BB BB AA BB BB BB 1 1
509 rs13478783 6 60682681 X BB BB BB AA AA AA 1 1
510 rs6378343 6 63916748 AA AA BB AA AA AA 1 1
511 rs13478801 6 65211036 AA AA BB AA AA AA 1 1
512 rs6353425 6 67548202 AA AA AA AA AA AA 1 1
513 rs6195266 6 69590221 BB BB BB BB BB BB 1 1
514 mhcCD8b4 6 71532444 AA AA BB AA AA AA 1 1
515 rs13478819 6 73538842 AA BB BB BB BB BB 1 1
516 rs3672029 6 75631345 AA BB AA BB BB BB 1 1
517 rs3699367 6 76679118 AA BB BB AA AA AA 1 1
518 rs13478841 6 78477103 AA AA BB BB BB BB 1 1
519 rs6377140 6 80032286 BB BB AA AA AA AA 1 1
520 rs6181382 6 81674296 AA BB AA AA AA AA 1 1
521 CEL-6_83434907 6 83434907 AA BB AA AA AA AA 1 1
522 rs13459097 6 85136988 BB AA AA AA AA AA 1 1
523 CEL-6_86289708 6 86289708 AA BB AA BB BB BB 1 1
524 rs13478882 6 90003224 BB AA BB AA AA AA 1 1
525 rs13478891 6 92361613 BB AA AA AA AA AA 1 1
526 rs6285738 6 93892091 BB BB AA BB BB BB 1 1
527 rs6239023 6 94413050 AA AA BB BB BB BB 1 1
528 rs6349084 6 97121415 BB AA BB BB BB BB 1 1
529 rs13478919 6 98304818 AA BB AA AA AA AA 1 1
530 rs4138572 6 98790763 AA BB BB AA AA AA 1 1
531 rs3718735 6 101508462 BB BB BB AA AA AA 1 1
532 rs13478943 6 104128964 BB AA AA AA AA AA 1 1
533 rs6208251 6 105270851 BB AA AA BB BB BB 1 1
534 rs13478952 6 106695156 BB AA AA BB BB BB 1 1
535 rs3670475 6 110397055 AA AA BB AA AA AA 1 1
536 rs13478971 6 111749805 BB AA AA BB BB BB 1 1
537 rs13478977 6 113036388 AA AA AA AA AA AA 1 1
538 rs6393943 6 114932370 AA BB BB BB BB BB 1 1
539 rs6401637 6 116477552 BB AA BB AA AA AA 1 1
540 mCV23042866 6 117147180 BB AA BB AA AA AA 1 1
541 rs13478997 6 118461935 BB AA AA AA AA AA 1 1
542 rs3695724 6 120403722 NC NC NC AA NC NC NA NA
543 rs13479006 6 121702158 BB BB BB AA AA AA 1 1
544 gnf06.122.747 6 124630688 BB AA AA BB BB BB 1 1
545 rs13479014 6 125666374 AA BB BB AA AA AA 1 1
546 rs6200835 6 126340874 BB AA AA AA AA AA 1 1
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547 rs6389420 6 127676012 AA BB BB AA AA AA 1 1
548 rs3681620 6 128654310 BB BB BB AA AA AA 1 1
549 CEL-6_130920075 6 130920075 BB BB BB AA AA AA 1 1
550 rs3722480 6 131616421 BB AA AA BB BB BB 1 1
551 rs6339546 6 134019679 AA BB BB AA AA AA 1 1
552 rs13479053 6 134303922 AA BB BB AA AA AA 1 1
553 rs3023102 6 135439528 AA AA AA BB BB BB 1 1
554 rs13479063 6 136451163 BB AA AA BB BB BB 1 1
555 rs13479071 6 138359897 AA BB BB BB BB BB 1 1
556 rs3672808 6 139965472 BB AA AA BB BB BB 1 1
557 rs6329892 6 142567031 AA AA AA AA AA AA 1 1
558 rs3658783 6 144465978 BB BB BB AA AA AA 1 1
559 rs6265387 6 147380171 BB BB AA AA AA AA 1 1
560 rs3711088 6 148456534 BB BB BB AA AA AA 1 1
561 gnf06.149.306 6 149418695 BB BB BB AA AA AA 1 1
562 mCV23738426 7 4906617 AA AA BB BB BB BB 1 1
563 CEL-7_5627457 7 5627457 BB AA BB BB BB BB 1 1
564 rs13479139 7 8241486 BB AA BB AA AA AA 1 1
565 rs6361142 7 9296425 BB AA BB AA AA AA 1 1
566 rs3689218 7 10546409 BB AA BB BB BB BB 1 1
567 gnf07.013.809 7 10926083 BB AA BB AA AA AA 1 1
568 rs13479153 7 13677268 BB BB BB AA AA AA 1 1
569 CEL-7_17114061 7 17114061 BB BB BB AA AA AA 1 1
570 rs4226499 7 17800749 BB BB AA BB BB BB 1 1
571 rs4226520 7 18758740 AA AA BB BB BB BB 1 1
572 rs3147860 7 19496283 BB AA AA AA AA AA 1 1
573 rs3719311 7 22647606 BB AA BB BB BB BB 1 1
574 rs6239372 7 23113384 AA AA AA AA AA AA 1 1
575 rs13479191 7 24555108 BB BB BB BB BB BB 1 1
576 gnf07.032.889 7 28379711 AA BB AA AA AA AA 1 1
577 rs4232449 7 28755779 AA AA AA AA AA AA 1 1
578 rs3719256 7 31933809 BB AA BB AA AA AA 1 1
579 rs8255275 7 33574760 AA AA AA BB BB BB 1 1
580 rs8260975 7 33835314 BB AA BB AA AA AA 1 1
581 CEL-7_36725559 7 36725559 BB AA BB AA AA AA 1 1
582 rs3699938 7 38476481 BB AA BB BB BB BB 1 1
583 rs13479251 7 39863901 AA AA AA BB BB BB 1 1
584 rs3718641 7 41170581 BB AA BB AA AA AA 1 1
585 rs3663313 7 43718739 AA BB AA BB BB BB 1 1
586 mCV23672419 7 45173762 AA AA AA AA AA AA 1 1
587 rs13479277 7 46313106 BB BB BB AA AA AA 1 1
588 mCV23423763 7 47949709 BB BB BB AA AA AA 1 1
589 rs3679779 7 51392430 BB BB BB AA AA AA 1 1
590 rs3714908 7 51544526 AA BB AA BB BB BB 1 1
591 rs6160140 7 53312532 AA BB AA BB BB BB 1 1
592 rs3705155 7 55557090 AA AA AA BB BB BB 1 1
593 rs13479319 7 56830620 BB BB BB AA AA AA 1 1
594 rs13479324 7 57878499 BB BB BB AA AA AA 1 1
595 rs3676254 7 59722158 AA AA AA BB BB BB 1 1
596 rs13479338 7 61105319 AA AA AA BB BB BB 1 1
597 rs13479347 7 63356038 AA AA AA BB BB BB 1 1
598 rs13479355 7 65348455 BB AA BB BB BB BB 1 1
599 rs13479358 7 66776784 AA BB AA AA AA AA 1 1
600 rs13479363 7 68228570 BB BB BB AA AA AA 1 1
601 rs6213614 7 69422276 AA BB AA AA AA AA 1 1
602 rs13479375 7 71406934 BB AA BB AA AA AA 1 1
603 rs13479385 7 74292260 AA BB AA AA AA AA 1 1
604 rs13479395 7 77234500 AA AA AA BB BB BB 1 1
605 CEL-7_77850273 7 77850273 AA BB AA AA AA AA 1 1
606 rs4226783 7 80158909 AA BB AA BB BB BB 1 1
607 rs13479414 7 82727616 BB AA AA BB BB BB 1 1
608 rs3699086 7 83322675 BB BB AA BB BB BB 1 1
609 rs3707067 7 85992410 AA AA BB BB BB BB 1 1
610 rs13479427 7 87305015 AA AA BB BB BB BB 1 1
611 rs3713052 7 89115174 BB BB BB AA AA AA 1 1
612 rs6357312 7 89751283 AA AA AA BB BB BB 1 1
613 rs3673653 7 94344049 BB BB BB AA AA AA 1 1
614 rs6386601 7 94870318 AA BB AA BB BB BB 1 1
615 rs13479455 7 96728523 AA AA AA AA AA AA 1 1
616 rs13479461 7 99220204 AA AA AA BB BB BB 1 1
617 rs6194926 7 101647757 BB AA AA BB BB BB 1 1
618 rs13479477 7 104533846 AA BB AA BB BB BB 1 1
619 rs3023159 7 106579694 AA BB BB AA AA AA 1 1
620 rs3709679 7 107424656 BB AA AA BB BB BB 1 1
621 rs6275579 7 111285662 BB BB BB BB BB BB 1 1
622 rs13479506 7 112152410 AA AA BB BB BB BB 1 1
623 rs3682038 7 113814867 AA BB BB BB BB BB 1 1
624 rs13479517 7 115461663 BB AA AA AA AA AA 1 1
625 CEL-7_115892950 7 115892950 BB AA AA BB BB BB 1 1
626 rs13479522 7 116540646 X BB BB BB AA AA AA 1 1
627 rs13479535 7 119192048 AA BB BB BB BB BB 1 1
628 rs3716088 7 120621563 BB BB BB AA AA AA 1 1
629 CEL-7_122752866 7 122752866 BB BB BB BB BB BB 1 1
630 rs13479553 7 124913079 AA AA AA AA AA AA 1 1
631 rs3663988 7 126965988 AA AA AA BB BB BB 1 1
632 rs3711570 8 4193008 BB BB AA AA AA AA 1 1
633 rs6360601 8 6795642 AA AA BB BB BB BB 1 1
634 rs6153168 8 8294541 BB AA AA AA AA AA 1 1
635 rs13479608 8 11675148 BB AA AA AA AA AA 1 1
636 rs6410533 8 14327885 BB BB BB BB BB BB 1 1
637 rs13479619 8 15319466 BB AA AA BB BB BB 1 1
638 rs3657963 8 16576750 AA AA AA BB BB BB 1 1
639 gnf08.014.711 8 18169937 AA AA AA BB BB BB 1 1
640 rs4140004 8 21285113 AA AA AA BB BB BB 1 1
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641 rs3661760 8 22251497 AA AA AA BB BB BB 1 1
642 rs13479656 8 24309617 BB BB BB AA AA AA 1 1
643 CEL-8_25963079 8 25963079 BB BB AA BB BB BB 1 1
644 rs13479673 8 28075869 AA AA AA BB BB BB 1 1
645 rs4227096 8 30204827 BB BB BB AA AA AA 1 1
646 rs3706948 8 30816540 AA AA AA BB BB BB 1 1
647 CEL-8_33812776 8 33812776 BB BB BB AA AA AA 1 1
648 rs3665028 8 35164032 BB BB BB AA AA AA 1 1
649 rs3667738 8 37536463 AA AA AA BB BB BB 1 1
650 rs13479716 8 38775830 BB AA AA BB BB BB 1 1
651 rs3703811 8 39770568 AA AA AA BB BB BB 1 1
652 rs3666140 8 42081791 BB BB AA AA AA AA 1 1
653 rs6386110 8 43934856 BB BB AA AA AA AA 1 1
654 UT_8_46.498556 8 45775629 AA BB BB BB BB BB 1 1
655 rs3719401 8 48804736 AA BB BB BB BB BB 1 1
656 rs13479755 8 50117838 BB AA AA AA AA AA 1 1
657 CEL-8_51607005 8 51607005 AA BB BB BB BB BB 1 1
658 rs13479768 8 53532210 AA BB BB BB BB BB 1 1
659 rs13479776 8 55177326 BB AA AA AA AA AA 1 1
660 rs3725286 8 56141367 AA BB BB BB BB BB 1 1
661 rs3707439 8 57724335 BB AA AA BB BB BB 1 1
662 rs3672639 8 60120308 BB AA AA BB BB BB 1 1
663 rs13479793 8 60901130 AA BB BB AA AA AA 1 1
664 rs6372901 8 63043201 AA BB BB AA AA AA 1 1
665 rs13479807 8 64586401 AA BB BB AA AA AA 1 1
666 rs13479811 8 66034595 AA AA BB AA AA AA 1 1
667 rs3656875 8 67222604 BB BB BB AA AA AA 1 1
668 rs3699406 8 68996069 AA AA AA BB BB BB 1 1
669 rs3667475 8 70497527 AA AA AA BB BB BB 1 1
670 rs13479830 8 72013995 AA AA AA BB BB BB 1 1
671 rs4227253 8 74193741 BB BB BB AA AA AA 1 1
672 rs3696502 8 74806749 AA AA BB BB BB BB 1 1
673 rs3698093 8 77144203 AA AA BB AA AA AA 1 1
674 CZECH-8_78291790 8 78291790 BB BB BB BB BB BB 1 1
675 rs4227276 8 80165835 AA AA BB AA AA AA 1 1
676 rs13479863 8 82188194 BB BB AA BB BB BB 1 1
677 rs13479871 8 84344531 BB BB AA BB BB BB 1 1
678 rs6257357 8 84826788 BB BB BB AA AA AA 1 1
679 rs13479880 8 86040626 BB BB AA AA AA AA 1 1
680 rs13479882 8 86397354 BB BB AA BB BB BB 1 1
681 rs13479884 8 86954362 AA AA BB BB BB BB 1 1
682 rs6391152 8 89169668 BB BB AA AA AA AA 1 1
683 rs13479922 8 91879489 AA AA BB BB BB BB 1 1
684 rs4137596 8 94037444 AA BB BB AA AA AA 1 1
685 rs6285803 8 95323284 BB BB AA AA AA AA 1 1
686 rs6287320 8 96735663 BB BB BB AA AA AA 1 1
687 rs13479947 8 98654267 AA AA AA AA AA AA 1 1
688 rs3706149 8 100766333 AA AA AA BB BB BB 1 1
689 rs3669235 8 101399186 AA AA BB AA AA AA 1 1
690 rs13479956 8 101681071 AA AA AA BB BB BB 1 1
691 rs3705275 8 102686478 BB BB BB AA AA AA 1 1
692 gnf08.108.032 8 106117382 BB BB BB AA AA AA 1 1
693 rs3662808 8 108727362 BB BB BB AA AA AA 1 1
694 rs6237645 8 109333466 BB BB BB AA AA AA 1 1
695 rs13479995 8 113066370 BB BB BB AA AA AA 1 1
696 rs4227398 8 113744792 AA BB BB BB BB BB 1 1
697 gnf08.118.027 8 116198601 AA AA BB AA AA AA 1 1
698 rs13480014 8 118001545 BB AA AA BB BB BB 1 1
699 rs3708073 8 121235325 BB BB BB AA AA AA 1 1
700 rs6377872 8 121825605 AA AA AA BB BB BB 1 1
701 rs3705725 8 123350039 BB BB BB AA AA AA 1 1
702 rs6400423 8 125966003 BB BB BB AA AA AA 1 1
703 rs3697596 8 127236890 BB BB BB AA AA AA 1 1
704 mCV23893269 9 3980881 AA BB BB BB BB BB 1 1
705 mCV23053483 9 6793269 AA BB BB BB BB BB 1 1
706 rs13480065 9 9289357 AA BB BB BB BB BB 1 1
707 mCV25073238 9 10587580 AA BB BB AA AA AA 1 1
708 rs13480071 9 12387092 BB AA AA BB BB BB 1 1
709 gnf09.012.310 9 17881329 AA BB BB BB BB BB 1 1
710 rs13480092 9 18988599 BB AA AA AA AA AA 1 1
711 rs8270115 9 21900659 BB BB BB BB BB BB 1 1
712 rs13480103 9 23359729 AA BB BB BB BB BB 1 1
713 rs3088801 9 24949186 AA AA AA AA AA AA 1 1
714 rs13480112 9 26555143 AA BB BB BB BB BB 1 1
715 rs6404775 9 28016429 AA AA AA AA AA AA 1 1
716 rs6385855 9 29608871 AA AA AA AA AA AA 1 1
717 rs13480122 9 31136193 X BB BB BB AA AA AA 1 1
718 rs3655898 9 33657166 BB BB BB AA AA AA 1 1
719 rs3711756 9 34437206 BB BB BB AA AA AA 1 1
720 UT_9_35.918713 9 35184595 BB BB BB AA AA AA 1 1
721 rs13480141 9 36959921 BB BB BB AA AA AA 1 1
722 rs13480150 9 39740553 AA AA AA BB BB BB 1 1
723 rs3714664 9 40768895 AA AA AA BB BB BB 1 1
724 rs4135590 9 43060131 BB BB BB AA AA AA 1 1
725 rs13462199 9 44740915 BB BB BB AA AA AA 1 1
726 rs13480173 9 46633516 AA BB BB AA AA AA 1 1
727 rs6395817 9 47519917 AA BB BB AA AA AA 1 1
728 gnf09.042.496 9 48315615 AA BB BB AA AA AA 1 1
729 rs13480186 9 50318725 BB AA AA BB BB BB 1 1
730 rs3723670 9 52682809 BB BB BB AA AA AA 1 1
731 rs13480208 9 55395056 AA BB BB BB BB BB 1 1
732 rs3666398 9 56790950 AA BB AA BB BB BB 1 1
733 rs13480217 9 58024426 BB BB AA BB BB BB 1 1
734 rs6224703 9 60196412 BB AA BB AA AA AA 1 1
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735 rs3714012 9 61377354 AA BB AA BB BB BB 1 1
736 gnf09.057.223 9 63239299 AA AA AA AA AA AA 1 1
737 rs3655717 9 65704935 BB AA BB AA AA AA 1 1
738 rs6174757 9 68381485 AA AA AA BB BB BB 1 1
739 rs6355445 9 70209362 AA BB BB AA AA AA 1 1
740 rs3721056 9 71328971 AA AA AA BB BB BB 1 1
741 rs13480271 9 73145678 BB AA AA BB BB BB 1 1
742 rs3724833 9 75221496 AA AA AA BB BB BB 1 1
743 rs13480285 9 76908789 BB AA AA BB BB BB 1 1
744 rs6257131 9 79059621 BB AA AA AA AA AA 1 1
745 gnf09.074.193 9 80458981 BB AA AA BB BB BB 1 1
746 rs6223687 9 82203633 BB BB BB BB BB BB 1 1
747 rs3676124 9 83548399 AA AA AA BB BB BB 1 1
748 rs3695050 9 85584599 BB AA AA BB BB BB 1 1
749 rs3700596 9 86745093 BB BB BB AA AA AA 1 1
750 rs3669564 9 88325825 BB BB BB AA AA AA 1 1
751 gnf09.087.298 9 90513305 AA AA AA BB BB BB 1 1
752 rs13480345 9 92060032 AA BB BB AA AA AA 1 1
753 rs13480351 9 94137054 AA AA AA BB BB BB 1 1
754 CEL-9_95875215 9 95875215 AA AA AA BB BB BB 1 1
755 rs3689336 9 96256381 BB BB BB AA AA AA 1 1
756 rs13480365 9 98418600 BB AA AA BB BB BB 1 1
757 rs6385971 9 99710289 AA BB BB AA AA AA 1 1
758 rs3717654 9 101878542 BB BB BB AA AA AA 1 1
759 rs13480386 9 103546788 AA BB BB AA AA AA 1 1
760 rs3711089 9 105418025 BB BB BB AA AA AA 1 1
761 rs13480399 9 106229354 AA AA AA BB BB BB 1 1
762 rs13480407 9 108690630 AA BB BB AA AA AA 1 1
763 rs13480413 9 109861337 AA BB BB AA AA AA 1 1
764 rs13480421 9 111862825 AA BB BB BB BB BB 1 1
765 gnf09.110.002 9 113307145 BB AA AA BB BB BB 1 1
766 rs6320810 9 115090216 BB BB BB AA AA AA 1 1
767 rs3669563 9 117891342 AA AA AA BB BB BB 1 1
768 rs13459114 9 121920390 AA BB BB AA AA AA 1 1
769 rs6304156 9 123162408 AA AA AA BB BB BB 1 1
770 rs3721803 10 3343120 AA AA AA BB BB BB 1 1
771 CEL-10_3989939 10 3989939 AA AA BB AA AA AA 1 1
772 rs13480473 10 4778214 BB BB AA AA AA AA 1 1
773 rs6185923 10 5384467 AA AA AA BB BB BB 1 1
774 rs3664101 10 9286770 BB BB BB AA AA AA 1 1
775 rs3685588 10 10540887 BB BB BB AA AA AA 1 1
776 rs4228112 10 12719980 AA BB BB BB BB BB 1 1
777 rs3686911 10 14116427 AA BB BB AA AA AA 1 1
778 rs3699409 10 15499377 AA AA AA BB BB BB 1 1
779 rs3712394 10 17639020 BB BB BB AA AA AA 1 1
780 rs13480527 10 19318252 BB AA AA BB BB BB 1 1
781 rs13459119 10 20027450 BB BB BB AA AA AA 1 1
782 rs3679120 10 22685808 BB AA BB AA AA AA 1 1
783 rs13480547 10 24247475 BB BB BB AA AA AA 1 1
784 rs13480554 10 25713665 AA AA AA BB BB BB 1 1
785 rs13480563 10 27924915 AA AA AA AA AA AA 1 1
786 gnf10.026.889 10 28746498 AA BB BB AA AA AA 1 1
787 rs13480569 10 30500013 BB AA BB BB BB BB 1 1
788 rs13480570 10 30794652 AA BB AA AA AA AA 1 1
789 rs13480578 10 34410603 AA AA AA BB BB BB 1 1
790 rs13480579 10 36058713 BB BB BB AA AA AA 1 1
791 rs13480581 10 38833025 AA BB BB BB BB BB 1 1
792 rs3716113 10 42609040 BB AA AA AA AA AA 1 1
793 rs13480601 10 44227379 AA AA AA BB BB BB 1 1
794 CEL-10_46671493 10 46671493 AA BB BB AA AA AA 1 1
795 rs3676667 10 46923056 BB AA AA BB BB BB 1 1
796 rs6382436 10 48683209 BB BB AA AA AA AA 1 1
797 gnf10.048.819 10 50989663 AA AA AA AA AA AA 1 1
798 rs3696307 10 53783742 BB BB BB AA AA AA 1 1
799 rs6190748 10 55832573 AA AA AA AA AA AA 1 1
800 rs13480619 10 57805922 X BB BB BB AA AA AA 1 1
801 CEL-10_58149652 10 58149652 X AA AA AA BB BB BB 1 1
802 rs6374078 10 60860895 BB BB BB BB BB BB 1 1
803 rs6359581 10 64294902 AA AA AA AA AA AA 1 1
804 rs3723140 10 66179274 AA BB AA BB BB BB 1 1
805 rs13480630 10 67595648 BB BB BB BB BB BB 1 1
806 rs13480638 10 69220086 BB AA BB AA AA AA 1 1
807 CEL-10_71736974 10 71736974 AA AA AA BB BB BB 1 1
808 rs13480652 10 74437771 AA AA AA BB BB BB 1 1
809 rs13480657 10 76584143 BB BB BB AA AA AA 1 1
810 rs13480664 10 80556929 BB AA BB BB BB BB 1 1
811 rs3717445 10 82649121 BB BB BB AA AA AA 1 1
812 rs13480678 10 84352470 BB AA AA BB BB BB 1 1
813 rs3679902 10 85007769 BB AA AA BB BB BB 1 1
814 rs13480684 10 85606566 AA AA AA AA AA AA 1 1
815 CEL-10_86322095 10 86322095 BB AA AA BB BB BB 1 1
816 rs3089366 10 89439033 BB AA BB BB BB BB 1 1
817 rs13480702 10 90830897 BB AA AA BB BB BB 1 1
818 gnf10.091.965 10 92745604 AA BB BB AA AA AA 1 1
819 rs13480712 10 93288075 AA AA AA BB BB BB 1 1
820 rs13480716 10 94290709 BB BB BB AA AA AA 1 1
821 rs13480722 10 97430180 BB BB BB AA AA AA 1 1
822 rs6175332 10 98639384 AA AA AA AA AA AA 1 1
823 rs3683912 10 99061427 BB BB AA BB BB BB 1 1
824 rs3710293 10 99892920 AA AA BB AA AA AA 1 1
825 rs13480734 10 102081906 BB BB BB AA AA AA 1 1
826 rs13480740 10 103764301 BB AA BB BB BB BB 1 1
827 rs3688351 10 104194765 AA BB AA BB BB BB 1 1
828 rs13480749 10 105674831 BB BB BB AA AA AA 1 1
Appendix
147
829 rs6290359 10 107672808 BB BB BB AA AA AA 1 1
830 rs6243755 10 108416966 BB BB BB AA AA AA 1 1
831 rs13480759 10 109059096 X AA AA AA BB BB BB 1 1
832 rs3680872 10 114181187 AA BB AA BB BB BB 1 1
833 rs13480773 10 114518973 AA AA BB BB BB BB 1 1
834 rs13480775 10 115590088 AA BB AA AA AA AA 1 1
835 rs6256918 10 117348939 AA BB AA BB BB BB 1 1
836 mCV24217147 10 117613736 AA BB BB AA AA AA 1 1
837 CEL-10_119602638 10 119602638 AA BB AA AA AA AA 1 1
838 rs13480803 10 122911418 AA BB BB AA AA AA 1 1
839 mCV22832306 10 126086653 BB AA AA BB BB BB 1 1
840 rs3697243 10 126634957 BB AA BB AA AA AA 1 1
841 rs3676330 10 128337313 AA AA AA BB BB BB 1 1
842 rs13480836 11 3448985 AA BB BB BB BB BB 1 1
843 rs13480837 11 3781731 BB BB AA AA AA AA 1 1
844 rs3682937 11 4575120 BB AA BB BB BB BB 1 1
845 rs6190775 11 6306994 AA BB BB AA AA AA 1 1
846 rs13480854 11 7518795 BB BB AA AA AA AA 1 1
847 rs13480863 11 9188410 AA AA AA BB BB BB 1 1
848 rs3023249 11 11065936 BB BB BB AA AA AA 1 1
849 rs13480875 11 12190600 BB AA AA AA AA AA 1 1
850 CEL-11_14992925 11 14992925 AA BB AA AA AA AA 1 1
851 rs6313050 11 15647995 AA BB AA AA AA AA 1 1
852 gnf11.017.294 11 18007841 BB AA BB AA AA AA 1 1
853 rs3723987 11 19364495 BB BB BB AA AA AA 1 1
854 rs3023251 11 20848871 BB BB BB AA AA AA 1 1
855 rs13480910 11 22709634 BB BB AA BB BB BB 1 1
856 rs3723990 11 26517914 BB BB AA AA AA AA 1 1
857 rs3706694 11 28310427 AA AA BB AA AA AA 1 1
858 rs3700830 11 30266839 BB AA BB BB BB BB 1 1
859 rs13459123 11 30954469 AA AA AA AA AA AA 1 1
860 rs3723833 11 32946888 AA AA BB AA AA AA 1 1
861 rs6239937 11 34700816 AA BB AA AA AA AA 1 1
862 rs13480968 11 36134794 AA BB BB AA AA AA 1 1
863 rs6359329 11 38177953 AA AA AA AA AA AA 1 1
864 rs6164170 11 39929979 BB BB BB AA AA AA 1 1
865 rs3701734 11 40967464 BB BB BB AA AA AA 1 1
866 rs3654344 11 43847855 BB BB BB AA AA AA 1 1
867 rs13481009 11 46168151 AA AA AA BB BB BB 1 1
868 rs13481011 11 46568199 AA AA AA BB BB BB 1 1
869 rs13481014 11 47757117 X BB BB BB AA AA AA 1 1
870 rs6199956 11 50385006 AA AA AA AA AA AA 1 1
871 rs13481033 11 54538623 BB AA BB AA AA AA 1 1
872 rs4228731 11 55034293 BB AA BB AA AA AA 1 1
873 rs3684076 11 56050650 AA BB AA BB BB BB 1 1
874 rs3697686 11 58180077 AA AA AA BB BB BB 1 1
875 rs3711357 11 61065104 BB AA AA AA AA AA 1 1
876 rs13481061 11 62605165 AA BB AA BB BB BB 1 1
877 rs13481071 11 64813366 BB BB AA AA AA AA 1 1
878 rs13481076 11 66331400 BB BB AA AA AA AA 1 1
879 rs13481084 11 68383073 AA AA AA BB BB BB 1 1
880 rs6197743 11 69789936 BB BB BB BB BB BB 1 1
881 mCV24113391 11 71092401 BB BB BB BB BB BB 1 1
882 rs13481094 11 72446973 AA BB BB BB BB BB 1 1
883 rs3701609 11 72876179 BB BB BB AA AA AA 1 1
884 rs13481109 11 76207708 AA AA AA BB BB BB 1 1
885 rs13481119 11 79159755 AA BB AA BB BB BB 1 1
886 rs6259742 11 82221268 AA AA AA AA AA AA 1 1
887 rs13481127 11 83014191 BB AA BB AA AA AA 1 1
888 rs3661657 11 84334033 BB AA BB AA AA AA 1 1
889 rs3719581 11 86560546 AA BB AA BB BB BB 1 1
890 rs13481145 11 88037356 AA BB AA BB BB BB 1 1
891 rs3688955 11 90207658 BB AA BB AA AA AA 1 1
892 rs13481161 11 92132381 BB BB BB BB BB BB 1 1
893 rs3714299 11 92734680 BB BB AA AA AA AA 1 1
894 rs13481170 11 95299225 AA BB BB AA AA AA 1 1
895 rs13481173 11 96275988 BB BB BB AA AA AA 1 1
896 rs3661058 11 98590564 BB AA BB AA AA AA 1 1
897 rs3090212 11 99721952 AA BB AA AA AA AA 1 1
898 rs6393948 11 103272243 AA BB AA AA AA AA 1 1
899 rs3698446 11 104908478 AA AA BB AA AA AA 1 1
900 rs6386362 11 106649550 BB BB BB AA AA AA 1 1
901 rs6370458 11 109065922 AA BB AA BB BB BB 1 1
902 rs13481227 11 110120256 AA BB BB BB BB BB 1 1
903 rs3672597 11 111905327 BB AA BB AA AA AA 1 1
904 rs3699056 11 113674817 BB BB BB AA AA AA 1 1
905 rs13481247 11 115572156 BB BB AA AA AA AA 1 1
906 rs3712881 11 120738678 BB AA BB BB BB BB 1 1
907 rs3713137 12 4720216 BB BB AA BB BB BB 1 1
908 rs3653990 12 5131626 BB BB AA BB BB BB 1 1
909 rs13481281 12 5648778 AA BB AA AA AA AA 1 1
910 rs3678128 12 7371530 BB AA AA BB BB BB 1 1
911 rs6292954 12 10028881 BB AA AA AA AA AA 1 1
912 rs13481297 12 10691032 AA NC NC AA AA AA 1 1
913 rs13481303 12 12036755 BB AA BB AA AA AA 1 1
914 rs3655057 12 13507742 AA AA BB BB BB BB 1 1
915 rs13481313 12 14987941 BB AA BB BB BB BB 1 1
916 rs3706330 12 16713381 BB BB AA AA AA AA 1 1
917 rs13481321 12 16811399 AA AA AA BB BB BB 1 1
918 rs13481324 12 17701648 AA BB BB BB BB BB 1 1
919 rs3717860 12 19689285 AA AA AA BB BB BB 1 1
920 rs6328018 12 21090189 AA BB AA AA AA AA 1 1
921 rs13481363 12 22949944 AA BB AA BB BB BB 1 1
922 rs3089800 12 23976362 AA BB BB AA AA AA 1 1
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923 UT_12_24.561109 12 24901541 AA AA AA BB BB BB 1 1
924 rs13481371 12 25180902 BB AA AA BB BB BB 1 1
925 rs6223000 12 29204179 BB AA AA BB BB BB 1 1
926 rs13481392 12 30659819 AA BB BB BB BB BB 1 1
927 rs6311081 12 32032739 AA BB BB AA AA AA 1 1
928 rs3658100 12 33110635 AA BB BB AA AA AA 1 1
929 rs13481406 12 34954150 AA AA AA AA AA AA 1 1
930 rs13481408 12 35475720 BB AA AA AA AA AA 1 1
931 CEL-12_38788391 12 38788391 AA BB BB AA AA AA 1 1
932 rs3726096 12 39432172 BB AA AA BB BB BB 1 1
933 CEL-12_40646532 12 40646532 AA BB BB BB BB BB 1 1
934 gnf12.046.238 12 43135664 BB AA AA BB BB BB 1 1
935 rs13481445 12 45537591 BB BB BB AA AA AA 1 1
936 rs13481454 12 47738222 BB BB BB AA AA AA 1 1
937 rs3670749 12 48181013 AA AA AA BB BB BB 1 1
938 rs3700857 12 49142988 AA AA AA BB BB BB 1 1
939 rs13481466 12 51192106 AA BB BB AA AA AA 1 1
940 rs3706319 12 53150903 AA AA AA BB BB BB 1 1
941 mCV22351241 12 54143643 AA BB BB BB BB BB 1 1
942 gnf12.061.363 12 58421210 BB AA AA BB BB BB 1 1
943 rs3677344 12 59848542 BB BB BB AA AA AA 1 1
944 rs6344105 12 63022076 AA AA AA AA AA AA 1 1
945 rs13481514 12 64869269 AA AA AA BB BB BB 1 1
946 rs13481521 12 66729742 BB BB BB AA AA AA 1 1
947 rs13481527 12 68166409 AA AA AA BB BB BB 1 1
948 rs3655558 12 70010856 BB AA BB AA AA AA 1 1
949 rs13481541 12 71665916 BB AA AA AA AA AA 1 1
950 gnf12.077.067 12 73900965 AA AA BB BB BB BB 1 1
951 rs3662628 12 74558132 AA AA BB BB BB BB 1 1
952 rs13481556 12 75962840 AA AA AA BB BB BB 1 1
953 rs13481561 12 77468587 AA AA BB AA AA AA 1 1
954 rs13481565 12 79092079 BB BB BB AA AA AA 1 1
955 rs3716095 12 82379744 BB AA BB AA AA AA 1 1
956 CEL-12_84750094 12 84750094 BB AA BB AA AA AA 1 1
957 rs3670410 12 85932990 BB AA BB AA AA AA 1 1
958 rs13481588 12 86574038 AA BB AA BB BB BB 1 1
959 rs6207869 12 88966851 AA AA BB AA AA AA 1 1
960 rs13481599 12 90714740 AA AA BB AA AA AA 1 1
961 rs13481604 12 92693591 BB AA BB AA AA AA 1 1
962 rs3716084 12 94501426 BB AA AA AA AA AA 1 1
963 rs13481614 12 95793494 AA AA BB BB BB BB 1 1
964 rs13481618 12 97207111 AA AA BB AA AA AA 1 1
965 rs8273308 12 99106508 BB AA BB BB BB BB 1 1
966 rs13481632 12 101121028 AA BB AA AA AA AA 1 1
967 rs6390948 12 103432150 AA AA BB AA AA AA 1 1
968 CEL-12_104545022 12 104545022 AA AA BB AA AA AA 1 1
969 rs13481655 12 106863515 BB BB AA BB BB BB 1 1
970 CEL-12_108727612 12 108727612 AA AA BB BB BB BB 1 1
971 rs3023711 12 111163171 AA AA AA BB BB BB 1 1
972 rs3692361 12 112704261 BB BB BB AA AA AA 1 1
973 rs6329833 12 114227574 BB AA BB AA AA AA 1 1
974 rs6215262 13 3556871 AA AA BB BB BB BB 1 1
975 rs13481668 13 4242635 AA AA BB BB BB BB 1 1
976 rs13481673 13 5374001 AA AA BB BB BB BB 1 1
977 rs6301008 13 7490090 BB BB BB BB BB BB 1 1
978 rs13481683 13 9267297 AA BB BB BB BB BB 1 1
979 rs13481689 13 10721776 BB AA AA AA AA AA 1 1
980 rs13481697 13 12961456 AA BB BB BB BB BB 1 1
981 rs6348604 13 14769173 AA BB BB BB BB BB 1 1
982 rs13481706 13 15697964 BB AA AA BB BB BB 1 1
983 rs13481715 13 18523821 BB BB AA AA AA AA 1 1
984 rs6314295 13 19481485 AA BB AA AA AA AA 1 1
985 rs3679784 13 20286264 BB AA AA BB BB BB 1 1
986 rs3663223 13 22465317 BB BB BB AA AA AA 1 1
987 rs8267104 13 23085429 BB BB BB BB BB BB 1 1
988 rs6275055 13 25304682 AA AA AA AA AA AA 1 1
989 rs13481734 13 26416832 X BB BB BB AA AA AA 1 1
990 CEL-13_27061395 13 27061395 BB AA AA BB BB BB 1 1
991 rs13481740 13 30057195 BB AA AA BB BB BB 1 1
992 rs3710348 13 30653000 BB BB BB AA AA AA 1 1
993 rs3707097 13 33614779 BB AA AA BB BB BB 1 1
994 rs3725187 13 34496200 BB AA AA BB BB BB 1 1
995 rs13481764 13 35994885 AA BB BB AA AA AA 1 1
996 gnf13.035.637 13 36959616 AA AA AA BB BB BB 1 1
997 gnf13.038.133 13 39478973 AA BB BB BB BB BB 1 1
998 rs13481783 13 42287337 AA BB AA BB BB BB 1 1
999 rs3712907 13 42620079 BB BB BB AA AA AA 1 1
1000 rs3688207 13 44823434 AA BB BB AA AA AA 1 1
1001 rs6411274 13 46624183 AA AA AA BB BB BB 1 1
1002 rs6244558 13 47310947 BB BB BB AA AA AA 1 1
1003 rs13481809 13 50702277 AA BB BB BB BB BB 1 1
1004 rs3693942 13 54042656 AA AA AA BB BB BB 1 1
1005 rs3720782 13 55330594 AA AA AA BB BB BB 1 1
1006 rs3700819 13 56358945 BB BB BB AA AA AA 1 1
1007 gnf13.056.787 13 57848844 AA BB AA AA AA AA 1 1
1008 rs3690198 13 59860578 BB BB AA AA AA AA 1 1
1009 rs4229817 13 63888326 BB AA AA BB BB BB 1 1
1010 rs3718727 13 65760534 AA BB AA BB BB BB 1 1
1011 rs13481871 13 67736821 BB BB BB AA AA AA 1 1
1012 rs13481880 13 70810674 BB BB BB AA AA AA 1 1
1013 rs13481883 13 71955117 BB BB BB AA AA AA 1 1
1014 rs13481893 13 74156236 AA BB AA BB BB BB 1 1
1015 gnf13.079.671 13 77019901 BB AA BB AA AA AA 1 1
1016 rs13481908 13 78683446 AA BB AA BB BB BB 1 1
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1017 mCV24625340 13 81332738 BB AA BB BB BB BB 1 1
1018 rs3686443 13 83174585 AA AA AA BB BB BB 1 1
1019 gnf13.088.732 13 84796434 BB AA AA BB BB BB 1 1
1020 rs3655061 13 86241392 AA AA BB BB BB BB 1 1
1021 rs6288319 13 87807463 AA AA BB AA AA AA 1 1
1022 rs6316213 13 88817196 AA BB BB BB BB BB 1 1
1023 gnf13.093.328 13 89447298 AA AA AA BB BB BB 1 1
1024 rs13481961 13 94000606 AA BB AA BB BB BB 1 1
1025 rs13481968 13 95596507 BB AA AA BB BB BB 1 1
1026 rs4230027 13 97200857 BB AA AA AA AA AA 1 1
1027 rs13481983 13 100181409 BB BB BB AA AA AA 1 1
1028 rs6389588 13 100595006 BB BB BB BB BB BB 1 1
1029 rs13481992 13 102442609 AA AA AA AA AA AA 1 1
1030 rs13481996 13 103563881 AA AA AA BB BB BB 1 1
1031 rs13482005 13 105593959 BB AA AA BB BB BB 1 1
1032 rs13482011 13 107432985 BB AA AA AA AA AA 1 1
1033 rs13482019 13 109707882 BB BB BB AA AA AA 1 1
1034 gnf13.115.241 13 110861665 AA AA AA AA AA AA 1 1
1035 rs6247696 13 112118515 AA AA AA AA AA AA 1 1
1036 rs13482028 13 113209165 BB BB BB AA AA AA 1 1
1037 rs13482035 13 115056838 BB AA BB BB BB BB 1 1
1038 rs4230144 14 3890426 AA AA BB AA AA AA 1 1
1039 rs6322899 14 5945767 BB AA BB AA AA AA 1 1
1040 rs3150398 14 7401248 AA BB AA BB BB BB 1 1
1041 rs13482084 14 8848582 AA BB AA BB BB BB 1 1
1042 rs6290836 14 9149500 BB BB BB AA AA AA 1 1
1043 rs3719629 14 12874743 AA AA AA BB BB BB 1 1
1044 rs3696385 14 14028895 BB AA BB AA AA AA 1 1
1045 rs3687889 14 15973497 BB AA AA AA AA AA 1 1
1046 rs13482096 14 19006267 AA BB AA BB BB BB 1 1
1047 rs3692121 14 20092583 BB AA AA AA AA AA 1 1
1048 rs13482104 14 22364262 BB BB BB AA AA AA 1 1
1049 rs6396829 14 24042337 BB AA AA BB BB BB 1 1
1050 rs4230248 14 27218513 BB AA AA AA AA AA 1 1
1051 rs13482124 14 27701835 BB AA AA AA AA AA 1 1
1052 rs6313230 14 28306368 BB AA AA AA AA AA 1 1
1053 rs3695383 14 29838823 AA BB BB BB BB BB 1 1
1054 rs13482135 14 31429298 BB AA AA AA AA AA 1 1
1055 rs3701775 14 33391532 AA BB BB BB BB BB 1 1
1056 rs13482143 14 35609633 BB BB BB BB BB BB 1 1
1057 rs13482148 14 37242020 BB BB BB BB BB BB 1 1
1058 rs13482159 14 38359897 AA AA AA BB BB BB 1 1
1059 rs13482170 14 41201261 BB BB BB AA AA AA 1 1
1060 mCV24777660 14 42906842 AA AA AA BB BB BB 1 1
1061 rs3666583 14 44880408 AA AA AA BB BB BB 1 1
1062 rs13482191 14 46619173 AA AA AA BB BB BB 1 1
1063 rs13482193 14 47596815 BB BB BB BB BB BB 1 1
1064 rs13482194 14 47801247 AA AA AA AA AA AA 1 1
1065 rs3692863 14 50807707 AA BB BB AA AA AA 1 1
1066 gnf14.055.608 14 52829293 AA BB BB AA AA AA 1 1
1067 rs13482216 14 53885592 BB AA BB BB BB BB 1 1
1068 rs3703075 14 54913181 AA BB AA BB BB BB 1 1
1069 rs13482231 14 58969551 AA BB AA BB BB BB 1 1
1070 rs3672425 14 60335045 AA BB AA AA AA AA 1 1
1071 rs13482239 14 61543475 AA BB BB BB BB BB 1 1
1072 rs13482247 14 63674408 BB BB AA AA AA AA 1 1
1073 rs6156908 14 66473686 BB AA BB AA AA AA 1 1
1074 rs13459144 14 67681669 AA BB BB BB BB BB 1 1
1075 rs13482265 14 70793464 AA AA AA BB BB BB 1 1
1076 rs3023413 14 71540901 AA AA AA AA AA AA 1 1
1077 CEL-14_73162771 14 73162771 BB BB BB BB BB BB 1 1
1078 rs13482272 14 74092548 BB BB BB BB BB BB 1 1
1079 rs6319148 14 75261976 BB AA AA AA AA AA 1 1
1080 rs13482284 14 78061668 BB AA AA BB BB BB 1 1
1081 rs3708535 14 78686463 BB AA AA BB BB BB 1 1
1082 rs13482296 14 80784363 BB AA AA BB BB BB 1 1
1083 rs6395984 14 82944063 BB AA AA BB BB BB 1 1
1084 rs6291434 14 83887230 BB AA AA BB BB BB 1 1
1085 rs13482311 14 85287050 AA BB BB AA AA AA 1 1
1086 rs13482327 14 89372338 BB AA AA BB BB BB 1 1
1087 rs3692362 14 92002849 AA AA AA BB BB BB 1 1
1088 rs6191117 14 92434091 AA BB BB BB BB BB 1 1
1089 CEL-14_94845626 14 94845626 BB BB BB AA AA AA 1 1
1090 rs13482354 14 98188914 BB AA AA AA AA AA 1 1
1091 rs3654132 14 98578208 AA BB BB AA AA AA 1 1
1092 rs13482356 14 99047545 AA AA AA BB BB BB 1 1
1093 gnf14.103.048 14 99774290 AA BB BB BB BB BB 1 1
1094 rs3708779 14 103068000 BB AA AA AA AA AA 1 1
1095 rs13482375 14 103981340 BB AA AA AA AA AA 1 1
1096 rs3726052 14 104244696 AA AA BB BB BB BB 1 1
1097 rs6256423 14 106108556 BB BB BB BB BB BB 1 1
1098 rs6169105 14 109578622 BB BB BB AA AA AA 1 1
1099 rs3665550 14 111354233 BB BB BB AA AA AA 1 1
1100 rs13482398 14 112310948 BB AA AA BB BB BB 1 1
1101 rs13482407 14 114388484 BB BB AA AA AA AA 1 1
1102 CEL-14_116404928 14 116404928 X AA AA AA BB BB BB 1 1
1103 rs13459176 15 3104758 AA BB BB BB BB BB 1 1
1104 rs13482418 15 3498960 BB AA AA AA AA AA 1 1
1105 CEL-15_4222769 15 4222769 AA BB BB BB BB BB 1 1
1106 rs3665826 15 5744460 BB BB AA BB BB BB 1 1
1107 CEL-15_8331158 15 8331158 BB AA BB AA AA AA 1 1
1108 CEL-15_9687257 15 9687257 BB AA AA AA AA AA 1 1
1109 rs13482431 15 11218285 BB AA AA AA AA AA 1 1
1110 rs3711814 15 13122871 BB BB BB AA AA AA 1 1
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1111 CEL-15_14786403 15 14786403 BB AA AA AA AA AA 1 1
1112 CEL-15_15482356 15 15482356 AA BB BB BB BB BB 1 1
1113 rs13482455 15 16643375 AA BB BB BB BB BB 1 1
1114 rs3715857 15 19261351 BB AA AA BB BB BB 1 1
1115 rs13482469 15 20978602 BB BB BB AA AA AA 1 1
1116 rs13482477 15 22545113 AA AA BB BB BB BB 1 1
1117 rs13482482 15 24640823 BB AA AA AA AA AA 1 1
1118 rs13482485 15 25491892 AA BB AA BB BB BB 1 1
1119 rs13482497 15 28363926 AA AA BB AA AA AA 1 1
1120 rs13482501 15 29311563 BB BB AA BB BB BB 1 1
1121 rs13482504 15 30361234 BB AA AA AA AA AA 1 1
1122 rs13482509 15 32096277 BB BB BB AA AA AA 1 1
1123 rs6188239 15 34383985 BB BB AA AA AA AA 1 1
1124 CEL-15_36490596 15 36490596 BB BB BB BB BB BB 1 1
1125 rs3695416 15 38562542 BB AA BB AA AA AA 1 1
1126 rs13482529 15 39096937 BB BB BB BB BB BB 1 1
1127 rs3683326 15 41359817 BB BB AA BB BB BB 1 1
1128 CEL-15_43206205 15 43206205 BB AA BB AA AA AA 1 1
1129 rs13482543 15 43892080 AA BB AA BB BB BB 1 1
1130 rs13482549 15 45665306 AA AA BB AA AA AA 1 1
1131 rs13482558 15 47188758 BB BB AA AA AA AA 1 1
1132 rs13482571 15 50021404 AA AA AA BB BB BB 1 1
1133 rs3658705 15 51403508 BB BB BB AA AA AA 1 1
1134 rs3707900 15 52526197 AA AA BB AA AA AA 1 1
1135 rs13482585 15 54079758 BB BB BB BB BB BB 1 1
1136 rs6400804 15 56998500 AA AA AA AA AA AA 1 1
1137 rs13482595 15 58814425 AA BB AA BB BB BB 1 1
1138 rs3683495 15 61406689 AA AA AA BB BB BB 1 1
1139 rs13482602 15 61631955 AA BB AA BB BB BB 1 1
1140 rs3677062 15 63677792 BB AA AA BB BB BB 1 1
1141 rs6381737 15 65856370 AA BB BB AA AA AA 1 1
1142 rs13482628 15 68143270 BB AA AA AA AA AA 1 1
1143 rs13482629 15 68448503 AA BB BB AA AA AA 1 1
1144 rs13482637 15 70770335 AA BB BB AA AA AA 1 1
1145 rs13482642 15 72483350 BB AA AA BB BB BB 1 1
1146 rs8259436 15 75141907 AA AA AA BB BB BB 1 1
1147 rs3660192 15 78151819 AA BB BB BB BB BB 1 1
1148 rs13482661 15 79085767 AA AA AA BB BB BB 1 1
1149 rs3665030 15 79719777 AA BB BB AA AA AA 1 1
1150 rs6276391 15 82164497 AA BB BB AA AA AA 1 1
1151 rs13482673 15 82560799 AA AA AA BB BB BB 1 1
1152 rs3660367 15 85057715 AA BB BB AA AA AA 1 1
1153 rs13482687 15 86303733 AA AA BB BB BB BB 1 1
1154 rs13482695 15 88856958 BB BB BB AA AA AA 1 1
1155 rs13482704 15 90816455 BB AA BB AA AA AA 1 1
1156 rs13482712 15 92664963 AA AA AA AA AA AA 1 1
1157 rs3719217 15 95679367 AA AA BB AA AA AA 1 1
1158 rs6285067 15 95741617 BB AA BB AA AA AA 1 1
1159 rs13482729 15 97550224 BB AA BB AA AA AA 1 1
1160 rs13482738 15 100255519 BB BB BB AA AA AA 1 1
1161 rs13482744 15 102030597 AA AA AA BB BB BB 1 1
1162 rs13482751 15 103433393 BB BB BB BB BB BB 1 1
1163 rs4152638 16 4009670 BB BB BB BB BB BB 1 1
1164 rs4152790 16 4532147 BB BB BB BB BB BB 1 1
1165 rs4231060 16 5907681 BB BB BB AA AA AA 1 1
1166 rs4158907 16 7650712 AA AA AA BB BB BB 1 1
1167 rs4160288 16 9258154 AA BB BB BB BB BB 1 1
1168 rs4162800 16 12215630 AA BB AA BB BB BB 1 1
1169 rs4163196 16 13143895 AA AA BB AA AA AA 1 1
1170 rs4165065 16 17188907 X BB BB BB AA AA AA 1 1
1171 rs4165081 16 19654956 BB AA BB AA AA AA 1 1
1172 rs4165279 16 21155526 BB AA BB AA AA AA 1 1
1173 rs4165440 16 24022362 BB BB AA BB BB BB 1 1
1174 rs4165467 16 25257147 BB BB BB BB BB BB 1 1
1175 rs4165602 16 27277369 BB BB AA BB BB BB 1 1
1176 rs4167031 16 28698520 AA AA BB BB BB BB 1 1
1177 rs4168640 16 30855920 AA AA BB BB BB BB 1 1
1178 rs4170308 16 32338346 AA BB BB AA AA AA 1 1
1179 rs4171932 16 34183107 BB AA BB AA AA AA 1 1
1180 rs4172915 16 35504262 AA AA BB AA AA AA 1 1
1181 rs4173902 16 37207323 BB AA AA BB BB BB 1 1
1182 rs4175608 16 39046740 BB AA AA BB BB BB 1 1
1183 rs4177651 16 40548715 AA BB AA BB BB BB 1 1
1184 rs4179075 16 42205435 BB AA BB BB BB BB 1 1
1185 rs4182243 16 46008686 AA BB AA BB BB BB 1 1
1186 rs4183448 16 47148630 BB AA BB AA AA AA 1 1
1187 rs4185639 16 50209266 BB AA AA AA AA AA 1 1
1188 rs4186744 16 51371684 AA BB BB AA AA AA 1 1
1189 rs3696661 16 51606253 AA AA BB AA AA AA 1 1
1190 rs6163640 16 53434895 BB BB AA BB BB BB 1 1
1191 CZECH-16_55104521 16 55104521 AA AA AA AA AA AA 1 1
1192 rs4189277 16 57472587 BB AA BB AA AA AA 1 1
1193 rs4191367 16 59391239 AA AA BB BB BB BB 1 1
1194 rs4193069 16 61234639 BB AA BB BB BB BB 1 1
1195 rs4194417 16 63055086 BB BB BB AA AA AA 1 1
1196 rs4197150 16 66573423 BB BB BB AA AA AA 1 1
1197 rs4197715 16 67541594 AA BB BB AA AA AA 1 1
1198 rs4198737 16 69301525 AA BB BB AA AA AA 1 1
1199 rs4200124 16 71033149 AA AA AA BB BB BB 1 1
1200 rs4201998 16 72860280 BB BB BB AA AA AA 1 1
1201 rs4204106 16 74547672 BB BB BB BB BB BB 1 1
1202 rs3718160 16 77227010 AA BB BB BB BB BB 1 1
1203 rs6317052 16 79873189 AA AA AA AA AA AA 1 1
1204 rs4211364 16 81210555 BB AA AA AA AA AA 1 1
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1205 rs4211664 16 83161949 AA AA AA BB BB BB 1 1
1206 rs3680665 16 84938923 AA AA AA BB BB BB 1 1
1207 rs4212102 16 85479261 AA BB BB AA AA AA 1 1
1208 rs4213268 16 86836511 AA BB BB AA AA AA 1 1
1209 rs4214396 16 87920304 AA AA BB AA AA AA 1 1
1210 petM-01322-2 16 88587815 AA AA BB BB BB BB 1 1
1211 rs4219905 16 93471889 BB BB BB AA AA AA 1 1
1212 rs3712360 16 94018736 AA AA AA BB BB BB 1 1
1213 rs3696981 16 98191753 BB BB BB AA AA AA 1 1
1214 rs4136382 17 3388654 AA AA AA BB BB BB 1 1
1215 rs13482843 17 4044700 AA AA AA BB BB BB 1 1
1216 rs13482845 17 4592511 AA BB BB AA AA AA 1 1
1217 UT_17_3.221024 17 5989632 BB AA AA BB BB BB 1 1
1218 rs6196216 17 8381669 BB AA AA AA AA AA 1 1
1219 rs3662575 17 9388595 AA BB BB AA AA AA 1 1
1220 rs3662820 17 11723443 BB BB AA BB BB BB 1 1
1221 rs3672065 17 13064499 AA AA BB BB BB BB 1 1
1222 rs3726555 17 15215815 BB BB BB AA AA AA 1 1
1223 rs13482899 17 16276466 AA AA AA BB BB BB 1 1
1224 rs13482914 17 19510335 AA AA AA BB BB BB 1 1
1225 rs3696835 17 21394398 BB BB BB AA AA AA 1 1
1226 rs3719497 17 24100880 AA AA AA BB BB BB 1 1
1227 rs6397584 17 26039914 AA AA AA BB BB BB 1 1
1228 rs3693494 17 28381655 AA AA AA BB BB BB 1 1
1229 rs3672987 17 31726297 AA AA AA BB BB BB 1 1
1230 rs3682923 17 34343989 AA BB AA BB BB BB 1 1
1231 rs6298471 17 35059374 AA AA BB AA AA AA 1 1
1232 rs6390174 17 37542832 AA BB BB AA AA AA 1 1
1233 rs3702604 17 39103029 BB AA BB AA AA AA 1 1
1234 CEL-17_39772541 17 39772541 AA AA BB BB BB BB 1 1
1235 rs13482997 17 41975280 BB AA AA BB BB BB 1 1
1236 rs13483002 17 43897393 BB BB BB BB BB BB 1 1
1237 rs6409750 17 45506664 AA AA BB BB BB BB 1 1
1238 rs13483016 17 47737011 AA BB BB AA AA AA 1 1
1239 rs3700227 17 50793087 BB BB BB AA AA AA 1 1
1240 rs6272475 17 51663908 AA AA AA BB BB BB 1 1
1241 rs3714226 17 53552802 BB BB BB AA AA AA 1 1
1242 rs3715723 17 56999568 AA BB BB BB BB BB 1 1
1243 rs13483055 17 58655424 X BB BB BB AA AA AA 1 1
1244 gnf17.064.100 17 61107080 AA BB AA BB BB BB 1 1
1245 rs6402097 17 62066360 AA AA AA AA AA AA 1 1
1246 rs3727008 17 66156395 AA AA AA BB BB BB 1 1
1247 rs13483085 17 66984514 BB AA BB BB BB BB 1 1
1248 rs3660112 17 69021924 AA AA AA BB BB BB 1 1
1249 rs3675634 17 69670995 AA AA AA BB BB BB 1 1
1250 rs3691628 17 70833240 AA AA AA BB BB BB 1 1
1251 rs13483103 17 72668814 BB AA AA BB BB BB 1 1
1252 rs6229946 17 73658199 AA BB AA BB BB BB 1 1
1253 rs3663088 17 75526825 BB BB BB AA AA AA 1 1
1254 rs13483117 17 77391928 BB BB AA AA AA AA 1 1
1255 gnf17.082.284 17 79515223 AA BB AA BB BB BB 1 1
1256 gnf17.083.842 17 81077502 AA BB AA BB BB BB 1 1
1257 rs13483135 17 82051202 AA BB AA BB BB BB 1 1
1258 rs13483144 17 84456436 BB AA AA BB BB BB 1 1
1259 rs4231720 17 85385338 BB BB BB AA AA AA 1 1
1260 rs13483157 17 87503632 AA BB BB AA AA AA 1 1
1261 rs6288047 17 90215134 BB BB BB AA AA AA 1 1
1262 rs6397044 17 91938734 BB AA BB AA AA AA 1 1
1263 rs3706382 17 92912930 AA AA BB AA AA AA 1 1
1264 rs13483183 18 3687056 AA AA AA AA AA AA 1 1
1265 rs13483184 18 3967037 BB BB BB BB BB BB 1 1
1266 gnf18.001.688 18 4813500 BB BB BB BB BB BB 1 1
1267 CEL-18_5565618 18 5565618 BB BB BB BB BB BB 1 1
1268 rs3689558 18 8254573 BB AA AA BB BB BB 1 1
1269 rs3660245 18 9491813 BB BB BB AA AA AA 1 1
1270 rs4231742 18 11306822 AA BB BB AA AA AA 1 1
1271 rs13483212 18 12477417 AA AA AA BB BB BB 1 1
1272 mCV23617245 18 14895705 BB BB BB AA AA AA 1 1
1273 rs6361186 18 15373312 BB BB BB AA AA AA 1 1
1274 rs6358426 18 16784949 BB AA AA AA AA AA 1 1
1275 rs13483244 18 21226461 BB AA AA AA AA AA 1 1
1276 rs4138020 18 23001325 AA AA BB BB BB BB 1 1
1277 gnf18.021.931 18 24860622 BB BB AA BB BB BB 1 1
1278 gnf18.022.796 18 25729264 AA AA BB AA AA AA 1 1
1279 rs13483263 18 26881733 AA BB AA BB BB BB 1 1
1280 rs13483271 18 29410281 AA BB BB AA AA AA 1 1
1281 rs3722973 18 31395543 AA AA AA BB BB BB 1 1
1282 rs3718586 18 33572164 BB AA AA BB BB BB 1 1
1283 rs3725637 18 34867922 BB BB BB AA AA AA 1 1
1284 rs13483299 18 36563136 BB AA AA BB BB BB 1 1
1285 rs3664831 18 37737388 BB BB BB AA AA AA 1 1
1286 rs3699816 18 39756682 BB BB BB AA AA AA 1 1
1287 rs13483319 18 41351739 BB BB AA AA AA AA 1 1
1288 rs3676196 18 43364740 AA AA AA BB BB BB 1 1
1289 rs4231834 18 44463060 AA BB BB BB BB BB 1 1
1290 CEL-18_46082735 18 46082735 AA BB BB BB BB BB 1 1
1291 rs6184541 18 47884501 AA BB BB AA AA AA 1 1
1292 mCV24106092 18 49464960 BB BB BB AA AA AA 1 1
1293 rs3674314 18 51674308 AA BB BB BB BB BB 1 1
1294 gnf18.051.412 18 53592447 BB BB BB BB BB BB 1 1
1295 rs13483368 18 54949689 BB BB BB AA AA AA 1 1
1296 rs3683378 18 56183873 AA BB BB AA AA AA 1 1
1297 rs6328845 18 58310005 AA AA AA BB BB BB 1 1
1298 CEL-18_60214752 18 60214752 AA AA BB BB BB BB 1 1
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1299 rs8237402 18 62695790 AA AA BB BB BB BB 1 1
1300 rs3720827 18 63808511 AA AA AA BB BB BB 1 1
1301 rs3688789 18 65035105 BB AA AA AA AA AA 1 1
1302 rs3691542 18 67000836 BB AA BB AA AA AA 1 1
1303 rs3658163 18 69187029 BB AA AA BB BB BB 1 1
1304 rs13483426 18 70651591 AA AA AA BB BB BB 1 1
1305 rs6161154 18 71978261 AA AA BB AA AA AA 1 1
1306 rs13483436 18 73957870 BB AA AA BB BB BB 1 1
1307 rs13459193 18 75265583 BB AA BB AA AA AA 1 1
1308 rs13483446 18 77080840 AA AA BB AA AA AA 1 1
1309 rs3706601 18 77890660 BB BB BB AA AA AA 1 1
1310 rs3720876 18 80361633 BB BB AA AA AA AA 1 1
1311 rs13483462 18 81619936 AA AA BB BB BB BB 1 1
1312 rs13483466 18 82712912 BB AA AA BB BB BB 1 1
1313 mCV24836796 18 86034550 AA BB BB AA AA AA 1 1
1314 rs13483482 18 86617418 BB AA AA BB BB BB 1 1
1315 rs4137441 18 89120861 BB AA AA AA AA AA 1 1
1316 rs3671671 19 4208173 BB AA AA BB BB BB 1 1
1317 rs3713033 19 4818261 BB AA AA BB BB BB 1 1
1318 CEL-19_5283144 19 5283144 AA BB BB AA AA AA 1 1
1319 rs6236348 19 6000186 AA BB BB AA AA AA 1 1
1320 rs13483525 19 9543124 BB AA AA BB BB BB 1 1
1321 UT_19_10.709331 19 9813271 AA AA BB AA AA AA 1 1
1322 rs6316813 19 10572580 BB AA BB BB BB BB 1 1
1323 CEL-19_12595293 19 12595293 AA AA BB AA AA AA 1 1
1324 rs13483540 19 14743248 BB AA AA BB BB BB 1 1
1325 rs3686467 19 16159229 BB AA AA AA AA AA 1 1
1326 rs6223359 19 17804343 AA AA AA BB BB BB 1 1
1327 gnf19.017.711 19 19283950 AA BB AA AA AA AA 1 1
1328 rs6372656 19 21112530 BB AA BB AA AA AA 1 1
1329 rs6309315 19 22859563 AA AA AA BB BB BB 1 1
1330 rs3720897 19 24396755 AA BB AA AA AA AA 1 1
1331 rs6293693 19 25362165 BB BB AA BB BB BB 1 1
1332 rs3090325 19 26007713 BB AA AA AA AA AA 1 1
1333 UT_19_29.979736 19 29540192 AA BB AA BB BB BB 1 1
1334 rs13459194 19 31358105 BB AA AA BB BB BB 1 1
1335 rs6237466 19 31672951 AA AA AA BB BB BB 1 1
1336 CEL-19_34542259 19 34542259 BB AA BB BB BB BB 1 1
1337 gnf19.035.019 19 36467112 AA AA BB BB BB BB 1 1
1338 rs3710829 19 37393165 AA AA AA BB BB BB 1 1
1339 rs3655407 19 39594395 BB BB AA AA AA AA 1 1
1340 rs3656289 19 41749395 AA AA AA BB BB BB 1 1
1341 rs3687275 19 42406846 AA AA BB BB BB BB 1 1
1342 rs13483643 19 44651448 AA AA BB BB BB BB 1 1
1343 mCV23390953 19 45356002 AA BB AA AA AA AA 1 1
1344 rs3023496 19 47482330 AA AA AA BB BB BB 1 1
1345 rs6194426 19 49475053 AA BB BB BB BB BB 1 1
1346 mCV23069572 19 52162185 AA AA AA BB BB BB 1 1
1347 rs6304326 19 52797648 BB BB BB AA AA AA 1 1
1348 rs13483682 19 54535312 BB BB BB AA AA AA 1 1
1349 rs6211533 19 56380821 AA AA BB AA AA AA 1 1
1350 rs6191324 19 58720409 AA AA BB AA AA AA 1 1
1351 UT_4_59.889271 19 59475231 BB BB BB AA AA AA 1 1
1352 rs6413270 18_random 804035 BB BB BB BB BB BB 1 1
1353 rs3714915 7_random 12206182 BB BB BB AA AA AA 1 1
1354 rs6384973 7_random 12916620 BB BB BB AA AA AA 1 1
1355 rs3659551 7_random 25331885 AA AA BB BB BB BB 1 1
1356 rs3658362 7_random 37176366 BB BB BB AA AA AA 1 1
1357 rs3700068 7_random 38982522 BB BB BB AA AA AA 1 1
1358 mCV24845756 Un_random 24466918 BB BB BB AA AA AA 1 1
1359 rs4217260 Un_random 82875108 BB BB BB BB BB BB 1 1
1360 rs13483712 X 7885141 BB AA BB AA AA AA 1 1
1361 CEL-X_8334947 X 8334947 BB AA BB AA AA AA 1 1
1362 CEL-X_9031623 X 9031623 BB BB AA BB BB BB 1 1
1363 rs13483724 X 28552142 AA AA AA BB BB BB 1 1
1364 gnfX.023.543 X 31247994 BB BB BB AA AA AA 1 1
1365 gnfX.026.801 X 34572975 BB BB BB AA AA AA 1 1
1366 rs13483731 X 34801132 AA BB BB AA AA AA 1 1
1367 CEL-X_39961894 X 39961894 AA AA BB BB BB BB 1 1
1368 rs13483738 X 40510546 BB BB AA AA AA AA 1 1
1369 rs13483746 X 42770100 BB BB BB AA AA AA 1 1
1370 gnfX.035.350 X 43278349 BB BB BB AA AA AA 1 1
1371 rs13483750 X 43720683 AA AA AA BB BB BB 1 1
1372 CEL-X_44311522 X 44311522 BB AA AA BB BB BB 1 1
1373 rs13483756 X 45475262 BB AA AA BB BB BB 1 1
1374 rs13483761 X 47895370 AA BB BB AA AA AA 1 1
1375 rs13483765 X 49186978 AA BB BB BB BB BB 1 1
1376 gnfX.044.260 X 52389338 AA AA AA BB BB BB 1 1
1377 rs13483777 X 52741694 BB AA AA BB BB BB 1 1
1378 rs13483781 X 53942181 AA BB BB AA AA AA 1 1
1379 rs13483783 X 55210782 AA BB BB AA AA AA 1 1
1380 rs13483786 X 56181989 AA BB BB AA AA AA 1 1
1381 CEL-X_59515625 X 59515625 AA BB BB AA AA AA 1 1
1382 CEL-X_60181392 X 60181392 AA AA AA BB BB BB 1 1
1383 petM-05810-1 X 61228987 BB AA AA AA AA AA 1 1
1384 rs3157124 X 63007260 BB BB BB AA AA AA 1 1
1385 rs13483825 X 65765926 BB AA AA BB BB BB 1 1
1386 CEL-X_66015326 X 66015326 NC BB BB AA AA AA 1 1
1387 rs13483831 X 67285372 BB AA AA AA AA AA 1 1
1388 CEL-X_68179178 X 68179178 AA BB BB AA AA AA 1 1
1389 CEL-X_72627341 X 72627341 BB AA AA BB BB BB 1 1
1390 CEL-X_72875547 X 72875547 AA BB BB AA AA AA 1 1
1391 rs13483858 X 73756646 AA BB BB AA AA AA 1 1
1392 rs13483862 X 74580193 BB AA AA BB BB BB 1 1
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1393 CEL-X_75125049 X 75125049 BB AA AA BB BB BB 1 1
1394 rs13483868 X 76146750 BB AA AA BB BB BB 1 1
1395 rs3725966 X 77048128 BB BB BB AA AA AA 1 1
1396 CEL-X_77780392 X 77780392 BB BB BB AA AA AA 1 1
1397 rs13483877 X 78499387 BB BB BB AA AA AA 1 1
1398 rs13483805 X 81745577 AA AA AA AA AA AA 1 1
1399 gnfX.076.619 X 84227028 BB AA AA AA AA AA 1 1
1400 rs13483884 X 85456399 AA BB BB AA AA AA 1 1
1401 rs13459181 X 86087663 BB AA AA BB BB BB 1 1
1402 gnfX.080.189 X 87586756 BB AA AA BB BB BB 1 1
1403 rs13483894 X 87902633 AA BB BB AA AA AA 1 1
1404 rs6182892 X 88379974 BB AA AA BB BB BB 1 1
1405 CEL-X_89752158 X 89752158 BB AA AA BB BB BB 1 1
1406 CEL-X_91222960 X 91222960 BB AA AA BB BB BB 1 1
1407 gnfX.084.751 X 92235622 BB AA AA BB BB BB 1 1
1408 gnfX.086.039 X 93530235 AA AA AA AA AA AA 1 1
1409 rs13483921 X 95063466 AA AA AA BB BB BB 1 1
1410 rs13483926 X 97492766 BB BB BB AA AA AA 1 1
1411 rs13483929 X 98226460 AA BB BB BB BB BB 1 1
1412 CEL-X_100299803 X 100299803 BB AA AA BB BB BB 1 1
1413 rs13483937 X 102010268 BB AA AA BB BB BB 1 1
1414 rs13483941 X 102845364 BB AA AA BB BB BB 1 1
1415 rs6342003 X 103875234 BB AA AA BB BB BB 1 1
1416 CEL-X_106858553 X 106858553 AA BB BB BB BB BB 1 1
1417 rs6363550 X 109582439 AA BB BB AA AA AA 1 1
1418 rs13483971 X 111135758 AA BB BB AA AA AA 1 1
1419 CEL-X_112457192 X 112457192 AA BB BB AA AA AA 1 1
1420 CEL-X_112904656 X 112904656 AA BB BB AA AA AA 1 1
1421 CZECH-X_116527625 X 116527625 BB AA AA BB BB BB 1 1
1422 CEL-X_117683749 X 117683749 BB AA AA BB BB BB 1 1
1423 rs6205221 X 120300412 BB BB BB AA AA AA 1 1
1424 rs6221690 X 121042456 BB AA AA AA AA AA 1 1
1425 rs13483997 X 122120659 AA AA AA BB BB BB 1 1
1426 rs13484004 X 123782683 BB BB BB AA AA AA 1 1
1427 rs3702256 X 124956381 BB BB BB AA AA AA 1 1
1428 CEL-X_125736335 X 125736335 AA AA AA BB BB BB 1 1
1429 rs3697198 X 126223821 AA BB AA BB BB BB 1 1
1430 rs13484024 X 128014181 BB BB AA BB BB BB 1 1
1431 rs13484031 X 129847872 BB BB AA AA AA AA 1 1
1432 rs13484034 X 130685594 AA AA BB BB BB BB 1 1
1433 rs13484042 X 132280571 BB BB AA AA AA AA 1 1
1434 rs13484043 X 132699243 BB BB AA AA AA AA 1 1
1435 CEL-X_133525088 X 133525088 BB AA BB BB BB BB 1 1
1436 rs13484050 X 134426687 BB AA BB BB BB BB 1 1
1437 rs13484060 X 136857358 BB AA BB AA AA AA 1 1
1438 rs13484070 X 140595720 AA BB AA AA AA AA 1 1
1439 CEL-X_142652525 X 142652525 AA AA BB BB BB BB 1 1
1440 CEL-X_143595976 X 143595976 BB AA BB AA AA AA 1 1
1441 rs13484087 X 145863727 BB AA BB BB BB BB 1 1
1442 rs13484094 X 147274623 AA BB AA AA AA AA 1 1
1443 rs6365259 X 150148872 AA BB AA AA AA AA 1 1
1444 gnfX.141.820 X 151555476 AA AA BB AA AA AA 1 1
1445 CEL-X_154048891 X 154048891 BB BB BB AA AA AA 1 1
1446 CEL-X_155542834 X 155542834 BB BB BB AA AA AA 1 1
1447 gnfX.146.867 X 156799296 BB BB BB AA AA AA 1 1
1448 gnfX.148.995 X 158940488 AA BB BB BB BB BB 1 1
1449 rs13483844 X_random 10762134 AA BB BB AA AA AA 1 1
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